<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">70207</article-id><article-id pub-id-type="doi">10.7554/eLife.70207</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Widespread discrepancy in <italic>Nnt</italic> genotypes and genetic backgrounds complicates granzyme A and other knockout mouse studies</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-238381"><name><surname>Rawle</surname><given-names>Daniel J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-238382"><name><surname>Le</surname><given-names>Thuy T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-237881"><name><surname>Dumenil</surname><given-names>Troy</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3032-8360</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-238398"><name><surname>Bishop</surname><given-names>Cameron</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5710-9942</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-238399"><name><surname>Yan</surname><given-names>Kexin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-238400"><name><surname>Nakayama</surname><given-names>Eri</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23379"><name><surname>Bird</surname><given-names>Phillip I</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-238401"><name><surname>Suhrbier</surname><given-names>Andreas</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8986-9025</contrib-id><email>Andreas.Suhrbier@qimrberghofer.edu.au</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>QIMR Berghofer Medical Research Institute</institution><addr-line><named-content content-type="city">Brisbane</named-content></addr-line><country>Australia</country></aff><aff id="aff2"><label>2</label><institution>Department of Virology I, National Institute of Infectious Diseases</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution>Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University</institution><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff4"><label>4</label><institution>Australian Infectious Disease Research Centre, GVN Center of Excellence</institution><addr-line><named-content content-type="city">Brisbane</named-content></addr-line><country>Australia</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Takayanagi</surname><given-names>Hiroshi</given-names></name><role>Reviewing Editor</role><aff><institution>The University of Tokyo</institution><country>Japan</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Isales</surname><given-names>Carlos</given-names></name><role>Senior Editor</role><aff><institution>Medical College of Georgia at Augusta University</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>04</day><month>02</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e70207</elocation-id><history><date date-type="received" iso-8601-date="2021-05-10"><day>10</day><month>05</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-01-10"><day>10</day><month>01</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-03-17"><day>17</day><month>03</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.03.16.435730"/></event></pub-history><permissions><copyright-statement>© 2022, Rawle et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Rawle et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-70207-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-70207-figures-v1.pdf"/><abstract><p>Granzyme A (GZMA) is a serine protease secreted by cytotoxic lymphocytes, with <italic>Gzma</italic><sup>-/-</sup> mouse studies having informed our understanding of GZMA’s physiological function. We show herein that <italic>Gzma</italic><sup>-/-</sup> mice have a mixed C57BL/6J and C57BL/6N genetic background and retain the full-length nicotinamide nucleotide transhydrogenase (<italic>Nnt</italic>) gene, whereas <italic>Nnt</italic> is truncated in C57BL/6J mice. Chikungunya viral arthritis was substantially ameliorated in <italic>Gzma</italic><sup>-/-</sup> mice; however, the presence of <italic>Nnt</italic> and the C57BL/6N background, rather than loss of GZMA expression, was responsible for this phenotype. A new CRISPR active site mutant C57BL/6J <italic>Gzma</italic><sup>S211A</sup> mouse provided the first insights into GZMA’s bioactivity free of background issues, with circulating proteolytically active GZMA promoting immune-stimulating and pro-inflammatory signatures. Remarkably, k-mer mining of the Sequence Read Archive illustrated that ≈27% of Run Accessions and ≈38% of BioProjects listing C57BL/6J as the mouse strain had <italic>Nnt</italic> sequencing reads inconsistent with a C57BL/6J genetic background. <italic>Nnt</italic> and C57BL/6N background issues have clearly complicated our understanding of GZMA and may similarly have influenced studies across a broad range of fields.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>granzyme A</kwd><kwd>nicotinamide nucleotide transhydrogenase</kwd><kwd>chikungunya</kwd><kwd>inflammation</kwd><kwd>C57BL/6J</kwd><kwd>C57BL/6N</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>APP1141421</award-id><principal-award-recipient><name><surname>Suhrbier</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>APP1173880</award-id><principal-award-recipient><name><surname>Suhrbier</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Granzyme A<sup>-/-</sup> mice, which have contributed to a body of research into this enzyme, emerge to have a mixed C57BL/6J-C57BL/6N genetic background, compromising our understanding of granzyme A and highlighting a widespread problem for knockout mouse studies generally.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Granzyme A (GZMA) is a granule trypsin-like serine protease (trypase) secreted by cytotoxic lymphocytes such as NK cells (<xref ref-type="bibr" rid="bib17">Fehniger et al., 2007</xref>; <xref ref-type="bibr" rid="bib149">Wu et al., 2019</xref>), NKT cells (<xref ref-type="bibr" rid="bib28">Gordy et al., 2011</xref>), and CD8+ cytotoxic T lymphocytes (<xref ref-type="bibr" rid="bib121">Suhrbier et al., 1991</xref>). The traditional view has been that GZMA is a cytotoxic mediator that is secreted into the immunological synapse, entering the target cell via perforin pores, whereupon certain cytoplasmic proteins are cleaved, resulting in the initiation of cell death pathway(s) (<xref ref-type="bibr" rid="bib47">Liesche et al., 2018</xref>; <xref ref-type="bibr" rid="bib54">Martinvalet et al., 2008</xref>; <xref ref-type="bibr" rid="bib149">Wu et al., 2019</xref>; <xref ref-type="bibr" rid="bib154">Zhou et al., 2020</xref>). A key tool in the quest to understand the physiological role of GZMA has been the use of <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="bibr" rid="bib15">Ebnet et al., 1995</xref>). For instance, control of viral infections can be compromised in <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="bibr" rid="bib49">Loh et al., 2004</xref>; <xref ref-type="bibr" rid="bib68">Müllbacher et al., 1996</xref>; <xref ref-type="bibr" rid="bib79">Pereira et al., 2000</xref>; <xref ref-type="bibr" rid="bib90">Riera et al., 2000</xref>), with cytotoxic lymphocytes from these mice reported to be less able to kill target cells (<xref ref-type="bibr" rid="bib76">Pardo et al., 2002</xref>; <xref ref-type="bibr" rid="bib77">Pardo et al., 2004</xref>; <xref ref-type="bibr" rid="bib107">Shresta et al., 1999</xref>; <xref ref-type="bibr" rid="bib127">Susanto et al., 2013</xref>). Like granzyme B (GzmB), GZMA has thus been classified as a cytotoxic granzyme (<xref ref-type="bibr" rid="bib27">Golstein and Griffiths, 2018</xref>; <xref ref-type="bibr" rid="bib67">Mpande et al., 2018</xref>; <xref ref-type="bibr" rid="bib70">Muraro et al., 2017</xref>; <xref ref-type="bibr" rid="bib154">Zhou et al., 2020</xref>), although in several studies a role for GZMA in mediating cellular cytotoxicity was not observed (<xref ref-type="bibr" rid="bib15">Ebnet et al., 1995</xref>; <xref ref-type="bibr" rid="bib36">Joeckel and Bird, 2014</xref>; <xref ref-type="bibr" rid="bib88">Regner et al., 2009</xref>; <xref ref-type="bibr" rid="bib89">Regner et al., 2011</xref>; <xref ref-type="bibr" rid="bib111">Smyth et al., 2003</xref>). In a range of settings, GZMA has also been associated with the promotion of inflammation, providing an additional or alternative view of its physiological role, although consensus on mechanisms has remained elusive (<xref ref-type="bibr" rid="bib60">Metkar et al., 2008</xref>; <xref ref-type="bibr" rid="bib78">Park et al., 2020</xref>; <xref ref-type="bibr" rid="bib98">Santiago et al., 2020</xref>; <xref ref-type="bibr" rid="bib97">Santiago et al., 2017</xref>; <xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>; <xref ref-type="bibr" rid="bib105">Shimizu et al., 2019</xref>; <xref ref-type="bibr" rid="bib137">van Daalen et al., 2020</xref>; <xref ref-type="bibr" rid="bib145">Wensink et al., 2015</xref>; <xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>), with a number of potential intracellular and extracellular targets for GZMA reported. These include pro-IL-1β (<xref ref-type="bibr" rid="bib31">Hildebrand et al., 2014</xref>), SET complex proteins (<xref ref-type="bibr" rid="bib52">Mandrup-Poulsen, 2017</xref>; <xref ref-type="bibr" rid="bib64">Mollah et al., 2017</xref>), gasdermin B (<xref ref-type="bibr" rid="bib154">Zhou et al., 2020</xref>), mitochondrial complex I protein NDUFS3 (<xref ref-type="bibr" rid="bib54">Martinvalet et al., 2008</xref>), protease activated receptors (<xref ref-type="bibr" rid="bib29">Hansen et al., 2005</xref>; <xref ref-type="bibr" rid="bib113">Sower et al., 1996</xref>; <xref ref-type="bibr" rid="bib124">Suidan et al., 1994</xref>; <xref ref-type="bibr" rid="bib125">Suidan et al., 1996</xref>), TLR2/4 (<xref ref-type="bibr" rid="bib139">van Eck et al., 2017</xref>), and TLR9 (<xref ref-type="bibr" rid="bib105">Shimizu et al., 2019</xref>). <italic>Gzma</italic><sup>-/-</sup> mice have also been used to show a role for GZMA in inter alia diabetes (<xref ref-type="bibr" rid="bib64">Mollah et al., 2017</xref>), cancer (<xref ref-type="bibr" rid="bib98">Santiago et al., 2020</xref>), bacterial infections (<xref ref-type="bibr" rid="bib21">García-Laorden et al., 2016</xref>; <xref ref-type="bibr" rid="bib22">García-Laorden et al., 2017</xref>; <xref ref-type="bibr" rid="bib138">van den Boogaard et al., 2016</xref>), and arthritis (<xref ref-type="bibr" rid="bib97">Santiago et al., 2017</xref>). GZMA’s bioactivity has generally (<xref ref-type="bibr" rid="bib80">Plasman et al., 2014</xref>; <xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>; <xref ref-type="bibr" rid="bib154">Zhou et al., 2020</xref>), but not always (<xref ref-type="bibr" rid="bib105">Shimizu et al., 2019</xref>; <xref ref-type="bibr" rid="bib139">van Eck et al., 2017</xref>), been associated with GZMA’s protease activity, with circulating GZMA in humans shown to be proteolytically active (<xref ref-type="bibr" rid="bib114">Spaeny-Dekking et al., 1998</xref>).</p><p>After infection with the arthritogenic alphavirus, chikungunya virus (CHIKV) (<xref ref-type="bibr" rid="bib123">Suhrbier, 2019</xref>), infected <italic>Gzma</italic><sup>-/-</sup> mice showed a substantially reduced overt arthritic foot swelling when compared to infected C57BL/6J (6J) mice (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>). However, we show herein that active site mutant <italic>Gzma</italic><sup>S211A</sup> mice generated by CRISPR on a 6J background showed no significant differences in CHIKV arthritic foot swelling when compared with 6J mice. The apparent contradiction was resolved when it emerged that <italic>Gzma</italic><sup>-/-</sup> mice had a mixed 6J and C57BL/6N (6N) background. <italic>Gzma</italic><sup>-/-</sup> mice retained expression of the full-length nicotinamide nucleotide transhydrogenase (<italic>Nnt</italic>) gene, whereas 6J mice have a truncated <italic>Nnt</italic> with a 5 exon deletion (<xref ref-type="bibr" rid="bib18">Fontaine and Davis, 2016</xref>). The presence of full-length <italic>Nnt</italic> and the mixed 6N/6J genetic background (rather than absence of GZMA expression) emerged to be responsible for amelioration of CHIKV arthritic foot swelling in <italic>Gzma</italic><sup>-/-</sup> mice. As much of our understanding of the physiological role of GZMA comes from studies in <italic>Gzma</italic><sup>-/-</sup> mice, we used the <italic>Gzma</italic><sup>S211A</sup> mice to gain new insights into GZMA function that were not compromised by genetic background.</p><p>The enzyme, nicotinamide nucleotide transhydrogenase (NNT), also known as proton-translocating NAD(P)+ transhydrogenase (EC 7.1.1.1), is located in the inner mitochondrial membrane and catalyzes the conversion of NADH plus NADP<sup>+</sup> to NAD<sup>+</sup> plus NADPH, while H<sup>+</sup> is pumped from the inter-membrane space into the mitochondrial matrix (<xref ref-type="bibr" rid="bib94">Rydström, 2006</xref>). NNT thereby sustains mitochondrial antioxidant capacity through generation of NADPH (<xref ref-type="bibr" rid="bib143">Ward et al., 2020</xref>), with the loss of active NNT in 6J mice associated with reduced ability to detoxify reactive oxygen species (ROS) via the glutathione and thioredoxin pathways (<xref ref-type="bibr" rid="bib55">McCambridge et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Meimaridou et al., 2018</xref>; <xref ref-type="bibr" rid="bib93">Ronchi et al., 2013</xref>; <xref ref-type="bibr" rid="bib94">Rydström, 2006</xref>). As redox regulation is involved in many cellular processes (<xref ref-type="bibr" rid="bib20">Gambhir et al., 2019</xref>; <xref ref-type="bibr" rid="bib48">Lingappan, 2018</xref>; <xref ref-type="bibr" rid="bib126">Sun et al., 2020</xref>) and genetic backgrounds are known to affect phenotypes (<xref ref-type="bibr" rid="bib43">Leskov et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Morales-Hernandez et al., 2018</xref>; <xref ref-type="bibr" rid="bib86">Rao et al., 2020</xref>; <xref ref-type="bibr" rid="bib96">Salerno et al., 2019</xref>; <xref ref-type="bibr" rid="bib142">Vozenilek et al., 2018</xref>; <xref ref-type="bibr" rid="bib146">Williams et al., 2021</xref>; <xref ref-type="bibr" rid="bib148">Wolf et al., 2016</xref>), we sought to determine how many other studies in GMO mice might have been affected by 6J vs. 6N background differences using the <italic>Nnt</italic> gene as a genetic marker. k-mer mining of RNA-Seq datasets deposited in the NCBI Sequence Read Archive (SRA) revealed that ≈27% of Run Accessions and ≈38% of BioProjects listing the mouse strain as ‘C57BL/6J’ had <italic>Nnt</italic> reads inconsistent with a 6J background. Although reported as underappreciated in the metabolism literature (<xref ref-type="bibr" rid="bib18">Fontaine and Davis, 2016</xref>), potential problems associated with differences in <italic>Nnt</italic> and/or other background genes clearly extends well beyond this field and are not restricted to <italic>Gzma</italic><sup>-/-</sup> mice.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>CHIKV inflammatory arthritis in <italic>Gzma</italic><sup>S211A</sup> mice</title><p>We reported previously that the inflammatory arthritis induced by CHIKV infection (manifesting as overt foot swelling) was significantly lower in <italic>Gzma</italic><sup>-/-</sup> mice than in C57BL/6J (6J) mice (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>); an observation we confirm herein (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). Injection of proteolytically active, but not proteolytically inactive, recombinant mouse GZMA induced inflammatory foot swelling, illustrating directly that GZMA’s protease activity is able to drive pro-inflammatory responses (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>). To confirm and extend these findings, a new homozygous GZMA active site mutant mouse was generated using CRISPR technology in 6J mice, with the reactive site serine changed to alanine (<italic>Gzma</italic><sup>S211A</sup>) (<xref ref-type="bibr" rid="bib127">Susanto et al., 2013</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a–c</xref>). Loss of enzyme activity was confirmed by BLT assays (<xref ref-type="bibr" rid="bib121">Suhrbier et al., 1991</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1d</xref>). Intracellular staining (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>) showed that expression of the GZMA proteins in resting splenic NK cells (<xref ref-type="bibr" rid="bib17">Fehniger et al., 2007</xref>) was comparable for <italic>Gzma</italic><sup>S211A</sup> and 6J mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1e</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Chikungunya virus (CHIKV) infection in <italic>Gzma</italic><sup>-/-</sup>, <italic>Gzma</italic><sup>S211A</sup>, 6N, and 6J mice.</title><p>(<bold>a</bold>) Percent increase in foot swelling for the indicated mouse strains. Data is from 2 to 4 independent experiments with 5–6 mice (10–12 feet) per group per experiment. From day 3 to day 10, feet from <italic>Gzma</italic><sup>S211A</sup> and 6J mice were significantly more swollen than feet from <italic>Gzma</italic><sup>-/-</sup> and 6N mice (Kolmogorov–Smirnov tests, p&lt;0.002). (<bold>b</bold>) Viremia for the mice in (<bold>a</bold>) (6N n = 12, <italic>Gzma</italic><sup>S211A</sup> n = 18, <italic>Gzma</italic><sup>-/-</sup> n = 15, 6J n = 17).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Construction and characterization of <italic>Gzma</italic><sup>S211A</sup> mice.</title><p>(<bold>a</bold>) The <italic>Gzma</italic><sup>S211A</sup> mouse was generated by CRISPR of C57BL/6J mice by the Australian Phenomics Network (APN), Monash University, Melbourne, Australia. (<bold>b</bold>) Genotyping was undertaken at APN using F 5′ <named-content content-type="sequence">TCAGCTGCTTTTGCCTGTTTCA</named-content> 3′ and R 5′ <named-content content-type="sequence">GAGAAAGTCCCCTGTCC</named-content>-TCGG 3′ primers to generate a 628 bp product, with BsaHI digestion (blue arrow in <bold>a</bold>) generating 290 bp and 338 bp fragments for the <italic>Gzma</italic><sup>S211A</sup> allele. (<bold>c</bold>) Heterozygous <italic>Gzma</italic><sup>S211A</sup> mice were interbred to generate homozygous <italic>Gzma</italic><sup>S211A</sup> mice at QIMR Berghofer MRI. The undigested 628 bp PCR products were sequenced to confirm that the correct product had been amplified. (<bold>d</bold>) Mouse splenic NK cells constitutively express active GZMA protein. NK cells from spleens were FACS sorted (NK1.1+, CD3-) and lysates analyzed by the benzyloxycarbonyl-L-lysine thiobenzylester (BLT) esterase activity in duplicate as described (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>). (<bold>e</bold>) NK cells (NK1.1+, CD3-) from spleens from the indicated mouse strains were analyzed by FACS for mouse GZMA expression using intracellular anti-GZMA antibody staining as described (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>). (<bold>f</bold>) <italic>Gzma</italic><sup>S211A</sup> and 6J mice were infected with chikungunya virus (CHIKV) and tissue viral titers in the feet determined as described (<xref ref-type="bibr" rid="bib23">Gardner et al., 2010</xref>). (<bold>g</bold>) Treatment of CHIKV-infected mice with Serpinb6b as described previously (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>) except using <italic>Gzma</italic><sup>S211A</sup> mice. Statistics (day 6) by <italic>t</italic>-test n = 12 feet from six mice per group.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig1-figsupp1-v1.tif"/></fig></fig-group><p>When infected with CHIKV, viral titers in feet were not significantly different for <italic>Gzma</italic><sup>S211A</sup> and 6J mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1f</xref>), arguing that enzymically active GZMA has no significant antiviral activity against CHIKV. This is consistent with our previous study using <italic>Gzma</italic><sup>-/-</sup> mice that also concluded that GZMA has no important antiviral function (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>). Surprisingly, however, foot swelling following CHIKV infection was <italic>not</italic> significantly different between the <italic>Gzma</italic><sup>S211A</sup> and 6J mice (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). If GZMA’s pro-inflammatory bioactivity (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>) depends on its protease activity (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>), the results from <italic>Gzma</italic><sup>-/-</sup> and <italic>Gzma</italic><sup>S211A</sup> mice (<xref ref-type="fig" rid="fig1">Figure 1a</xref>) would appear to provide contradictory results.</p><p>The effective amelioration of CHIKV arthritic foot swelling in 6J mice following treatment with Serpinb6b (an inhibitor of GZMA) also supported the view that GZMA promotes inflammation in this setting (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>). However, Serpinb6b also inhibited CHIKV foot swelling in <italic>Gzma</italic><sup>S211A</sup> mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1g</xref>), arguing that Serpinb6b can inhibit other unknown proteases involved in promoting arthritic inflammation. The contention is supported by the broad inhibitory activity of the human orthologue, SerpinB6 (<xref ref-type="bibr" rid="bib119">Strik et al., 2004</xref>).</p><p>Taken together, these new data argued that the role of GZMA in promoting CHIKV arthritis and the results obtained from <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>) required re-evaluation.</p></sec><sec id="s2-2"><title><italic>Gzma</italic><sup>-/-</sup> mice have a mixed C57BL/6N-C57BL/6J genetic background</title><p>To reconcile the apparent contradictory data from <italic>Gzma</italic><sup>S211A</sup> and <italic>Gzma</italic><sup>-/-</sup> mice, and cognizant of previously described issues with knockout mice (<xref ref-type="bibr" rid="bib131">Teoh et al., 2014</xref>), whole-genome sequencing (WGS) of <italic>Gzma</italic><sup>-/-</sup> mice was undertaken (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/PRJNA664888">NCBI SRA; PRJNA664888</ext-link>). This analysis unequivocally demonstrated that <italic>Gzma</italic><sup>-/-</sup> mice have a mixed genetic background, with ≈60% of the genome showing single-nucleotide polymorphisms (SNPs) and indels present in the C57BL/6N (6N) genome (<xref ref-type="bibr" rid="bib59">Mekada et al., 2015</xref>; <xref ref-type="bibr" rid="bib109">Simon, 2013</xref>), with the rest reflecting a 6J background (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). The strain origin of the BL/6-III ES cells used to generate <italic>Gzma</italic><sup>-/-</sup> mice was only reported as C57BL/6 (<xref ref-type="bibr" rid="bib15">Ebnet et al., 1995</xref>). As ES cells from 6J mice have a low rate of germline transmission, ES from 6N mice cells were frequently used to generate knockout mice (<xref ref-type="bibr" rid="bib18">Fontaine and Davis, 2016</xref>), with our studies clearly arguing that BL/6-III ES cells also have a 6N background. The reported backcrossing of <italic>Gzma</italic><sup>-/-</sup> mice onto C57BL/6 mice (<xref ref-type="bibr" rid="bib69">Müllbacher et al., 1999</xref>) also clearly did not involve extensive backcrossing onto 6J mice.</p><p>Importantly, a large body of literature has resulted from the use of inbred <italic>Gzma</italic><sup>-/-</sup> mice (and <italic>Gzma</italic><sup>-/-</sup>/<italic>Gzmb</italic><sup>-/-</sup> double knockout mice derived from them) with 6J mice used as controls, without being aware of the presence and potential confounding influence of the 6N background (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></sec><sec id="s2-3"><title><italic>Gzma</italic><sup>-/-</sup> mice and 6N (<italic>Gzma</italic><sup>+/+</sup>) mice both have reduced foot swelling after CHIKV infection</title><p>An explanation for the significantly lower CHIKV-induced foot swelling seen in <italic>Gzma</italic><sup>-/-</sup> mice is that the partial 6N background is influencing the foot swelling phenotype. To test this contention, 6J and 6N mice (both <italic>Gzma</italic><sup>+/+</sup>) were infected with CHIKV. 6N mice showed a significant reduction in foot swelling when compared with 6J mice (<xref ref-type="fig" rid="fig1">Figure 1a</xref>), arguing that the 6N background, rather than loss of GZMA expression, was primarily responsible for amelioration of foot swelling in <italic>Gzma</italic><sup>-/-</sup> mice.</p><p>The reduced foot swelling in 6N and <italic>Gzma</italic><sup>-/-</sup>mice was unlikely to be due to reduced viral loads as there were no significant differences in viremia for 6N, 6J, <italic>Gzma</italic><sup>-/-</sup>, or <italic>Gzma</italic><sup>S211A</sup> mice (<xref ref-type="fig" rid="fig1">Figure 1b</xref>).</p></sec><sec id="s2-4"><title>RNA-Seq of CHIKV foot swelling for <italic>Gzma</italic><sup>-/-</sup> vs. 6J mice</title><p>To gain insights into the reduced foot swelling in <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig1">Figure 1a</xref>), RNA-Seq was undertaken on day 6 (peak arthritis) to compare gene expression in feet from CHIKV-infected <italic>Gzma</italic><sup>-/-</sup> mice vs. 6J mice (NCBI BioProject PRJNA664644; full gene list in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2a</xref>). Differentially expressed genes (DEGs) (n = 1073) were generated after application of a q &lt; 0.01 filter (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2b</xref>). When the 1073 DEGs (for <italic>Gzma</italic><sup>-/-</sup> + CHIKV vs. 6J + CHIKV; <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2b</xref>) were analyzed for <italic>Diseases and Functions</italic> using Ingenuity Pathway Analysis (IPA), the dominant annotations were associated with decreased cell movement (often leukocyte migration) (<xref ref-type="fig" rid="fig2">Figure 2a</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2c</xref>). These findings are consistent with immunohistochemistry data showing significantly reduced T cell and NK cells in the arthritic infiltrates in feet after CHIKV infection of <italic>Gzma</italic><sup>-/-</sup> mice when compared with infected 6J mice (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>). IPA upstream regulator (USR) analysis of the 1073 DEGs (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2d</xref>) also illustrated that a series of pro-inflammatory cytokine USRs were downregulated in the infected feet of <italic>Gzma</italic><sup>-/-</sup> + CHIKV vs. 6J + CHIKV mice (<xref ref-type="fig" rid="fig2">Figure 2b</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2e</xref>), consistent with the reduced foot swelling seen in infected <italic>Gzma</italic><sup>-/-</sup> mice when compared with infected 6J mice (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>RNA-Seq of <italic>Gzma</italic><sup>-/-</sup> + chikungunya virus (CHIKV) vs. 6J + CHIKV day 6 feet.</title><p>(<bold>a</bold>) Selected Ingenuity Pathway Analysis (IPA) <italic>Diseases and Function</italic> annotations for the 469 downregulated differentially expressed genes (DEGs) for <italic>Gzma</italic><sup>-/-</sup> + CHIKV vs. 6J + CHIKV (full set of annotations shown in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2c</xref>). (<bold>b</bold>) IPA cytokine upstream regulators (USRs) downregulated in CHIKV-infected feet of <italic>Gzma</italic><sup>-/-</sup> mice (<italic>Gzma</italic><sup>-/-</sup>+CHIKV vs. 6J + CHIKV; <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2e</xref>) plotted by p-value and z-score. Black circles – minor USRs for <italic>Gzma</italic><sup>-/-</sup> + CHIKV vs. 6J + CHIKV not identified for 6J + CHIKV vs. 6J mock (see also <xref ref-type="fig" rid="fig4">Figure 4e</xref>). (<bold>c</bold>) RNA-Seq identified 1557 DEGs upregulated in feet for 6J + CHIKV vs. 6J mock infection (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2g</xref>). RNA-Seq of <italic>Gzma</italic><sup>-/-</sup> + CHIKV vs. 6J + CHIKV day 6 feet identified 469 downregulated DEGs in <italic>Gzma</italic><sup>-/-</sup> mice associated with the reduced foot swelling (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2b</xref>). Only 19 of these DEGs were shared by these datasets. (<bold>d</bold>) Gene Set Enrichment Analysis (GSEA) of downregulated DEGs from <italic>Gzma</italic><sup>-/-</sup> + CHIKV vs. 6J + CHIKV day 6 feet (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2b</xref>) vs. all genes (preranked by fold change) from feet 6J + CHIKV vs. 6J mock infection (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2f</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig2-v1.tif"/></fig><p>We previously characterized the CHIKV arthritis signature by undertaking RNA-Seq of infected feet during peak foot swelling relative to control uninfected feet (6J + CHIKV vs. 6J mock infection) (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>). We reanalyzed the data (FastQ files NCBI BioProject PRJNA431476) using STAR aligner, RSEM EdgeR, and the more recent mouse genome build (GRCm38 Gencode vM23); all genes are shown in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2f</xref>, and a DEG list (with filters q &lt; 0.01, fold change &gt;2) is shown in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2g</xref>. The latter 2201 DEGs (for 6J + CHIKV vs. 6J mock infection) were analyzed by IPA, with the USRs shown in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2h</xref>. Of these USRs, 103 cytokine USR annotations showed significant upregulation (positive z-scores) after CHIKV infection (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2i</xref>). As might be expected, key pro-inflammatory cytokine USRs such as TNF, IFNG, IL6, and IL1B (<xref ref-type="bibr" rid="bib123">Suhrbier, 2019</xref>) that were upregulated during CHIKV arthritis (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2i</xref>) were downregulated (negative z-scores) in the ameliorated foot swelling seen in <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig2">Figure 2b</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2e</xref>). Curiously, however, five minor USRs (PPBP, CTF1, WNT7A, NAMPT, TIMP1) were downregulated in <italic>Gzma</italic><sup>-/-</sup> mice, but were not upregulated during CHIKV infection (<xref ref-type="fig" rid="fig2">Figure 2b</xref>, black circles; <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2e</xref>, yellow). Furthermore, of the 469 DEGs downregulated during CHIKV arthritis in <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2b</xref>), only 19 were upregulated DEGs for CHIKV arthritis (<xref ref-type="fig" rid="fig2">Figure 2c</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2g</xref>). Gene Set Enrichment Analysis (GSEA) similarly revealed that DEGs downregulated in <italic>Gzma</italic><sup>-/-</sup> mice were not significantly enriched in the upregulated genes for CHIKV arthritis in 6J mice (<xref ref-type="fig" rid="fig2">Figure 2d</xref>). Thus, although feet from CHIKV-infected <italic>Gzma</italic><sup>-/-</sup> mice showed annotations associated with reduced cellular infiltrates and pro-inflammatory cytokines, this amelioration of arthritic signatures was associated with downregulation of genes largely not associated with CHIKV arthritis in 6J mice. In summary, arthritis amelioration in <italic>Gzma</italic><sup>-/-</sup> mice was due to the downregulation of a largely distinct set of genes (and some distinct pathways), again arguing that the 6N background plays a key role in this phenotype.</p></sec><sec id="s2-5"><title><italic>Gzma</italic><sup>-/-</sup> mice have an intact nicotinamide nucleotide transhydrogenase gene</title><p>There are multiple genes associated with inflammation and/or arthritis that differ between <italic>Gzma</italic><sup>-/-</sup> (mixed 6N/6J background) and 6J mice (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). One gene that has been highlighted as a key difference between 6J and 6N mice is <italic>Nnt</italic> (<xref ref-type="bibr" rid="bib19">Freeman et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">Mekada et al., 2009</xref>; <xref ref-type="bibr" rid="bib91">Ripoll et al., 2012</xref>; <xref ref-type="bibr" rid="bib93">Ronchi et al., 2013</xref>; <xref ref-type="bibr" rid="bib142">Vozenilek et al., 2018</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1c</xref>, red box). The function of NNT is primarily to sustain mitochondrial antioxidant capacity through the generation of NADPH, which supports the antioxidant capacity of the glutathione and thioredoxin systems (<xref ref-type="bibr" rid="bib55">McCambridge et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Meimaridou et al., 2018</xref>; <xref ref-type="bibr" rid="bib93">Ronchi et al., 2013</xref>; <xref ref-type="bibr" rid="bib94">Rydström, 2006</xref>; <xref ref-type="bibr" rid="bib143">Ward et al., 2020</xref>). These systems are generally viewed as having broad anti-inflammatory activities (<xref ref-type="bibr" rid="bib25">Ghezzi, 2021</xref>; <xref ref-type="bibr" rid="bib152">Yodoi et al., 2017</xref>).</p><p>6N mice have a full-length <italic>Nnt</italic> gene with 21 protein-coding exons, whereas 6J mice have an in-frame 5-exon deletion removing exons 7–11 (<xref ref-type="bibr" rid="bib19">Freeman et al., 2006</xref>). Confusingly, the MM10 mouse build numbers the <italic>Nnt</italic> exons differently and includes the noncoding exon 1 that is located before the ATG start site. According to this numbering (which is used herein), 6J mice have lost exons 8–12 of 22 exons. The <italic>Nnt</italic> gene is located only ≈6.2 megabases from the <italic>Gzma</italic> gene on mouse chromosome 13, so &gt;30 backcrosses would be required to segregate these two loci (<xref ref-type="bibr" rid="bib108">Silver, 2008</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). The close association of <italic>Nnt</italic> and <italic>Gzma</italic> genes also means <italic>Gzma</italic><sup>-/-</sup><italic>Gzmb</italic><sup>-/-</sup> double-knockout mice (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) would also very likely have full-length <italic>Nnt</italic>. Another <italic>Gzma</italic><sup>-/-</sup> mouse generated using 129/SvJ ES cells (<xref ref-type="bibr" rid="bib106">Shresta et al., 1997</xref>) would likely have the same issue as 129/SvJ mice also have a full-length <italic>Nnt</italic> gene.</p><p>Alignment of the WGS of <italic>Gzma</italic><sup>-/-</sup> mice (PRJNA664888) to the standard 6J MM10 mouse genome build allowed identification of the neomycin cassette insertion site into the <italic>Gzma</italic> gene that was used to generate the <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="bibr" rid="bib15">Ebnet et al., 1995</xref>; <xref ref-type="fig" rid="fig3">Figure 3a</xref>). Curiously, this alignment shows a 12-nucleotide insertion in the 6J genome at the <italic>Nnt</italic> exon 8–12 deletion junction (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). The 12 nucleotides are also absent in other 6N WGS data (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3a</xref>), indicating this is not a unique feature of <italic>Gzma</italic><sup>-/-</sup> mice. This insertion in 6J may have accompanied deletion of <italic>Nnt</italic> exons 8–12 during the generation of 6J mice (<xref ref-type="bibr" rid="bib18">Fontaine and Davis, 2016</xref>; <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3b</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Nnt</italic> deletion in 6J but not <italic>Gzma</italic><sup>-/-</sup> mice.</title><p>(<bold>a</bold>) Whole-genome sequencing (WGS) of <italic>Gzma</italic><sup>-/-</sup> mice aligned to the 6J (MM10) reference genome build, illustrating the insertion site of the neomycin cassette into the <italic>Gzma</italic> gene to create the knockout. (<bold>b</bold>) As for (<bold>a</bold>) but showing the site of the <italic>Nnt</italic> deletion, with the additional 12 nucleotides present in the 6J genome. (<bold>c</bold>) WGS of <italic>Gzma</italic><sup>-/-</sup> and 6J mice aligned to the C3H/HeJ reference genome, illustrating that the <italic>Nnt</italic> deletion present in 6J mice is absent in <italic>Gzma</italic><sup>-/-</sup> mice. The deletion is in chromosome 13; position 120,695,141–120,711,874 (C3H/HeJ numbering). (<bold>d</bold>) Reads from RNA-Seq of chikungunya virus (CHIKV)-infected 6J and <italic>Gzma</italic><sup>-/-</sup> mice aligned to the C3H/HeJ and 6J (MM10) reference genomes showing the Sashimi plot (Integrative Genomics Viewer) for the <italic>Nnt</italic> gene. (<bold>e</bold>) RT-PCR of testes using primers either side of exons 8–12 in the <italic>Nnt</italic> mRNA.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>Gzma<sup>-/-</sup></italic> mice have a mixed 6N (yellow)/6J (green) background.</title><p>(<bold>a</bold>) Single-nucleotide polymorphisms (<xref ref-type="bibr" rid="bib109">Simon, 2013</xref>). (<bold>b</bold>) Single-nucleotide polymorphisms (<xref ref-type="bibr" rid="bib59">Mekada et al., 2015</xref>). (<bold>c</bold>) Insertions/deletions (<xref ref-type="bibr" rid="bib109">Simon, 2013</xref>). Whole-genome sequencing (WGS) data for <italic>Gzma<sup>-/-</sup></italic> mice provided in PRJNA664888. <italic>Nnt</italic> highlighted in red box.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title><italic>Nnt</italic> and <italic>Gzma</italic> gene locations and backcrossing requirements.</title><p>(<bold>a</bold>) Both <italic>Gzma</italic> and <italic>Nnt genes</italic> are located on mouse chromosome 13 and are separated by about 6.2 million bp. (<bold>b</bold>) Over 30 backcrosses would be needed to separate the <italic>Gzma</italic> locus from the <italic>Nnt</italic> locus (graph taken from <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/silver/index.shtml">http://www.informatics.jax.org/silver/index.shtml</ext-link>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title><italic>Nnt</italic> locus inserts and alignments.</title><p>(<bold>a</bold>) 6J whole-genome sequencing (WGS) reads (SRR8573456) aligned to 6J reference compared with 6N WGS reads (SRR7592164, ERR2814681) aligned to 6J reference, across the 12 nucleotide insert. (<bold>b</bold>) Proposed source of the 12 nucleotide insertion shown in (<bold>a</bold>) and <xref ref-type="fig" rid="fig3">Figure 3b</xref>. The insertion sequence matches the reverse complement of a sequence ≈1 kb downstream of the <italic>Nnt</italic> deletion site. The insertion is present in 6J genomes. (<bold>c</bold>) Location of <italic>Nnt</italic> exons in the C3H/HeJ mouse genome build (GenBank assembly accession: GCA_001632575.1). Exons highlighted in yellow are missing in 6J mice. (<bold>d</bold>) A series of WGS with 6J listed as the mouse strain were analyzed as described in <xref ref-type="fig" rid="fig3">Figure 3c</xref> and the absence of exon 8–12 confirmed (Y). WGS from CBA/J F1 hybrids (<xref ref-type="bibr" rid="bib40">Korablev et al., 2020</xref>), mice with an NMRI background (<xref ref-type="bibr" rid="bib134">Tumiati et al., 2015</xref>), and a WGS with no mouse strain provided, all contained full-length <italic>Nnt</italic> genes (<bold>N</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig3-figsupp3-v1.tif"/></fig></fig-group><p>Although a 6N genome sequence is available, it is poorly annotated, hence the C3H/HeJ genome build was used for alignments as it also has a full-length <italic>Nnt</italic> gene (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3c</xref>).</p><p>Alignment of WGS reads from <italic>Gzma</italic><sup>-/-</sup> mice to the C3H/HeJ genome clearly showed that <italic>Gzma</italic><sup>-/-</sup> mice had a full-length <italic>Nnt</italic> gene, whereas 6J mice had the expected ≈16 kb deletion (<xref ref-type="fig" rid="fig3">Figure 3c</xref>). The approach (<xref ref-type="fig" rid="fig3">Figure 3c</xref>) was further validated using other 6J and non-6J WGS submissions (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3d</xref>).</p><p>Sashimi plots of RNA-Seq reads aligned to the C3H/HeJ build clearly illustrated that <italic>Nnt</italic> mRNA from 6J mice was missing exons 8–12, whereas in <italic>Gzma</italic><sup>-/-</sup> mice the full-length <italic>Nnt</italic> mRNA was expressed (<xref ref-type="fig" rid="fig3">Figure 3d</xref>, top). Alignment to the 6J genome and viewed by Sashimi plot showed that exons 7 and 13 are linked in the <italic>Nnt</italic> mRNA from 6J mice, consistent with expression of a truncated <italic>Gzma</italic> mRNA species. In contrast, exons 7 and 13 are <italic>not</italic> linked in the <italic>Nnt</italic> mRNA from <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig3">Figure 3d</xref>, blue arrow) as the mRNA, but not the MM10 genome build, contains exons 8–12.</p><p>These results were confirmed by RT-PCR using primers located on either side of the exon 8–12 deletion (<xref ref-type="bibr" rid="bib33">Huang et al., 2006</xref>; <xref ref-type="fig" rid="fig3">Figure 3e</xref>). <italic>Gzma</italic><sup>-/-</sup> mice have the longer 6N <italic>Nnt</italic> PCR product as this <italic>Nnt</italic> mRNA includes exons 8–12, whereas 6J mice, <italic>Gzma</italic><sup>S211A</sup> (generated by CRISPR on a 6J background), and type I IFN receptor knockout (<italic>Ifnar<sup>-/-</sup></italic>) mice (also on a 6J background <xref ref-type="bibr" rid="bib128">Swann et al., 2007</xref>), all showed a shorter PCR product, consistent with the deletion of exons 8–12 in the <italic>Nnt</italic> mRNA (<xref ref-type="fig" rid="fig3">Figure 3e</xref>). In a separate RT-PCR run, <italic>Gzmb<sup>-/-</sup></italic> mice (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>) were shown to be missing <italic>Nnt</italic> exons 8–12, consistent with a 6J background (<xref ref-type="fig" rid="fig3">Figure 3e</xref>).</p></sec><sec id="s2-6"><title>The <italic>Nnt</italic> deletion promotes CHIKV-induced foot swelling</title><p>To determine whether the <italic>Nnt</italic> gene deletion seen in 6J mice might be responsible for promoting the arthritic foot swelling in CHIKV-infected mice, we generated 6N<sup>∆<italic>Nnt</italic>8-12</sup> mice wherein exons 8–12 of <italic>Nnt</italic> were deleted from 6N mice using CRISPR (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). 6N<sup>∆<italic>Nnt</italic>8-12</sup> mice thus have the same deletion of <italic>Nnt</italic> exons as 6J mice. As before, CHIKV-induced foot swelling was significantly higher in 6J mice when compared with 6N mice (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). Importantly, foot swelling in 6N<sup>∆<italic>Nnt</italic>8-12</sup> mice was significantly higher than in 6N mice, with the <italic>Nnt</italic> exon 8–12 deletion increasing foot swelling to levels comparable to those seen in 6J mice (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). There were no significant differences in viremia between the mouse strains (<xref ref-type="fig" rid="fig4">Figure 4b</xref>). This data illustrates that the absence of a functional <italic>Nnt</italic> gene (6N<sup>∆<italic>Nnt</italic>8-12</sup>) can by itself promote overt foot swelling after CHIKV infection. The data also argues that the presence of functional <italic>Nnt</italic> gene in <italic>Gzma</italic><sup>-/-</sup> mice likely contributes to the ameliorated foot swelling seen in <italic>Gzma</italic><sup>-/-</sup> mice.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>6N<sup>∆<italic>Nnt</italic>8-12</sup> mice.</title><p>(<bold>a</bold>) 6N<sup>∆<italic>Nnt</italic>8-12</sup> mice have the same <italic>Nnt</italic> exon deletion as 6J mice. Age-matched female 6N<sup>∆<italic>Nnt</italic>8-12</sup>, 6N, and 6J mice were infected with chikungunya virus (CHIKV) and foot swelling measured over time (n = 5 mice and 10 feet per group). Foot swelling was significantly higher in 6N<sup>∆<italic>Nnt</italic>8-12</sup> mice when compared with 6N mice on days 2–7 (day 2 p=0.0026, day 7 p=0.0027, <italic>t</italic>-tests, parametric data distributions; days 3–6 p=0.003, Kolmogorov–Smirnov tests, nonparametric data distributions). Foot swelling was significantly lower in 6N mice when compared with 6J mice (day 2 p=0.042, day 6 p=0.001, day 7 p=0.0005, <italic>t</italic>-tests, parametric data distributions; days 3 and 5, p=0.002, Kolmogorov–Smirnov tests, nonparametric data distributions). (<bold>b</bold>) Viremia for the same mice as in (<bold>a</bold>). (<bold>c</bold>) H&amp;E staining of feet from 6N<sup>∆<italic>Nnt</italic>8-12</sup> and 6N mice day 6 post infection showing subcutaneous edema (*). (<bold>d</bold>) Percentage of foot section area showing overt subcutaneous edema (statistics by Kolmogorov–Smirnov test). (<bold>e</bold>) RNA-Seq data for four comparisons was analyzed by Ingenuity Pathway Analysis (IPA) and cytokine upstream regulator (USR) overlaps shown. Only cytokine USRs with positive z-scores associated with increased foot swelling are shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Generation of 6N<sup>∆</sup><italic><sup>Nnt</sup></italic><sup>8-12</sup> mice.</title><p>(<bold>a</bold>) Deletion of exons 8–12 from the 6N <italic>Nnt</italic> gene. (<bold>b</bold>) sgRNAs and location of cuts (blue arrowheads). (<bold>c</bold>) Primers for genotyping 6N <italic>Nnt</italic> allele. (<bold>d</bold>) Primers for genotyping 6N<sup>∆</sup><italic><sup>Nnt</sup></italic><sup>8-12</sup> allele. (<bold>e</bold>) Example of 764 bp PCR products for first-generation 6N<sup>∆</sup><italic><sup>Nnt</sup></italic><sup>8-12</sup> pups. (<bold>f</bold>) Example of sequencing 764 bp PCR product. Mice were bred to homozygosity to produce 6N<sup>∆</sup><italic><sup>Nnt</sup></italic><sup>8-12</sup> mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Histological analyses for 6N<sup>∆</sup><italic><sup>Nnt</sup></italic><sup>8-12</sup> mice feet.</title><p>(<bold>a</bold>) Examples of H&amp;E staining of feet showing the prominently mononuclear cellular infiltrates (purple) in muscle tissues. (<bold>b</bold>) Quantitation of H&amp;E staining of feet using blue (nuclei) over red (cytoplasm) pixel count ratios determined by Aperio pixel count. Six sections total from two independent H&amp;E staining rounds were averaged to produce one value per mouse (n = 6 mice per group). Statistics by <italic>t</italic>-test. (<bold>c</bold>) Examples of anti-CD3 immunohistochemistry staining in foot sections (Warp red with toluidine blue counterstain). (<bold>d</bold>) Quantitation of anti-CD3 staining by Aperio pixel count. Three sections were averaged to produce one value per mouse (n = 6 mice per group). Area (denominator) was normalized (mean factor of 1.18) to account for the increased area associated with edema in the 6N<sup>∆</sup><italic><sup>Nnt</sup></italic><sup>8-12</sup> group. Statistics by Kolmogorov–Smirnov test (nonparametric–high kurtosis). Remains nonsignificant even without normalization.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig4-figsupp2-v1.tif"/></fig></fig-group><p>Histology and H&amp;E staining of arthritic feet illustrated that the increased foot swelling seen in 6N<sup>∆<italic>Nnt</italic>8-12</sup> mice (compared with 6N mice) was due primarily to increased edema (<xref ref-type="fig" rid="fig4">Figure 4c and d</xref>), with no significant differences in cellular infiltrates (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a and b</xref>). Edema is a recognized feature of alphaviral arthritides and is well described in CHIKV mouse models (<xref ref-type="bibr" rid="bib23">Gardner et al., 2010</xref>; <xref ref-type="bibr" rid="bib81">Poo et al., 2014</xref>; <xref ref-type="bibr" rid="bib84">Prow et al., 2019</xref>). Immunohistochemistry with anti-CD3 also showed no significant differences in T cell numbers in the inflammatory infiltrates (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2c and d</xref>). To further characterize the role of <italic>Nnt</italic> in CHIKV arthritis, day 6 feet from 6N<sup>∆<italic>Nnt</italic>8-12</sup> + CHIKV vs. 6N + CHIKV were compared using RNA-Seq (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4a and b</xref>). IPA USR analysis (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4c</xref>) provided 14 cytokine annotations with positive z-scores (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4d</xref>) that were associated with the increased foot swelling in 6N<sup>∆<italic>Nnt</italic>8-12</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4e</xref>, brown circle). These 14 cytokine USRs were also upregulated during CHIKV arthritis (<xref ref-type="fig" rid="fig4">Figure 4e</xref>, yellow brown overlap). The IPA cytokine classification also includes chemokines, with no chemokine USRs identified within these 14 annotations (<xref ref-type="fig" rid="fig4">Figure 4e</xref>, brown circle), consistent with the lack of a significant cell migration phenotype (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). In contrast, several chemokine annotations were identified for the <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4e</xref>, blue circle, blue text) consistent with the reduced inflammatory infiltrate (<xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>). Furthermore, only 8/27 cytokine USRs identified for <italic>Gzma</italic><sup>-/-</sup> + CHIKV vs. 6J + CHIKV were also identified for the 6N<sup>∆<italic>Nnt</italic>8-12</sup> + CHIKV vs. 6N + CHIKV comparison (<xref ref-type="fig" rid="fig4">Figure 4e</xref>, blue-brown overlap), arguing that other 6N background genes apart from <italic>Nnt</italic> ameliorated inflammatory cytokine activity in the feet of CHIKV-infected <italic>Gzma</italic><sup>-/-</sup> mice.</p><p>Perhaps consistent with the arthritis literature in general (<xref ref-type="bibr" rid="bib38">Kato, 2020</xref>; <xref ref-type="bibr" rid="bib50">Ma and Xu, 2013</xref>; <xref ref-type="bibr" rid="bib75">Ogata et al., 2019</xref>; <xref ref-type="bibr" rid="bib123">Suhrbier, 2019</xref>), pronounced foot swelling in all comparisons (including MitoTEMPO, see below) was associated with upregulation of TNF, IFNG, and IL-6 USRs (<xref ref-type="fig" rid="fig4">Figure 4e</xref>, red box). IL-13 was also a consistently upregulated USR, with IL-13 associated with resolution of arthritic inflammation (<xref ref-type="bibr" rid="bib101">Schett, 2019</xref>), with peak CHIKV arthritis in 6J mice associated with a significant resolution phase signature (<xref ref-type="bibr" rid="bib84">Prow et al., 2019</xref>).</p></sec><sec id="s2-7"><title>MitoTEMPO ameliorates CHIKV arthritis in 6J mice</title><p>As NNT’s primary function is to sustain mitochondrial antioxidant capacity (<xref ref-type="bibr" rid="bib55">McCambridge et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Meimaridou et al., 2018</xref>; <xref ref-type="bibr" rid="bib93">Ronchi et al., 2013</xref>; <xref ref-type="bibr" rid="bib94">Rydström, 2006</xref>; <xref ref-type="bibr" rid="bib143">Ward et al., 2020</xref>), the data argues that the reduced arthritic foot swelling in 6N mice (and to some extent in <italic>Gzma</italic><sup>-/-</sup> mice) is due to increased mitochondrial antioxidant capacity. MitoTEMPO has been widely used as an experimental antioxidant treatment to scavenge mitochondrial ROS in a variety of disease settings (<xref ref-type="bibr" rid="bib3">Aoyama et al., 2012</xref>; <xref ref-type="bibr" rid="bib46">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib132">To et al., 2020</xref>; <xref ref-type="bibr" rid="bib141">Vincent et al., 2020</xref>; <xref ref-type="bibr" rid="bib150">Wu et al., 2020</xref>). Treatment of CHIKV arthritis in 6J mice with MitoTEMPO from day 3 to 8 post infection significantly ameliorated peak foot swelling (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). Viremia was not significantly affected by MitoTEMPO treatment, even when treatment was initiated on day 0 (<xref ref-type="fig" rid="fig5">Figure 5b</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>MitoTEMPO treatment.</title><p>(<bold>a</bold>) 6J mice were infected with chikungunya virus (CHIKV) and then treated with MitoTEMPO or PBS i.v. daily on days 3–8 post infection and foot swelling measured (n = 5/6 mice and 10/12 feet per group). Statistics by <italic>t</italic>-tests, days 6, 7, and 8, <italic>p</italic> &lt; 0.001. (<bold>b</bold>) Viremia for the mice in (<bold>a</bold>), with an additional group of six mice treated daily with MitoTEMPO from day 0 till day 6. (<bold>c</bold>) H&amp;E staining of muscle tissues in feet of mice day 6 post CHIKV infection for mice treated with PBS or MitoTEMPO from day 3 to day 6. Clusters of small blue spots in and around the muscle bundles illustrate nuclei of infiltrating leukocytes. (<bold>d</bold>) Aperio pixel count of blue (nuclear) over red (cytoplasmic) pixels; a measure of leukocyte infiltration (statistics by <italic>t</italic>-test). (<bold>e</bold>) H&amp;E staining of feet as in (<bold>c</bold>) but showing overt subcutaneous edema. (<bold>f</bold>) Percentage of foot section areas showing overt subcutaneous edema (statistics by <italic>t</italic>-test).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Additional H&amp;E images of feet subcutaneous edema (as in <xref ref-type="fig" rid="fig5">Figure 5e</xref>).</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Histology and H&amp;E staining revealed that MitoTEMPO treatment significantly reduced the cellular infiltrate in feet day 6 post CHIKV infection of 6J mice when compared with PBS treatment (<xref ref-type="fig" rid="fig5">Figure 5c and d</xref>). Edema was also significantly reduced by MitoTEMPO treatment (<xref ref-type="fig" rid="fig5">Figure 5e and f</xref>); additional images are shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>. RNA-Seq analysis (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5a and b</xref>) and IPA USR analysis (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5c</xref>) illustrated that MitoTEMPO treatment was associated with downregulation of 24 cytokine USRs (<xref ref-type="fig" rid="fig4">Figure 4e</xref>, green circle; <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5d</xref>), with 10 of these also downregulated in 6N vs. 6N<sup>∆<italic>Nnt</italic>8-12</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4e</xref>, green and brown circle overlap). MitoTEMPO treatment in 6J mice and an intact <italic>Nnt</italic> gene in 6N mice thus provided overlapping anti-inflammatory activities. However, MitoTEMPO was also able to inhibit a series of additional pro-inflammatory arthritic responses including the chemokine CXCL8 and complement factor 5 (C5), with complement promoting arthritic infiltrates in a related alphavirus, Ross River virus (<xref ref-type="bibr" rid="bib66">Morrison et al., 2007</xref>). Inhibition of CXCL8 and/or C5 is consistent with the reduced cellular infiltrate (<xref ref-type="fig" rid="fig5">Figure 5c and d</xref>).</p></sec><sec id="s2-8"><title>Reinvestigation of the physiological role of GZMA using poly(I:C)</title><p>Our current understanding of the physiological function of GZMA comes, to a large extent, from multiple studies comparing <italic>Gzma</italic><sup>-/-</sup> (and <italic>Gzma</italic><sup>-/-</sup>/<italic>Gzmb</italic><sup>-/-</sup>) mice with 6J mice (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Given the results herein, many of the reported phenotypes are likely to have arisen, at least in part, from an intact <italic>Nnt</italic> gene and/or the 6N background, complicating any conclusions regarding the physiological role of GZMA.</p><p>To gain new insights into GZMA’s activity in vivo, we sought to find an experimental setting where high levels of GZMA are secreted. We have shown previously that humans, nonhuman primates, and mice have elevated serum GZMA levels after infection with CHIKV (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>; <xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>). Infection of mice with a series of other RNA viruses also resulted in high serum GZMA levels early in infection, with NK cells identified as the likely source (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>). Resting NK cells constitutively contain abundant levels of GZMA protein (<xref ref-type="bibr" rid="bib17">Fehniger et al., 2007</xref>), which is usually stored in granules as a mature protease, with the low pH of the granule preventing (premature) proteolytic activity (<xref ref-type="bibr" rid="bib118">Stewart et al., 2012</xref>).</p><p>Polyinosinic:polycytidylic acid (poly(I:C)) can often mimic aspects of the innate responses to RNA viruses (<xref ref-type="bibr" rid="bib82">Prow et al., 2017</xref>). We thus injected poly(I:C) i.v. into 6J mice and showed that serum GZMA levels reached mean peak serum levels of ≈20 ng/ml of serum after 2 hr, with levels dropping to baseline after 24 hr (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). Although poly(I:C) treatment is known to activate NK cells (<xref ref-type="bibr" rid="bib13">Djeu et al., 1979</xref>; <xref ref-type="bibr" rid="bib17">Fehniger et al., 2007</xref>; <xref ref-type="bibr" rid="bib61">Miyake et al., 2009</xref>; <xref ref-type="bibr" rid="bib72">Ngoi et al., 2008</xref>), this rapid and prodigious poly(I:C)-induced release of GZMA into the circulation, to the best of our knowledge, has hitherto not been reported. Type I interferons (IFNs) are also rapidly induced by poly(I:C) (<xref ref-type="bibr" rid="bib11">Dempoya et al., 2012</xref>; <xref ref-type="bibr" rid="bib99">Santiago-Raber et al., 2003</xref>), and NK cells express the type I IFN receptor and can respond to type I IFNs (<xref ref-type="bibr" rid="bib51">Madera et al., 2016</xref>; <xref ref-type="bibr" rid="bib62">Mizutani et al., 2012</xref>). Injection of poly(I:C) i.v. into <italic>Ifnar</italic><sup>-/-</sup> mice resulted in a significantly blunted elevation of GZMA (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). Type I IFNs thus appear to augment this rapid GZMA release; however, the absence of type I IFN signaling does not prevent GZMA secretion, consistent with previous data (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>). Poly(I:C) treatment of <italic>Gzma</italic><sup>S211A</sup> mice resulted in serum GZMA levels not significantly different from those seen in 6J mice (<xref ref-type="fig" rid="fig6">Figure 6a</xref>), illustrating that the active site mutation does not significantly affect production, secretion, or stability. Finally, although GZMB and GZMA are often considered to be co-expressed (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), in this setting no serum GZMB was detected (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). GZMB and perforin proteins are not expressed in resting NK cells and appear only after ≈24 hr of appropriate stimulation (<xref ref-type="bibr" rid="bib17">Fehniger et al., 2007</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Polyinosinic:polycytidylic acid (poly(I:C)) injection into <italic>Gzma</italic><sup>S211A</sup>, 6J mice, and <italic>Ifnar</italic><sup>-/-</sup>.</title><p>(<bold>a</bold>) <italic>Gzma</italic><sup>S211A</sup>, 6J, and <italic>Ifnar</italic><sup>-/-</sup> mice were injected i.v. with 250 µg of poly(I:C) in 150 µl of PBS, and serum samples were taken at the indicated times and assayed for GZMA concentration using a capture ELISA kit (6J n = 5–8, <italic>Ifnar</italic><sup>-/-</sup> n = 5–6 and <italic>Gzma</italic><sup>S211A</sup> n = 3 mice per time point). (<bold>b</bold>) <italic>Gzma</italic><sup>S211A</sup> and 6J mice were injected i.v. with 250 µg of poly(I:C) and feet removed 6 hr later and analyzed by RNA-Seq. The differentially expressed genes (DEGs) (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6b</xref>) were analyzed by Cytoscape and Ingenuity Pathway Analysis (IPA). The full gene list (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6a</xref>) was analyzed using the Molecular Signature Database (MSigDB).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Serum granzyme B (GZMB) levels after i.v. injection of polyinosinic:polycytidylic acid (poly(I:C)).</title><p>(<bold>a</bold>) 6J mice were injected i.v. with 250 µg of poly(I:C) and serum samples taken at the indicated times and assayed for GZMB concentrations by capture ELISA (MyBioSource, San Diego, CA; MBS453704) (n = 5 mice per time point). (<bold>b</bold>) Standard curve.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>RNA-Seq for polyinosinic:polycytidylic acid (poly(I:C)) injection into <italic>Gzma</italic><sup>S211A</sup> vs. 6J mice.</title><p><bold>(a)</bold> Pooling strategy for RNA derived from six mice 6 hr after i.v. poly(I:C) injection. (<bold>b</bold>) Multi-dimensional scaling (MDS) plot for RNA-Seq data for <italic>Gzma</italic><sup>S211A</sup> vs. 6J feet, illustrating clear segregation of the three replicates for each mouse strain. (<bold>c</bold>) STAR read mapping data showing high percentage and number of unique mapping reads. (<bold>d</bold>) Mean-difference (MD) plots. Red, upregulated differentially expressed genes (DEGs); blue, downregulated DEGs.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>The gene expression signatures in feet seen 6 hr after injection of polyinosinic:polycytidylic acid (poly(I:C)) in <italic>Gzma</italic><sup>S211A</sup> vs. 6J mice are not significantly recapitulated in spleen.</title><p>Genes were preranked by fold change.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig6-figsupp3-v1.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>Ingenuity Pathway Analysis (IPA) and Gene Set Enrichment Analysis (GSEA) for polyinosinic:polycytidylic acid (poly(I:C)) injection into <italic>Gzma</italic><sup>S211A</sup> vs. 6J mice.</title><p>(<bold>a</bold>) IPA upstream regulator (USR) analysis (direct only) for 199 feet differentially expressed genes (DEGs) from <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6b</xref> (for <italic>Gzma</italic><sup>S211A</sup> vs. 6J). This analysis largely restricts the output to transcription factors. The transcription factors with well-known inflammation and immune functions are highlighted in yellow and are plotted on the bubble graph. Red circles indicate transcription factors where the -log<sub>10</sub> p-value &gt; 2 and z-score &lt; -0.75. The USRs are downregulated in <italic>Gzma</italic><sup>S211A</sup> mice (negative z-score) and are thus upregulated by proteolytically active granzyme A (GZMA) in 6J mice. (<bold>b</bold>) Interrogation of the Molecular Signature Database (<ext-link ext-link-type="uri" xlink:href="http://www.gsea-msigdb.org/gsea/msigdb/index.jsp">http://www.gsea-msigdb.org/gsea/msigdb/index.jsp</ext-link>) identified DEGs listed for GSE19888 as showing significant enrichment in the downregulated genes in <italic>Gzma</italic><sup>S211A</sup> feet (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6h</xref>; preranked by fold change). Thus, DEGs upregulated in activated monocytes were significantly enriched in the genes upregulated in 6J mice by GZMA.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig6-figsupp4-v1.tif"/></fig></fig-group></sec><sec id="s2-9"><title>RNA-Seq after poly(I:C) injection in <italic>Gzma</italic><sup>S211A</sup> vs. 6J mice</title><p><italic>Gzma</italic><sup>S211A</sup> and 6J mice are both on a 6J genetic background, are both missing <italic>Nnt</italic> exons 8–12, and both show similar levels of serum GZMA secretion after poly(I:C) treatment (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). Thus, the only difference between these strains is that GZMA in <italic>Gzma</italic><sup>S211A</sup> mice is enzymically inactive (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1d</xref>). <italic>Gzma</italic><sup>S211A</sup> and 6J mice were injected with poly(I:C) (as in <xref ref-type="fig" rid="fig6">Figure 6a</xref>), with feet and spleens removed 6 hr later and analyzed by RNA-Seq (NCBI BioProject PRJNA666748). The rationale for this time point was to capture early transcriptional events after the peak of serum GZMA. The sample preparation strategy and RNA-Seq data overview is provided in <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>. The full gene list for feet is provided in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6a</xref>, with the 199 DEGs listed in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6b</xref>. For spleen, the full gene list is shown in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6c</xref> and the four DEGs in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6d</xref>. This represents the first study of GMO mice targeting <italic>Gzma</italic> that is free from the potentially confounding influence of the mixed 6J/6N background.</p></sec><sec id="s2-10"><title>Immune/inflammation signatures stimulated by circulating proteolytically active GZMA</title><p>Circulating proteolytically active GZMA would appear to have limited influence in the spleen as only four DEGs were identified in the spleen of poly(I:C)-treated <italic>Gzma</italic><sup>S211A</sup> vs. 6J mice (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6d</xref>). Interestingly, the only significantly upregulated DEG in <italic>Gzma</italic><sup>S211A</sup> spleens was Mid1, a gene involved in controlling granule exocytosis by cytotoxic lymphocytes (<xref ref-type="bibr" rid="bib5">Boding et al., 2014</xref>; <xref ref-type="bibr" rid="bib6">Boding et al., 2015</xref>). GSEA also illustrated that neither up- nor downregulated DEGs identified in the feet were enriched in spleen (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>), arguing that in this setting the activity of GZMA in the periphery is not significantly recapitulated in spleen.</p><p>Of the 199 DEGs identified in the feet of poly(I:C)-treated <italic>Gzma</italic><sup>S211A</sup> vs. 6J mice, 100 were downregulated, with the top annotations associated with negative regulation of protease activity and negative regulation of cell signaling after Cytoscape analysis (<xref ref-type="fig" rid="fig6">Figure 6b</xref>, <xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). This result supports the view that GZMA is proteolytically active in vivo (<xref ref-type="bibr" rid="bib115">Spaeny-Dekking et al., 2000</xref>) and that GZMA’s proteolytic activity mediates cell signaling events under physiological conditions. IPA <italic>Disease and Functions</italic> analysis of the 199 DEGs from feet (<italic>Gzma</italic><sup>S211A</sup> + polyIC vs. 6J + polyIC; <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6b</xref>) identified downregulation (negative z-scores) of a series of inflammation and leukocyte activation signatures (<xref ref-type="fig" rid="fig6">Figure 6b</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6f</xref>). IPA USR analysis (core analysis with direct and indirect interactions) indicated downregulation of a series of cytokine, immune receptor, and transcription factor USRs (<xref ref-type="fig" rid="fig6">Figure 6b</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6g</xref>). An IPA USR analysis using the direct-only interaction option, which largely limits the analysis to transcription factors, showed STAT6, STAT3, NFATC2, JUN, NFKB1, and STAT1 to be the dominant downregulated transcription factor signatures in <italic>Gzma</italic><sup>S211A</sup> mice by z-score and p-values (<xref ref-type="fig" rid="fig6">Figure 6b</xref>, <xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4a</xref>). These transcription factors are associated with various innate and adaptive immune responses, with NFATC2 playing a central role in the activation of T cells during the development of an immune response. STAT3 and NF-κB have previously been shown to be activated in macrophages by recombinant GZMA in vitro (<xref ref-type="bibr" rid="bib98">Santiago et al., 2020</xref>), with monocytes/macrophages reported as targets for GZMA activity in a variety of settings (<xref ref-type="bibr" rid="bib24">Garzón-Tituaña et al., 2021</xref>; <xref ref-type="bibr" rid="bib60">Metkar et al., 2008</xref>; <xref ref-type="bibr" rid="bib97">Santiago et al., 2017</xref>; <xref ref-type="bibr" rid="bib116">Spencer et al., 2013</xref>; <xref ref-type="bibr" rid="bib136">Uranga et al., 2016</xref>). Interrogation of the Molecular Signature Database (MSigDB) (<xref ref-type="bibr" rid="bib120">Subramanian et al., 2005</xref>) using GSEAs also identified gene sets associated with activated monocytes (GSE19888) that were significantly enriched in the downregulated genes for <italic>Gzma</italic><sup>S211A</sup> + polyIC vs. 6J + polyIC (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4b</xref>). This observation supports the contention that monocytes/macrophages are activated by circulating GZMA (<xref ref-type="fig" rid="fig6">Figure 6b</xref>). IPA of the 150 core enriched genes from these GSEAs also identified STAT6, STAT3, NFATC2, JUN, NFKB1, and STAT1 as significant USRs, even though only 10 of these 150 genes were significant DEGs for <italic>Gzma</italic><sup>S211A</sup> vs. 6J (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6h</xref>). These USR signatures would thus appear to be a consistent feature of the RNA-Seq data for <italic>Gzma</italic><sup>S211A</sup> + polyIC vs. 6J + polyIC.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Cytoscape analysis of downregulated differentially expressed genes (DEGs) in <italic>Gzma</italic><sup>S211A</sup> mice.</title><p>RNA-Seq of feet taken from <italic>Gzma</italic><sup>S211A</sup> vs. 6J mice 6 hr after polyinosinic:polycytidylic acid (poly(I:C)) injection provided 199 differentially expressed genes (DEGs), of which 100 were downregulated in <italic>Gzma</italic><sup>S211A</sup> mice (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6b</xref>). When analyzed by Cytoscape, the top annotations were associated with negative regulation (underlined) of protease activities (bold) or negative regulation of protein metabolism (which includes anabolism and catabolism). Also significant were a series of annotations associated with negative regulation of cell signaling (italics). The complete list is shown in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6e</xref>; top annotations are shown here with duplicates removed.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Category</th><th align="left" valign="bottom">Description</th><th align="left" valign="bottom">FDR value</th></tr></thead><tbody><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><underline>Negative</underline> regulation of cellular protein metabolic process</td><td align="char" char="hyphen" valign="bottom">1.91E-06</td></tr><tr><td align="left" valign="bottom">UniProt Keywords</td><td align="left" valign="bottom"><bold>Protease inhibitor</bold></td><td align="char" char="hyphen" valign="bottom">9.20E-06</td></tr><tr><td align="left" valign="bottom">SMART Domains</td><td align="left" valign="bottom"><bold>SERine Proteinase INhibitors</bold></td><td align="char" char="hyphen" valign="bottom">2.60E-05</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><underline><bold>Negative</bold></underline> <bold>regulation of catalytic activity</bold></td><td align="char" char="hyphen" valign="bottom">6.73E-05</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><underline>Negative</underline> regulation of nitrogen compound metabolic process</td><td align="char" char="hyphen" valign="bottom">7.86E-05</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><underline>Negative</underline> regulation of cellular metabolic process</td><td align="char" char="hyphen" valign="bottom">7.86E-05</td></tr><tr><td align="left" valign="bottom">InterPro Domains</td><td align="left" valign="bottom"><bold>Serpin superfamily</bold></td><td align="char" char="hyphen" valign="bottom">1.10E-04</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><underline>Negative</underline> regulation of molecular function</td><td align="char" char="hyphen" valign="bottom">1.30E-04</td></tr><tr><td align="left" valign="bottom">GO Function</td><td align="left" valign="bottom"><bold>Enzyme inhibitor activity</bold></td><td align="char" char="hyphen" valign="bottom">1.50E-04</td></tr><tr><td align="left" valign="bottom">UniProt Keywords</td><td align="left" valign="bottom"><bold>Serine protease inhibitor</bold></td><td align="char" char="hyphen" valign="bottom">1.50E-04</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><underline>Negative</underline> regulation of macromolecule metabolic process</td><td align="char" char="hyphen" valign="bottom">1.90E-04</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><underline>Negative</underline> regulation of protein modification process</td><td align="char" char="hyphen" valign="bottom">2.60E-04</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><underline><bold>Negative</bold></underline> <bold>regulation of hydrolase activity</bold></td><td align="char" char="hyphen" valign="bottom">2.80E-04</td></tr><tr><td align="left" valign="bottom">GO Function</td><td align="left" valign="bottom"><bold>Serine-type endopeptidase inhibitor activity</bold></td><td align="char" char="hyphen" valign="bottom">6.60E-04</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><underline>Negative</underline> regulation of phosphate metabolic process</td><td align="char" char="hyphen" valign="bottom">7.40E-04</td></tr><tr><td align="left" valign="bottom">GO Function</td><td align="left" valign="bottom"><bold>Endopeptidase inhibitor activity</bold></td><td align="char" char="hyphen" valign="bottom">8.50E-04</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><underline><bold>Negative</bold></underline> <bold>regulation of endopeptidase activity</bold></td><td align="char" char="." valign="bottom">0.001</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><italic><underline>Negative</underline> regulation of intracellular signal transduction</italic></td><td align="char" char="." valign="bottom">0.0014</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><italic><underline>Negative</underline> regulation of protein phosphorylation</italic></td><td align="char" char="." valign="bottom">0.0014</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom">Regulation of protein metabolic process</td><td align="char" char="." valign="bottom">0.0015</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><italic><underline>Negative</underline> regulation of MAPK cascade</italic></td><td align="char" char="." valign="bottom">0.0061</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><italic><underline>Negative</underline> regulation of cellular process</italic></td><td align="char" char="." valign="bottom">0.0063</td></tr><tr><td align="left" valign="bottom">GO Process</td><td align="left" valign="bottom"><italic><underline>Negative</underline> regulation of biological process</italic></td><td align="char" char="." valign="bottom">0.0071</td></tr></tbody></table></table-wrap></sec><sec id="s2-11"><title>Summary of CHIKV foot swelling results and GZMA’s protease bioactivity</title><p>The CHIKV foot swelling data so far is summarized in <xref ref-type="fig" rid="fig7">Figure 7a</xref> and argues that the 6N background, which includes a functional <italic>Nnt</italic> gene, rather than the absence of GZMA expression, causes the ameliorated foot swelling in <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). The presence of an intact <italic>Nnt</italic> gene can itself reduce foot swelling, although other 6N background genes in <italic>Gzma</italic><sup>-/-</sup> mice also contribute (<xref ref-type="fig" rid="fig4">Figure 4e</xref>). MitoTEMPO treatment and NNT activity share anti-inflammatory activities (<xref ref-type="fig" rid="fig4">Figure 4e</xref>), presumably because both are involved in mitochondrial ROS mitigation. As CHIKV-infected <italic>Gzma</italic><sup>S211A</sup> mice (on a 6J background) show no reduction in foot swelling, the data argues that GZMA is not a major player in CHIKV arthritis.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Summary of chikungunya virus (CHIKV) foot swelling and granzyme A (GZMA) bioactivity, and the poor concordance between the two.</title><p>(<bold>a</bold>) Summary of foot swelling results. 6N and <italic>Gzma</italic><sup>-/-</sup> mice have a 6N or mixed 6J/6N background and have an intact <italic>Nnt</italic> gene and show reduced CHIKV-induced foot swelling. MitoTEMPO treatment also reduced foot swelling. 6J, <italic>Gzma</italic><sup>S211A</sup>, and 6N<sup>∆<italic>Nnt</italic>8-12</sup> mice are all missing exons 8–12 of <italic>Nnt</italic> and show increased foot swelling. (<bold>b</bold>) Summary of GZMA bioactivity. Using polyinosinic:polycytidylic acid (poly(I:C)) to induce high levels of GZMA secretion from NK cells, studies in <italic>Gzma</italic><sup>S211A</sup> mice illustrated that proteolytically active circulating GZMA promotes certain immune-stimulating/pro-inflammatory responses (dominant transcription factor upstream regulators (USRs) are shown; Figure S11a). No clear consensus has emerged regarding the molecular target(s) of GZMA (??); two potential extracellular candidate targets are shown; protease activated receptors and pro-IL-1. (<bold>c</bold>) Low overlap between CHIKV and GZMA induced differentially expressed genes (DEGs). DEGs upregulated in feet by CHIKV infection of 6J mice on days 2 and 7 (a low stringency filter of q &lt; 0.05 was applied to the all gene lists in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2f</xref> to provide these DEGs) were compared with the DEGs upregulated in feet by active GZMA in 6J mice 6 hr after poly(I:C) treatment (i.e., downregulated in <italic>Gzma</italic><sup>S211A</sup> mice; <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6b</xref>). Overlapping genes (n = 27 and 20) are listed in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6i</xref>. The mean peak levels of serum GZMA for each group are shown below the Venn diagrams. (<bold>d</bold>) Cytokine USRs for GZMA vs. CHIKV. A series of cytokine USRs were induced by proteolytically active GZMA (i.e., upregulated for 6J + polyIC vs. <italic>Gzma</italic><sup>S211A</sup> + polyIC; <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6g</xref>, column R). The same USRs were significantly more upregulated by CHIKV infection (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2i</xref>). Data for GZMA (orange) and CHIKV (yellow) are plotted with bubble size representing number of molecules in dataset.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig7-v1.tif"/></fig><p>The <italic>Gzma</italic><sup>S211A</sup> poly(I:C) data is summarized in <xref ref-type="fig" rid="fig7">Figure 7b</xref>. Poly(I:C) induces high levels of circulating GZMA, which is potentiated by type I IFNs, with NK cells the likely source of GZMA (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>). IPA of RNA-Seq data comparing <italic>Gzma</italic><sup>S211A</sup> + poly(I:C) vs. 6J + poly(I:C) supports the view that GZMA’s proteolytic function is required for its bioactivity (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>; <xref ref-type="fig" rid="fig6">Figure 6b</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Circulating proteolytically active GZMA promotes certain immune-stimulating and pro-inflammatory activities (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>; <xref ref-type="bibr" rid="bib105">Shimizu et al., 2019</xref>; <xref ref-type="bibr" rid="bib137">van Daalen et al., 2020</xref>; <xref ref-type="bibr" rid="bib145">Wensink et al., 2015</xref>), with STAT6, STAT3, NFATC2, JUN, NFKB1, and STAT1 identified as dominant transcription factor USRs (<xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig7">7b</xref>; <xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4a</xref>). Consensus regarding the molecular target(s) of extracellular GZMA’s protease activity (<xref ref-type="fig" rid="fig7">Figure 7b</xref>, indicated as ??) remains elusive, but may include protease-activated receptors (<xref ref-type="bibr" rid="bib29">Hansen et al., 2005</xref>; <xref ref-type="bibr" rid="bib113">Sower et al., 1996</xref>; <xref ref-type="bibr" rid="bib124">Suidan et al., 1994</xref>; <xref ref-type="bibr" rid="bib125">Suidan et al., 1996</xref>) and/or pro-IL-1 <xref ref-type="bibr" rid="bib31">Hildebrand et al., 2014</xref>; the latter can become extracellular when cells lyse (<xref ref-type="bibr" rid="bib1">Afonina et al., 2015</xref>).</p></sec><sec id="s2-12"><title>Minor role for GZMA in CHIKV infection and arthritis</title><p>If proteolytically active GZMA is present and has immune-stimulating and pro-inflammatory activities (<xref ref-type="fig" rid="fig7">Figure 7b</xref>), why does it have no significant role in driving the overt CHIKV arthritic foot swelling (with no ameliorated foot swelling in <italic>Gzma</italic><sup>S211A</sup> mice, <xref ref-type="fig" rid="fig7">Figure 7a</xref>)? Firstly, the serum GZMA levels during CHIKV infection and arthritis (≈0.2 and ≈0.075 ng/ml) were substantially lower than those seen after poly(I:C) treatment (≈20 ng/ml) (<xref ref-type="fig" rid="fig7">Figure 7c</xref>), and very much lower than the ≈5 µg of recombinant GZMA-injected intraplantar to generate overt foot swelling in the absence of any other stimuli (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>). Secondly, when the DEGs (q &lt; 0.05) that were upregulated in feet during CHIKV peak viremia (day 2) and peak arthritis (day 7 in the Wilson et al. study) (6J + CHIKV vs. 6J mock infection) were compared with DEGs upregulated by proteolytically active GZMA (6J + poly(I:C) vs. <italic>Gzma</italic><sup>S211A</sup> + poly(I:C); <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6b</xref>), only small overlaps were evident, 27 genes for day 2 and 20 genes for day 7 (<xref ref-type="fig" rid="fig7">Figure 7c</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6i</xref>). Thirdly, although CHIKV infection showed upregulation of many transcription factor and cytokine USRs (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2h</xref>), with some of these also upregulated by poly(I:C) treatment (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6g</xref>), the magnitude of the effects (by p-value and z-scores) was very much smaller for poly(I:C) treatment (shown for cytokine USRs, <xref ref-type="fig" rid="fig7">Figure 7d</xref>). So CHIKV infection (day 2) and arthritis (day 6) stimulate immune and inflammation pathways that overlap with those stimulated by GZMA, but GZMA only plays a minor role in stimulating these pathways during CHIKV viremia (day 2) and arthritis (day 6).</p></sec><sec id="s2-13"><title>6J SRA accessions with <italic>Nnt</italic> exon reads inconsistent with a 6J background</title><p>Given the data presented herein and elsewhere (<xref ref-type="bibr" rid="bib7">Bourdi et al., 2011</xref>; <xref ref-type="bibr" rid="bib18">Fontaine and Davis, 2016</xref>; <xref ref-type="bibr" rid="bib43">Leskov et al., 2017</xref>; <xref ref-type="bibr" rid="bib55">McCambridge et al., 2019</xref>; <xref ref-type="bibr" rid="bib58">Mekada et al., 2009</xref>; <xref ref-type="bibr" rid="bib86">Rao et al., 2020</xref>; <xref ref-type="bibr" rid="bib91">Ripoll et al., 2012</xref>; <xref ref-type="bibr" rid="bib94">Rydström, 2006</xref>; <xref ref-type="bibr" rid="bib133">Toye et al., 2005</xref>; <xref ref-type="bibr" rid="bib142">Vozenilek et al., 2018</xref>) and given that redox regulation affects many cellular processes (<xref ref-type="bibr" rid="bib20">Gambhir et al., 2019</xref>; <xref ref-type="bibr" rid="bib48">Lingappan, 2018</xref>; <xref ref-type="bibr" rid="bib126">Sun et al., 2020</xref>), <italic>Nnt</italic> emerges as a legitimate focus of concern. In addition, the presence of <italic>Nnt</italic> exons 8–12 provides a useful genetic marker to illustrate that a mouse strain is not on a pure 6J background, with genetic backgrounds, as shown herein and elsewhere, able to have a profound influence on phenotype (<xref ref-type="bibr" rid="bib43">Leskov et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Morales-Hernandez et al., 2018</xref>; <xref ref-type="bibr" rid="bib96">Salerno et al., 2019</xref>; <xref ref-type="bibr" rid="bib142">Vozenilek et al., 2018</xref>; <xref ref-type="bibr" rid="bib146">Williams et al., 2021</xref>; <xref ref-type="bibr" rid="bib148">Wolf et al., 2016</xref>). We thus undertook a k-mer mining approach to interrogate the NCBI SRA (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1a</xref>), which (at the time of analysis) contained 61,443 RNA-Seq Run Accessions listing ‘C57BL/6J’ in the strain field of the metadata.</p><p>For ‘C57BL/6J’ Run Accessions, k-mer mining was used to count the number of RNA-Seq reads with sequence homology to <italic>Nnt</italic> exon 2 or exon 9, with these two exons being of similar length (203 bp for exon 2 and 192 bp for exon 9). RNA-Seq analysis of 6J tissues would ordinarily provide reads for exon 2, whereas the presence of exon 9 reads would be inconsistent with a pure 6J background. A conservative k-mer mining approach was used; (i) only an exact match for ‘C57BL/6J’ in the strain field was allowed, (ii) Run Accessions with small or large compressed file sizes (&lt;200 Mb and &gt;1500 Mb) were excluded, (iii) nucleotide mismatches for the 31-nucleotide k-mers were disallowed, (iv) where there were technical replicates, only one was mined, and (v) a read count of <underline>&gt;</underline>10 per exon was used as a cutoff. This k-mer mining analysis revealed that 1008 Run Accessions had reads aligning to both <italic>Nnt</italic> exons 2 and 9, indicating full-length <italic>Nnt</italic> (<italic>Nnt+</italic>), which is not consistent with a 6J background (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7a</xref>). In contrast, 2469 had exon 2 reads, but no exon 9 reads indicating truncated <italic>Nnt</italic> (<italic>Nnt-</italic>), which <italic>is</italic> consistent with a 6J background (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7b</xref>). Lastly, 267 Run Accessions had equivocal results (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7c</xref>). Therefore ≈27% (1008 of 3744) of Run Accessions listing ‘C57BL/6J’ in the strain field had sequencing reads not consistent with a 6J background. The k-mer mining approach was validated for a selected group of Run Accessions using NCBI BLAST alignments, which illustrated excellent concordance with the k-mer mining read count data (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7d</xref>).</p><p>The startlingly high percentage (≈27%) of SRA Accessions listing ‘C57BL/6J’ but having <italic>Nnt</italic> reads inconsistent with a 6J genetic background argues that the <italic>Nnt</italic> gene and associated mixed 6N/6J genetic backgrounds are widely underappreciated in a broad range of research areas. It should be noted that a large number of Run Accessions (n = 206,586) list ‘C57BL/6’ in the strain field and thus do not provide information on the substrain (<xref ref-type="bibr" rid="bib58">Mekada et al., 2009</xref>) being used.</p></sec><sec id="s2-14"><title>BioProjects comparing mice with truncated <italic>Nnt</italic> to mice with full-length <italic>Nnt</italic></title><p>Based on the results of k-mer mining of ‘C57BL/6J’ Run Accessions, BioProjects (n = 373) were grouped into three categories: (i) BioProjects where all the Run Accessions with ‘C57BL/6J’ in the strain field had RNA-Seq reads that were consistent with 6J (<italic>Nnt-</italic>) (62%), (ii) BioProjects where all the Run Accessions with ‘C57BL/6J’ in the strain field were not consistent with 6J (<italic>Nnt+</italic>) (23%), and (iii) BioProjects where some Run Accessions with ‘C57BL/6J’ in the strain field were <italic>Nnt-</italic> and others were <italic>Nnt+</italic> (n = 57; 15%). Thus, 38% (15% plus 23%) of BioProjects had Run Accessions with ‘C57BL/6J’ strain listings not compatible with a 6J background.</p><p>Of the 57 aforementioned BioProjects, 43 had at least one publication associated with the study. These BioProjects were then manually interrogated to identify studies where it was clear (from the paper and the metadata) that comparisons had been made between two groups, where all the Run Accessions in one group were <italic>Nnt</italic>+, and all the Run Accessions in the other group were <italic>Nnt</italic>- (<xref ref-type="fig" rid="fig8">Figure 8</xref>, <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1b</xref>, <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7d and e</xref>). Aside from the CHIKV BioProject described herein, several others emerged (<xref ref-type="fig" rid="fig8">Figure 8</xref>). For example, <italic>Mir31<sup>-/-</sup></italic> mice showed reduced CD8 T cell dysfunction during chronic viral infection when compared to 6J mice (<xref ref-type="bibr" rid="bib63">Moffett et al., 2017</xref>); however, <italic>Mir31<sup>-/-</sup></italic> mice were <italic>Nnt</italic>+ (<xref ref-type="fig" rid="fig8">Figure 8</xref>, BioProject PRJNA385694; <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7d</xref>). <italic>Rel<sup>-/-</sup>;Nfkb1<sup>-/-</sup>;Cd4<sup>Cre</sup>;Rela<sup>fx/fx</sup></italic> mice were compared with 6J mice to implicate RIPK1 and IKK in thymocyte survival (<xref ref-type="bibr" rid="bib144">Webb et al., 2019</xref>); however, the control 6J mice were <italic>Nnt</italic>+ (<xref ref-type="fig" rid="fig8">Figure 8</xref>, BioProject PRJEB30085; <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7d</xref>). Bruce4 ES cells were reported to be on a 6J background (<xref ref-type="bibr" rid="bib2">Ank et al., 2008</xref>) and were derived from a B6 mouse strain congenic for the Thy1.1 allele from an NZB mouse (<xref ref-type="bibr" rid="bib34">Hughes et al., 2007</xref>; <xref ref-type="bibr" rid="bib39">Köntgen et al., 1993</xref>), with these ES cells clearly <italic>Nnt</italic>+ (<xref ref-type="fig" rid="fig8">Figure 8</xref>, accession SRR923434; <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7d</xref>). The reported differences between Bruce4 and 6J genomes were thus likely more to do with the background than with genetic instability (<xref ref-type="bibr" rid="bib34">Hughes et al., 2007</xref>). <italic>Il28ra<sup>-/-</sup></italic> mice were generated using Bruce4 cells and were compared with 6J mice (<xref ref-type="bibr" rid="bib2">Ank et al., 2008</xref>); however, RNA-Seq analysis of <italic>Il28ra</italic><sup>-/-</sup> mice showed that (like Bruce4 cells) these mice had full-length <italic>Nnt</italic> (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2</xref>). <italic>Myd88<sup>-/-</sup>;Trif<sup>-/-</sup></italic> double knockout mice were compared with 6J mice during infection with <italic>Staphylococcus aureus</italic> (<xref ref-type="bibr" rid="bib102">Scumpia et al., 2017</xref>); however, the 6J (wild-type) mice were <italic>Nnt</italic>+ (<xref ref-type="fig" rid="fig8">Figure 8</xref>, BioProject PRJNA382450; <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7e</xref>). Female <italic>Cystatin C<sup>-/-</sup></italic> mice display significantly lower clinical signs of experimental autoimmune encephalomyelitis (EAE) when compared with 6J mice (<xref ref-type="bibr" rid="bib32">Hoghooghi et al., 2020</xref>); however, <italic>Cystatin C<sup>-/-</sup></italic> mice were all <italic>Nnt+</italic> (<xref ref-type="fig" rid="fig8">Figure 8</xref>, BioProject PRJNA662247; <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7d</xref>). Deletion of <italic>Nr1h3</italic> resulted in reduced chromatin access at a large fraction of Kupffer-cell-specific enhancers (<xref ref-type="bibr" rid="bib95">Sakai et al., 2019</xref>); however, <italic>Nr1h3<sup>-/-</sup>,</italic> but not the wild-type control, were all <italic>Nnt+</italic> (<xref ref-type="fig" rid="fig8">Figure 8</xref>, BioProject PRJNA528435; <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7d</xref>). <italic>Sesn1<sup>-/-</sup></italic> mice were used to show that loss of Sestrin1 aggravates disuse-induced muscle atrophy when compared with 6J mice (<xref ref-type="bibr" rid="bib103">Segalés et al., 2020</xref>); however, <italic>Sesn1<sup>-/-</sup></italic> mice were all <italic>Nnt+</italic> (<xref ref-type="fig" rid="fig8">Figure 8</xref>, BioProject PRJNA563889; <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7d</xref>).</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>k-mer mining of BioProjects where Nnt<sup>+</sup> mice were compared with <italic>Nnt</italic><sup>-</sup> mice.</title><p>The NCBI Sequence Read Archive (SRA) database was interrogated by k-mer mining for BioProjects where (i) some Run Accessions (listing 6J as the mouse strain) had reads compatible with a 6J background (reads for <italic>Nnt</italic> exon 2, but not exon 9) and (ii) other Run Accessions in that BioProject (listing 6J as the mouse strain) had reads not compatible with a 6J background (reads for <italic>Nnt</italic> exons 2 and 9). The methodology is described in <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1a</xref>, validated by BLAST alignments (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1b</xref>), with raw data in <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7d and e</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig8-v1.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>k-mer mining methodology and validation.</title><p>(<bold>a</bold>) Outline of bioinformatics approach. See Materials and methods for details. (<bold>b</bold>) Reads aligned to <italic>Nnt</italic> mRNA for selected accessions from <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>. The results illustrate that where k-mer mining showed the presence of reads for exons 2 and 9, those Run Accessions had full-length <italic>Nnt</italic> mRNA (not consistent with 6J). k-mer mining showing the presence of reads for exon 2, but not 9, represent runs where exons 8–12 are missing (consistent with 6J).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig8-figsupp1-v1.tif"/></fig><fig id="fig8s2" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 2.</label><caption><title>Bruce4 ES cell line and <italic>IL28RA<sup>-/-</sup></italic> mouse <italic>Nnt</italic> genotypes.</title><p>(<bold>a</bold>) Integrative Genomics Viewer (IGV) Sashimi plots of RNA-Seq alignments to the <italic>Nnt</italic> gene using the C3H/HeJ reference genome. Undertaken as described for <xref ref-type="fig" rid="fig3">Figure 3d</xref>. <italic>Il28ra<sup>-/-</sup></italic> mice were available in-house and were subjected to RNA-Seq analysis. Bruce4 RNA-Seq data was obtained from SRR923434. (<bold>b</bold>) RNA-Seq analysis showed that, as expected, <italic>Il28ra</italic> (<italic>Ifnlr1</italic>) mRNA expression is lost in <italic>Il28ra<sup>-/-</sup></italic> mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70207-fig8-figsupp2-v1.tif"/></fig></fig-group><p>Of the 57 BioProjects containing <italic>Nnt+</italic> and <italic>Nnt+</italic> Run Accessions, several contained comparisons in which one group contained a combination of <italic>Nnt+</italic> and <italic>Nnt-</italic> Run Accessions<italic>,</italic> while the other group(s) contained either all <italic>Nnt+</italic> or all <italic>Nnt-</italic> Run Accessions (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7f</xref>).</p><p>Whether the <italic>Nnt</italic> differences (or other background gene differences) would have significantly affected the interpretation of phenotypes in the aforementioned studies remains to be established. It is worth noting that herein we have only compared phenotypes of homozygotes (<xref ref-type="fig" rid="fig7">Figure 7a</xref>), with intermediate phenotypes potentially seen for heterozygotes (<xref ref-type="bibr" rid="bib93">Ronchi et al., 2013</xref>). Our k-mer mining analysis also did not distinguish between <italic>Nnt<sup>+/+</sup></italic> and <italic>Nnt<sup>+/-</sup></italic>, doing so would require extraction of <italic>Nnt</italic> reads, alignment to the C3H/HeJ genome, and analysis using Sashimi plots (as in <xref ref-type="fig" rid="fig3">Figure 3d</xref>). Nevertheless, the data argues that differences in <italic>Nnt</italic> or other background gene differences are widely underappreciated in a range of research fields and have the potential to compromise a wide range of studies.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Despite a large body of literature, no clear consensus has emerged regarding the physiological function of GZMA (see ‘Introduction’). This lack of consensus might now, at least in part, be explained by the extensive use of <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). We show herein that this mouse strain is on a mixed 6J/6N genetic background and contains a full-length <italic>Nnt</italic> gene, with both <italic>Nnt</italic> and other 6N background genes, rather than loss of GZMA expression, responsible for the ameliorated CHIKV arthritis phenotype. Whether all the phenotypes reported for <italic>Gzma</italic><sup>-/-</sup> mice (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) are compromised by <italic>Nnt</italic> and/or the mixed background remains unclear and would require new experiments to resolve, similar to those described herein for CHIKV arthritis. However, <italic>Nnt</italic> has been reported to affect redox regulation and activation in macrophages (<xref ref-type="bibr" rid="bib91">Ripoll et al., 2012</xref>; <xref ref-type="bibr" rid="bib96">Salerno et al., 2019</xref>), with an intact <italic>Nnt</italic> gene conceivably reducing cross-presentation (<xref ref-type="bibr" rid="bib12">Dingjan et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Nalle et al., 2020</xref>) and CD8 T cell responses (<xref ref-type="bibr" rid="bib74">Oberkampf et al., 2018</xref>). In addition, 6N vs. 6J background differences (as herein) have shown clear phenotypes in a wide range of settings (<xref ref-type="bibr" rid="bib43">Leskov et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Morales-Hernandez et al., 2018</xref>; <xref ref-type="bibr" rid="bib86">Rao et al., 2020</xref>; <xref ref-type="bibr" rid="bib96">Salerno et al., 2019</xref>; <xref ref-type="bibr" rid="bib142">Vozenilek et al., 2018</xref>; <xref ref-type="bibr" rid="bib146">Williams et al., 2021</xref>; <xref ref-type="bibr" rid="bib148">Wolf et al., 2016</xref>).</p><p>The data from <italic>Gzma</italic><sup>S211A</sup> mice (that were generated using CRISPR on a 6J background) represents the first in vivo assessment of the physiological function of GZMA without the confounding influence of differences in <italic>Nnt</italic> or other genes associated with the mixed genetic background. The results from this analysis support the view that the physiological activity of GZMA is mediated by its protease activity (<xref ref-type="fig" rid="fig7">Figure 7b</xref>; <xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>). This is an important point because protease-independent functions have been documented for several proteases (<xref ref-type="bibr" rid="bib9">Calhan and Seyrantepe, 2017</xref>; <xref ref-type="bibr" rid="bib56">McNutt et al., 2007</xref>; <xref ref-type="bibr" rid="bib85">Pu et al., 2019</xref>; <xref ref-type="bibr" rid="bib129">Szabo et al., 2016</xref>). One of the proposed activities for GZMA, the binding to TLR9 and potentiation of TLR9 signaling (<xref ref-type="bibr" rid="bib105">Shimizu et al., 2019</xref>), was not reported to require GZMA’s protease activity. However, using mice defective in TLR9 signaling, we were unable to find evidence that TLR9 is required for GZMA’s pro-inflammatory activity (<xref ref-type="supplementary-material" rid="supp8">Supplementary file 8</xref>). Our studies also support the view that secreted extracellular GZMA has biological activity in the absence of perforin (or GZMB) (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). This contrasts with the traditional view of GZMA as a mediator of cell death, which requires perforin to deliver GZMA to the cytoplasm, where a series of target molecules are cleaved (<xref ref-type="bibr" rid="bib47">Liesche et al., 2018</xref>; <xref ref-type="bibr" rid="bib149">Wu et al., 2019</xref>; <xref ref-type="bibr" rid="bib154">Zhou et al., 2020</xref>). Cleavage of SET complex proteins (<xref ref-type="bibr" rid="bib52">Mandrup-Poulsen, 2017</xref>; <xref ref-type="bibr" rid="bib64">Mollah et al., 2017</xref>) would similarly require delivery of GZMA to the cytoplasm. Although we cannot formally exclude translocation of circulating GZMA into the cytoplasm via some unknown mechanism, the <italic>Gzma</italic><sup>S211A</sup> RNA-Seq experiment does ostensibly exclude perforin as NK cells only produce perforin (and GZMB) protein after ≈24 hr of appropriate stimulation (<xref ref-type="bibr" rid="bib17">Fehniger et al., 2007</xref>). Extracellular target candidates for GZMA include protease-activated receptors (<xref ref-type="bibr" rid="bib29">Hansen et al., 2005</xref>; <xref ref-type="bibr" rid="bib113">Sower et al., 1996</xref>; <xref ref-type="bibr" rid="bib124">Suidan et al., 1994</xref>; <xref ref-type="bibr" rid="bib125">Suidan et al., 1996</xref>) and may also include pro-IL-1 (<xref ref-type="bibr" rid="bib31">Hildebrand et al., 2014</xref>; <xref ref-type="fig" rid="fig7">Figure 7c</xref>) as pro-IL-1 can become extracellular when cells lyse (<xref ref-type="bibr" rid="bib1">Afonina et al., 2015</xref>). Overall one might speculate that in such settings NK-derived GZMA synergizes with type I IFN responses to act as a systemic alarmin (<xref ref-type="fig" rid="fig7">Figure 7b</xref>). <italic>Gzma</italic><sup>S211A</sup> mice will provide an invaluable tool for future studies into further refining our understanding of the role and molecular targets of GZMA.</p><p>The ability to reduce CHIKV arthritis in 6J mice with MitoTEMPO might suggest such antioxidant drugs have potential utility as anti-inflammatory treatments for alphaviral arthritides (<xref ref-type="bibr" rid="bib122">Suhrbier et al., 2012</xref>; <xref ref-type="bibr" rid="bib153">Zaid et al., 2021</xref>). However, MitoTEMPO treatment may simply be correcting (at least in part, <xref ref-type="fig" rid="fig4">Figure 4e</xref>) the <italic>Nnt</italic> defect in 6J mice by scavenging excess mitochondrial ROS arising from the loss of functional NNT (<xref ref-type="bibr" rid="bib143">Ward et al., 2020</xref>). The argument that similar antioxidant treatments would be effective in human diseases may thus not be overly compelling, given that most humans have a functional <italic>Nnt</italic> gene. Perhaps noteworthy is that &gt;300 papers listed in PubMed use MitoTEMPO in 6J mice, with many reporting effective disease amelioration with MitoTEMPO treatments, for example (<xref ref-type="bibr" rid="bib3">Aoyama et al., 2012</xref>; <xref ref-type="bibr" rid="bib46">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib132">To et al., 2020</xref>; <xref ref-type="bibr" rid="bib141">Vincent et al., 2020</xref>; <xref ref-type="bibr" rid="bib150">Wu et al., 2020</xref>). Unfortunately, antioxidants have not shown clear benefits in human clinical trials (<xref ref-type="bibr" rid="bib10">Casas et al., 2020</xref>; <xref ref-type="bibr" rid="bib35">Jiang et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Kovacic, 2020</xref>; <xref ref-type="bibr" rid="bib117">Steinhubl, 2008</xref>).</p><p>The Jackson Laboratory generated the 6J inbred mouse strain in the 1920s–1930s, with this mouse strain the most frequently used mouse strain in biomedical research. Although differences in the <italic>Nnt</italic> gene (or other background genes) have previously been reported as underappreciated in metabolism research (<xref ref-type="bibr" rid="bib18">Fontaine and Davis, 2016</xref>), the data herein and elsewhere argue that this issue extends to other areas of research (<xref ref-type="bibr" rid="bib7">Bourdi et al., 2011</xref>; <xref ref-type="bibr" rid="bib43">Leskov et al., 2017</xref>; <xref ref-type="bibr" rid="bib55">McCambridge et al., 2019</xref>; <xref ref-type="bibr" rid="bib65">Morales-Hernandez et al., 2018</xref>; <xref ref-type="bibr" rid="bib86">Rao et al., 2020</xref>; <xref ref-type="bibr" rid="bib91">Ripoll et al., 2012</xref>; <xref ref-type="bibr" rid="bib96">Salerno et al., 2019</xref>; <xref ref-type="bibr" rid="bib142">Vozenilek et al., 2018</xref>; <xref ref-type="bibr" rid="bib146">Williams et al., 2021</xref>; <xref ref-type="bibr" rid="bib148">Wolf et al., 2016</xref>), with age effects also reported (<xref ref-type="bibr" rid="bib26">Ghosh et al., 2014</xref>; <xref ref-type="bibr" rid="bib135">Ubaida-Mohien et al., 2019</xref>). Of concern was that ≈27% of SRA Run Accessions and ≈38% of BioProjects listing C57BL/6J as the mouse strain had <italic>Nnt</italic> sequence data not consistent with a pure 6J background. Mouse strain listing errors or inadequate backcrossing to 6J would thus appear to be common for SRA RNA-Seq submissions. The full extent to which <italic>Nnt</italic> and/or genetic backgrounds have complicated interpretation of knockout mouse studies remains to be addressed, but may require extensive new experiments such as those described herein for GZMA.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (chikungunya virus)</td><td align="left" valign="bottom">CHIKV</td><td align="left" valign="bottom">Dr. P. Roques (CEA, Fontenay-aux-Roses, France)</td><td align="left" valign="bottom">KT449801.1</td><td align="left" valign="bottom">Isolate LR2006-OPY1</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TRIzol</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# 15596026</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MitoTEMPO</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat#1334850-99-5</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">TruSeq RNA Sample Prep Kit (v2)</td><td align="left" valign="bottom">Illumina</td><td align="left" valign="bottom">SCR_010233</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">TruSeq Stranded mRNA library preparation kit</td><td align="left" valign="bottom">Illumina</td><td align="left" valign="bottom">SCR_010233</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">QIAamp DNA Micro Kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat# 56304</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">iScript cDNA Synthesis Kit</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom">Cat# 1708890</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Q5 Hot Start High-Fidelity DNA Polymerase</td><td align="left" valign="bottom">NEB</td><td align="left" valign="bottom">Cat# M0493S</td><td align="left" valign="bottom">Enzyme</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Illumina HiSeq 2000 Sequencer</td><td align="left" valign="bottom">Illumina</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_010233">SCR_010233</ext-link></td><td align="left" valign="bottom">Sequencing platform</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">NextSeq 550</td><td align="left" valign="bottom">Illumina</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016381">SCR_016381</ext-link></td><td align="left" valign="bottom">Sequencing platform</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">NovaSeq 6000</td><td align="left" valign="bottom">Illumina</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016387">SCR_016387</ext-link></td><td align="left" valign="bottom">Sequencing platform</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">k-mer_mining_SRA</td><td align="left" valign="bottom">GitHub</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/CameronBishop/k-mer_mining_SRA">https://github.com/CameronBishop/k-mer_mining_SRA</ext-link></td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Cercopithecus aethiops</italic>)</td><td align="left" valign="bottom">Vero cells</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0059">CVCL_0059</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Aedes albopictus</italic>)</td><td align="left" valign="bottom">C6/36 cells</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_Z230">CVCL_Z230</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6J</td><td align="left" valign="bottom">Animal Resources Centre (Canning Vale, WA, Australia)</td><td align="left" valign="bottom">IMSR_JAX:000664</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57BL/6N</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">Stock no. 005304</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57BL/6-<italic>Gzma</italic><sup>-/-</sup></td><td align="left" valign="bottom">Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia</td><td align="left" valign="bottom">Knockout mouse</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57BL/6J-<italic>Gzmb</italic><sup>-/-</sup></td><td align="left" valign="bottom">Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia</td><td align="left" valign="bottom">Knockout mouse</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57BL/6J-<italic>Gzma</italic><sup>S211A</sup></td><td align="left" valign="bottom">The Australian Phenomics Network, Monash University, Melbourne, Australia (this paper)</td><td align="left" valign="bottom">Mutant mouse</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57BL/6N<sup>∆<italic>Nnt</italic>8-12</sup></td><td align="left" valign="bottom">The Australian Phenomics Network, Monash University, Melbourne, Australia (this paper)</td><td align="left" valign="bottom">Knockout mouse</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57BL/6J-<italic>Ifnar</italic><sup>-/-</sup></td><td align="left" valign="bottom">Dr P. Hertzog (Monash University, Melbourne, Australia)</td><td align="left" valign="bottom">Knockout mouse</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57BL/6-<italic>Il28ra</italic><sup>-/-</sup></td><td align="left" valign="bottom">Bristol-Myers Squibb (PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25901316/">25901316</ext-link>)</td><td align="left" valign="bottom">Knockout mouse</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Nnt_RTPCR_F1</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AACAGTGCAAGGAGGTGGAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Nnt_RTPCR_R1</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GTGCCAAGGTAAGCCACAAT</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FastQC</td><td align="left" valign="bottom">Babraham Institute</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014583">SCR_014583</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MultiQC</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27312411/">27312411</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014982">SCR_014982</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cutadapt</td><td align="left" valign="bottom">DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.14806/ej.17.1.200">https://doi.org/10.14806/ej.17.1.200</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_011841">SCR_011841</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">STAR</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23104886/">23104886</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_004463">SCR_004463</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RSEM</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21816040/">21816040</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013027">SCR_013027</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">EdgeR</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27280887/">27280887</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_012802">SCR_012802</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">‘Ingenuity Pathway Analysis’ (IPA)</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008653">SCR_008653</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cytoscape</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/14597658/">14597658</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003032">SCR_003032</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">STRING</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30476243/">30476243</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_005223">SCR_005223</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">‘Gene Set Enrichment Analysis’ (GSEA)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16199517/">16199517</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003199">SCR_003199</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">‘Integrative Genomics Viewer‘ (IGV)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21221095/">21221095</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_011793">SCR_011793</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">minimap2</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29750242/">29750242</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018550">SCR_018550</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">BigQuery</td><td align="left" valign="bottom">Google Cloud Platform</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001011">SCR_001011</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">fasterq-dump</td><td align="left" valign="bottom">SRA tool kit</td><td align="left" valign="bottom">sra-tools v 2.9.1</td><td align="left" valign="bottom"> </td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Cell lines and CHIKV</title><p>Vero (ATCC#: CCL-81) and C6/36 cells (ATCC# CRL-1660) were cultured as described (<xref ref-type="bibr" rid="bib73">Nguyen et al., 2020</xref>). Cells were checked for mycoplasma using MycoAlert Mycoplasma Detection Kit (Lonza, Basel, Switzerland). FBS was checked for endotoxin contamination using RAW264.7-HIV-LTR-luc cells (<xref ref-type="bibr" rid="bib37">Johnson et al., 2005</xref>) before purchase. CHIKV (isolate LR2006-OPY1; GenBank KT449801.1; DQ443544.2) was a kind gift from Dr. P. Roques (CEA, Fontenay-aux-Roses, France), was propagated in C6/36 cells, and titers determined by CCID<sub>50</sub> assays (<xref ref-type="bibr" rid="bib73">Nguyen et al., 2020</xref>). Virus was also checked for mycoplasma (<xref ref-type="bibr" rid="bib42">La Linn et al., 1995</xref>).</p></sec><sec id="s4-2"><title>Mice and CHIKV infections</title><p>C57BL/6J mice were purchased from Animal Resources Centre (Canning Vale, WA, Australia). C57BL/6N mice were purchased from The Jackson Laboratory (stock no. 005304). <italic>Gzma</italic><sup>-/-</sup> mice were generated as described (<xref ref-type="bibr" rid="bib15">Ebnet et al., 1995</xref>) and were provided by the Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. <italic>Gzmb<sup>-/-</sup></italic> mice were generated as described (<xref ref-type="bibr" rid="bib69">Müllbacher et al., 1999</xref>) and were backcrossed onto C57BL/6J mice a total of 12 times and were provided by the Peter MacCallum Cancer Centre. The Australian Phenomics Network, Monash University, Melbourne, Australia, used CRISPR to generate (i) <italic>Gzma</italic><sup>S211A</sup> mice on a 6J background and (ii) 6N<sup>∆<italic>Nnt</italic>8-12</sup> mice on a 6N background. <italic>Ifnar</italic><sup>-/-</sup> mice (<xref ref-type="bibr" rid="bib151">Yan et al., 2020</xref>) were kindly provided by Dr P. Hertzog (Monash University). <italic>Il28ra<sup>-/-</sup></italic> mice (<xref ref-type="bibr" rid="bib2">Ank et al., 2008</xref>) were kindly provided by Bristol-Myers Squibb (<xref ref-type="bibr" rid="bib112">Souza-Fonseca-Guimaraes et al., 2015</xref>). All GMO mice were bred in-house at QIMR Berghofer MRI.</p><p>Female mice 6–8 weeks old were infected with 10<sup>4</sup> CCID<sub>50</sub> CHIKV (isolate LR2006 OPY1) s.c. into each hind foot, with foot measurements and viremia determined as described (<xref ref-type="bibr" rid="bib23">Gardner et al., 2010</xref>; <xref ref-type="bibr" rid="bib73">Nguyen et al., 2020</xref>; <xref ref-type="bibr" rid="bib83">Prow et al., 2018</xref>).</p></sec><sec id="s4-3"><title>RNA-Seq of feet of CHIKV-infected GMO mice</title><p>Mice were infected with CHIKV, feet collected on day 6, and RNA samples prepared as described previously (<xref ref-type="bibr" rid="bib30">Hazlewood et al., 2021</xref>; <xref ref-type="bibr" rid="bib87">Rawle et al., 2021</xref>; <xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>) with minor modifications. Briefly, library preparation and sequencing were conducted by the Australian Genome Research Facility (Melbourne, Australia) (<xref ref-type="bibr" rid="bib30">Hazlewood et al., 2021</xref>) or were conducted in-house (<xref ref-type="bibr" rid="bib87">Rawle et al., 2021</xref>). RNA concentration and quality was measured using TapeStation D1K TapeScreen assay (Agilent). cDNA libraries were prepared using a TruSeq RNA Sample Prep Kit (v2) (Illumina Inc, San Diego, USA), which included isolation of poly-adenylated RNA using oligo-dt beads or total RNA library preparation with rRNA depletion (NEBNext Ultra II Directional RNA Library Prep Kit for Illumina and NEBNext rRNA Depletion Kit v2). Paired end reads were generated using the Illumina HiSeq 2000 Sequencer (Illumina Inc) (100 bp) or Illumina NextSeq 550 platform (75 bp). Per-base sequence quality for &gt;90% bases was above Q30 for all samples. Raw sequencing reads were assessed using FastQC (v0.11.8) (<xref ref-type="bibr" rid="bib110">Simons, 2010</xref>) and MultiQC (v1.7) (<xref ref-type="bibr" rid="bib16">Ewels et al., 2016</xref>) and trimmed using Cutadapt (v2.3) (<xref ref-type="bibr" rid="bib53">Martin, 2011</xref>) to remove adapter sequences and low-quality bases. Trimmed reads were aligned to the GRCm38 primary assembly reference and the GENCODE M23 gene model using STAR aligner (v2.7.1a) (<xref ref-type="bibr" rid="bib14">Dobin et al., 2013</xref>), with more than 95% of reads mapping to protein coding regions. Counts per gene were generated using RSEM (v1.3.1) (<xref ref-type="bibr" rid="bib44">Li and Dewey, 2011</xref>), and differential expression analysis was undertaken using EdgeR in Galaxy (<xref ref-type="bibr" rid="bib140">Varet et al., 2016</xref>) with default settings and a count sum <underline>&gt;</underline>1 filter applied. Counts were normalized using the TMM method and modeled using the likelihood ratio test, glmLRT().</p></sec><sec id="s4-4"><title>Bioinformatic analyses</title><p>Pathway analysis of DEGs in direct and indirect or direct-only interactions was investigated using IPA (QIAGEN; <xref ref-type="bibr" rid="bib104">Shannon et al., 2003</xref>). Enrichment for biological processes, molecular functions, KEGG pathways, and other gene ontology categories in DEG lists was elucidated using the STRING database (<xref ref-type="bibr" rid="bib130">Szklarczyk et al., 2019</xref>) in Cytoscape (v3.7.2) (<xref ref-type="bibr" rid="bib104">Shannon et al., 2003</xref>). GSEA (<xref ref-type="bibr" rid="bib120">Subramanian et al., 2005</xref>) was performed on a desktop application (GSEA v4.0.3) (<ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/gsea/">http://www.broadinstitute.org/gsea/</ext-link>) to look for enrichment of DEGs in full gene sets preranked by fold change.</p></sec><sec id="s4-5"><title>WGS of <italic>Gzma</italic><sup>-/-</sup> mice</title><p>QIAamp DNA Micro Kit (QIAGEN) was used to purify genomic DNA from <italic>Gzma</italic><sup>-/-</sup> mice spleen as per the manufacturer’s instructions. DNA was sent to the Australian Genome Research Facility (AGRF) for WGS using the Illumina NovaSeq platform with 150 bp paired end reads. The primary sequence data was generated using the Illumina bcl2fastq 2.20.0.422 pipeline. Reads were mapped to the mm10 genome assembly (GRCm38) using BWA-mem, and .bam files were provided. Mapped reads were viewed in Integrative Genomics Viewer (IGV) (<xref ref-type="bibr" rid="bib92">Robinson et al., 2011</xref>) and 6N features identified manually based on previous publications (<xref ref-type="bibr" rid="bib59">Mekada et al., 2015</xref>; <xref ref-type="bibr" rid="bib109">Simon, 2013</xref>).</p></sec><sec id="s4-6"><title>Alignment to mouse genomes</title><p>FastQ files were generated as described or were downloaded from the SRA using Aspera. Reads were trimmed using Cutadapt (<xref ref-type="bibr" rid="bib53">Martin, 2011</xref>) and mapped using STAR aligner (v2.7.1a) for RNA-Seq or minimap 2 (<xref ref-type="bibr" rid="bib45">Li, 2018</xref>) for WGS data. IGV was used to visualize reads mapping to the <italic>Nnt</italic> gene after mapping to the GRCm38 primary assembly reference for the truncated version of the gene and to the mouse C3H_HeJ_v1 reference (GCA_001632575.1) to observe full-length <italic>Nnt</italic>.</p></sec><sec id="s4-7"><title><italic>Nnt</italic> RT-PCR</title><p>RT-PCR was undertaken essentially as described using the primer set (F1 <named-content content-type="sequence">AACAGTGCAAGGAGGTGGAC</named-content>, R1 <named-content content-type="sequence">GTGCCAAGGTAAGCCACAAT</named-content>) (Integrated DNA Technologies; <xref ref-type="bibr" rid="bib33">Huang et al., 2006</xref>). RNA was extracted from testes using TRIzol (Sigma-Aldrich) according to the manufacturer’s instructions. cDNA was generated using iScript cDNA Synthesis Kit (Bio-Rad) and Q5 Hot Start High-Fidelity DNA Polymerase (NEB) was used for PCR.</p></sec><sec id="s4-8"><title>Histology</title><p>Histology and H&amp;E staining were undertaken as described (<xref ref-type="bibr" rid="bib87">Rawle et al., 2021</xref>). Sections were scanned using Aperio AT Turbo (Aperio, Vista, CA) and analyzed using Aperio Image-Scope software (Leica Biosystems, Mt Waverley, Australia) (v10). Quantitation using Positive Pixel Count v9 was used to generate blue/red pixel ratios as a measure of leukocyte infiltrates, as described (<xref ref-type="bibr" rid="bib81">Poo et al., 2014</xref>).</p></sec><sec id="s4-9"><title>MitoTEMPO treatment</title><p>Mice were injected i.v. daily, on the indicated day post CHIKV infection, with 62.5 µg of MitoTEMPO (Sigma-Aldrich) in 150 µl of PBS.</p></sec><sec id="s4-10"><title>RNA-Seq of poly(I:C) injection for <italic>Gzma</italic><sup>S211A</sup> vs. 6J mice</title><p>Age-matched female <italic>Gzma</italic><sup>S211A</sup> and 6J mice were injected i.v. with 250 µg of poly(I:C) in 150 µl of PBS. After 6 hr, mice were euthanized, spleen and whole feet were harvested, and RNA isolated as described previously (<xref ref-type="bibr" rid="bib84">Prow et al., 2019</xref>; <xref ref-type="bibr" rid="bib147">Wilson et al., 2017</xref>). Three RNA pools were generated for each mouse strain, whereby each pool contained equal amounts of RNA from four feet from four mice, or two spleens from two mice. RNA-Seq of polyadenylated RNA was then undertaken in-house at QIMR Berghofer MRI. RNA integrity was assessed using the TapeStation system (Agilent Technologies), and libraries were prepared using the TruSeq Stranded mRNA library preparation kit (Illumina). Sequencing was performed on the Illumina NextSeq 550 platform with 75 bp paired end reads. Per-base sequence quality for &gt;92% bases was above Q30 for all samples. Raw sequencing reads were then processed as above.</p></sec><sec id="s4-11"><title>k-mer mining</title><p>An exact-match (31 mer) k-mer mining approach was used to identify RNA-Seq read files (Accessions) with C57BL/6J mice listed as the mouse strain, but where <italic>Nnt</italic> reads were incompatible with 6J background. Metadata associated with the National Center for Biotechnology Information’s SRA was screened using the Google Cloud Platform’s BigQuery service with the Structured Query Language (SQL) command: SELECT m.bioproject, m.acc, m.sample_name, m.platform, m.mbytes, m.mbases FROM nih-sra-datastore.sra.metadata as m, UNNEST (m.attributes) as a WHERE m.organism = ‘<italic>Mus musculus</italic>’ and m.assay_type = ‘RNA-Seq’ and a.v = ‘C57BL/6J.’ Technical replicates for the same sample were collapsed by taking only the first accession for each Biosample. Accessions were then filtered on the basis of their compressed size so that only those between 200 Mb and 1500 Mb were retained; we found that read files of this size provided adequate sequencing depth to detect <italic>Nnt</italic> exon reads. Accessions were sorted according to BioProject and used as input for a bioinformatics pipeline executed on the Google Cloud Platform, which allowed access to the ‘SRA in the cloud’ database. A copy of our Bash script to automate the pipeline is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/CameronBishop/k-mer_mining_SRA">https://github.com/CameronBishop/k-mer_mining_SRA</ext-link> (<xref ref-type="bibr" rid="bib4">Bishop, 2021</xref>). Accession read files were converted to FastQ format using fasterq-dump (SRA tool kit). BBduk version 38.87 (<xref ref-type="bibr" rid="bib8">Bushnell, 2020</xref>) was used with default parameters to screen each read for sequence homology to exons 2 and 9 of the <italic>Nnt</italic> gene. Reads sharing at least one 31-mer with either exon were counted as a ‘match’ for that exon. FastQ files with at least 10 matches to exon 2 and 0 matches to exon 9 were classed as consistent with a 6J genotype (truncated <italic>Nnt</italic>), while FastQ files with at least 10 matches to each exon were classed as not consistent with a 6J genotype. Results were curated using BigQuery to confirm that for each Accession’s metadata entry the ‘strain_sam’ field (or equivalent) of the metadata ‘Attributes’ table was listed as C57BL/6J.</p><p>BioProjects were identified where some read files contained exon 2 reads and no exon 9 reads, whereas others contained both exon 2 and exon 9 reads. The literature and Gene Expression Omnibus submissions associated with these BioProjects were then consulted to identify BioProjects where mice with full-length <italic>Nnt</italic> had been compared with mice with truncated <italic>Nnt</italic>.</p></sec><sec id="s4-12"><title>Determination of GZMA levels in mouse serum samples</title><p>Mouse serum was collected in Microvette 500 Z gel tubes (Sarstedt) with GZMA levels determined using a GZMA ELISA kit (MyBioSource, San Diego, CA, MBS704766) according to the manufacturer’s instructions.</p></sec><sec id="s4-13"><title>Statistics</title><p>Statistical analysis of experimental data was performed using IBM SPSS Statistics for Windows, version 19.0. The <italic>t</italic>-test was performed when the difference in variances was &lt;4, skewness was &gt;-2, and kurtosis was &lt;2, otherwise the Kolmogorov–Smirnov test was used.</p></sec><sec id="s4-14"><title>Data, code, and GMO mouse availability</title><p>All data are provided in the article and accompanying supplementary files. Raw sequencing data generated for this publication has been deposited in the NCBI SRA. RNA-Seq NCBI BioProjects: (i) 6J + CHIKV vs. 6J mock infection, day 2 and day 7 feet (PRJNA431476); <italic>Gzma</italic><sup>-/-</sup> + CHIKV vs. 6J + CHIKV, day 6 feet (PRJNA664644); (ii) 6N<sup>∆<italic>Nnt</italic>8-12</sup> + CHIKV vs. 6N + CHIKV, day 6 feet (PRJNA779556); (iii) 6J + MitoTEMPO + CHIKV vs. 6J + PBS + CHIKV (PRJNA779556); and (iv) 6J <italic>Gzma</italic><sup>S211A</sup> + poly(I:C) vs. 6J + poly(I:C) feet and spleen 6 hr (PRJNA666748). WGS of <italic>Gzma</italic><sup>-/-</sup> mice NCBI BioProject PRJNA664888.</p><p>A copy of our code to automate the k-mer mining pipeline is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/CameronBishop/k-mer_mining_SRA">https://github.com/CameronBishop/k-mer_mining_SRA</ext-link> (<xref ref-type="bibr" rid="bib4">Bishop, 2021</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:439009609bd1ec2052fb1f2cbceab60dc48f5622;origin=https://github.com/CameronBishop/k-mer_mining_SRA;visit=swh:1:snp:0cb753db1380263f4ef875b7e076de0778a176d5;anchor=swh:1:rev:372d29b02972d96e8eff7b6c431883ea8dfb5c50">swh:1:rev:372d29b02972d96e8eff7b6c431883ea8dfb5c50</ext-link>). CRISPR GMO mouse lines 6N<italic><sup>∆Nnt8-12</sup></italic> and <italic>Gzma</italic><sup>S211A</sup> are available on request.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation, Conceptualization</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Funding acquisition, Methodology, Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All mouse work was conducted in accordance with the &quot;Australian code for the care and use of animals for scientific purposes&quot; as defined by the National Health and Medical Research Council of Australia. Mouse work was approved by the QIMR Berghofer Medical Research Institute animal ethics committee (P2235 A1606-618M), with infectious CHIKV work conducted in a biosafety level-3 (PC3) facility at the QIMR Berghofer MRI (Australian Department of Agriculture, Water and the Environment certification Q2326 and Office of the Gene Technology Regulator certification 3445).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Summary of studies using <italic>Gzma<sup>-/-</sup></italic> mice.</title><p>Compilation of studies employing <italic>Gzma<sup>-/-</sup></italic> or <italic>Gzma<sup>-/-</sup> Gzmb<sup>-/-</sup></italic> double KO mice that reveal a phenotype or do not show a phenotype.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-70207-supp1-v1.docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>RNA-Seq of <italic>Gzma<sup>-/-</sup></italic>+ chikungunya virus (CHIKV) vs. 6J + CHIKV and 6J + CHIKV vs. 6J mock infection.</title><p>Datasets for RNA-Seq and Ingenuity Pathway Analysis (IPA) of mice feet day 6 post infection from CHIKV-infected <italic>Gzma<sup>-/-</sup></italic> mice vs. CHIKV-infected 6J mice and of mice feet day 7 post infection from 6J + CHIKV vs. 6J mock infection.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70207-supp2-v1.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Genetic differences between <italic>Gzma<sup>-/-</sup></italic> and C57BL/6J.</title><p>Genetic differences potentially involved in inflammation or arthritis are indicated. <italic>Nnt</italic> not included. Differences in introns not included.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-70207-supp3-v1.docx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>RNA-Seq for 6N<italic>Nnt</italic>∆8-12+ chikungunya virus (CHIKV) vs. 6N + CHIKV.</title><p>Datasets for RNA-Seq and Ingenuity Pathway Analysis (IPA) of mice feet day 6 post infection; 6N<italic>Nnt</italic>∆8-12+ CHIKV vs. 6N + CHIKV.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70207-supp4-v1.xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>RNA-Seq of chikungunya virus (CHIKV)-infected mice treated with MitoTEMPO.</title><p>Datasets for RNA-Seq and Ingenuity Pathway Analysis (IPA) of mice feet day 6 post infection; 6J + MitoTEMPO + CHIKV vs. 6J + PBS + CHIKV.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70207-supp5-v1.xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>RNA-Seq of <italic>Gzma</italic><sup>S211A</sup> vs. 6J mice injected with polyinosinic:polycytidylic acid (poly(I:C)).</title><p>Datasets for RNA-Seq, Ingenuity Pathway Analysis (IPA), and Cytoscape analyses of mice feet and spleen taken 6 hr after injection with poly(I:C); <italic>Gzma</italic><sup>S211A</sup> vs. 6J.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70207-supp6-v1.xlsx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>k-mer mining of the NCBI Sequence Read Archive (SRA).</title><p>Datasets for exact-match (31 mer) k-mer mining approach to identify full-length Nnt reads (6N background) in accessions listing C57BL/6J mice as the mouse strain.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70207-supp7-v1.xlsx"/></supplementary-material><supplementary-material id="supp8"><label>Supplementary file 8.</label><caption><title>No evidence for TLR9 involvement.</title><p>(<bold>a</bold>) <italic>Tlr9<sup>-/-</sup></italic> and 6J mice were injected intraplantar into the feet with 5 µg recombinant mouse granzyme A (GZMA) in 20 µl and foot swelling measured over time as described (<xref ref-type="bibr" rid="bib100">Schanoski et al., 2019</xref>) (n = 4 mice and four feet per group; statistics by Kolmogorov–Smirnov tests). <italic>Tlr9<sup>-/-</sup></italic> mice were derived from 129/Ola × C57BL/6F1 progeny (<ext-link ext-link-type="uri" xlink:href="http://www.myv.ne.jp/obs/index.files/tlr_eng.htm">http://www.myv.ne.jp/obs/index.files/tlr_eng.htm</ext-link>). (<bold>b</bold>) As for (<bold>a</bold>) using <italic>Tlr9</italic><sup>M7Btlr</sup>/Mmjax and 6J mice. <italic>Tlr9</italic><sup>M7Btlr</sup>/Mmjax mice have a <italic>Tlr9</italic> missense point mutation and do not respond to oligonucleotides containing CpG motifs (<ext-link ext-link-type="uri" xlink:href="https://www.jax.org/strain/014534">https://www.jax.org/strain/014534</ext-link>). (<bold>c</bold>) <italic>Tlr9<sup>-/-</sup></italic> mice (like 6J) do not encode the full <italic>Nnt</italic> gene. (<bold>d</bold>) Female 8–10-week-old <italic>Tlr9<sup>-/-</sup></italic> and 6J mice (n = 6 mice and 12 feet per group) were infected with chikungunya virus (CHIKV) and feet measured over time. Statistics by Kolmogorov–Smirnov tests. (<bold>e</bold>) Female C57BL/6J-<italic>Tlr9<sup>M7Btlr</sup></italic>/Mmjax mice (n = 6 mice and 12 feet per group) were infected as for (<bold>d</bold>). (<bold>f</bold>) Viremia for the mice in (<bold>d</bold>). After GZMA injection, <italic>Tlr9<sup>-/-</sup></italic> mice showed increased foot swelling (<bold>a</bold>), whereas C57BL/6J-<italic>Tlr9<sup>M7Btlr</sup></italic>/Mmjax mice showed no significant difference (<bold>b</bold>). <italic>Tlr9<sup>-/-</sup></italic> mice also have the <italic>Nnt</italic> deletion (<bold>c</bold>); however, they are on a mixed 129/Ola and C57BL/6 background (Hemmi et al. 2000), with 129/SvJ mice showing increased inflammatory infiltrates in certain settings (Hoover-Plow et al., 2008). After CHIKV infection, foot swelling was again increased in <italic>Tlr9<sup>-/-</sup></italic> (<bold>d</bold>), but not <italic>Tlr9</italic><sup>M7Btlr</sup>/Mmjax mice (<bold>e</bold>). <italic>Tlr9<sup>-/-</sup></italic> mice did not show an increased viremia (<bold>f</bold>). These data do not support a contention that TLR9 is required for GZMA’s bioactivity.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-70207-supp8-v1.zip"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-70207-transrepform1-v1.docx"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Source data for DNA gel images.</title><p>Source data for DNA gel images in <xref ref-type="fig" rid="fig3">Figure 3e</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b,c</xref>, and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1e</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-70207-supp9-v1.zip"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Five supplementary files have been provided which constitute source data for all the results cited in the manuscript. Raw sequencing data was uploaded to SRA: BioProject accessions: PRJNA666748, PRJNA664888, PRJNA664644, PRJNA779556.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>RNA-Seq of Granzyme A proteolytic site mutant mice injected with Poly (I:C)</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA666748">PRJNA666748</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Whole genome sequencing of a Granzyme A knock out mouse</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA664888">PRJNA664888</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>RNA-Seq of Granzyme A knockout mice infected with chikungunya Virus</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA664644">PRJNA664644</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>RNA_Seq of C57BL/6N Nnt knockout mice and MitoTEMPO treatment of C57BL/6J mice infected with CHIKV</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA779556">PRJNA779556</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the following staff at QIMR Berghofer MRI for their assistance; animal house staff, Dr I Anraku (BSL3 facility manager), Dr R Johnston (Bioinformatics), and Dr Viviana Lutzky (for proof reading). We thank Dr Dion Kaiserman (Monash University, Australia) for supplying recombinant GZMA. We also thank Dr Mark Heise (University of North Carolina) for valuable discussions.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afonina</surname><given-names>IS</given-names></name><name><surname>Müller</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>SJ</given-names></name><name><surname>Beyaert</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme</article-title><source>Immunity</source><volume>42</volume><fpage>991</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.003</pub-id><pub-id pub-id-type="pmid">26084020</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ank</surname><given-names>N</given-names></name><name><surname>Iversen</surname><given-names>MB</given-names></name><name><surname>Bartholdy</surname><given-names>C</given-names></name><name><surname>Staeheli</surname><given-names>P</given-names></name><name><surname>Hartmann</surname><given-names>R</given-names></name><name><surname>Jensen</surname><given-names>UB</given-names></name><name><surname>Dagnaes-Hansen</surname><given-names>F</given-names></name><name><surname>Thomsen</surname><given-names>AR</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Haugen</surname><given-names>H</given-names></name><name><surname>Klucher</surname><given-names>K</given-names></name><name><surname>Paludan</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity</article-title><source>Journal of Immunology</source><volume>180</volume><fpage>2474</fpage><lpage>2485</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.4.2474</pub-id><pub-id pub-id-type="pmid">18250457</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoyama</surname><given-names>T</given-names></name><name><surname>Paik</surname><given-names>Y-H</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Laleu</surname><given-names>B</given-names></name><name><surname>Gaggini</surname><given-names>F</given-names></name><name><surname>Fioraso-Cartier</surname><given-names>L</given-names></name><name><surname>Molango</surname><given-names>S</given-names></name><name><surname>Heitz</surname><given-names>F</given-names></name><name><surname>Merlot</surname><given-names>C</given-names></name><name><surname>Szyndralewiez</surname><given-names>C</given-names></name><name><surname>Page</surname><given-names>P</given-names></name><name><surname>Brenner</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent</article-title><source>Hepatology</source><volume>56</volume><fpage>2316</fpage><lpage>2327</lpage><pub-id pub-id-type="doi">10.1002/hep.25938</pub-id><pub-id pub-id-type="pmid">22806357</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Bishop</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>k-mer_mining_SRA</data-title><version designator="swh:1:rev:372d29b02972d96e8eff7b6c431883ea8dfb5c50">swh:1:rev:372d29b02972d96e8eff7b6c431883ea8dfb5c50</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:439009609bd1ec2052fb1f2cbceab60dc48f5622;origin=https://github.com/CameronBishop/k-mer_mining_SRA;visit=swh:1:snp:0cb753db1380263f4ef875b7e076de0778a176d5;anchor=swh:1:rev:372d29b02972d96e8eff7b6c431883ea8dfb5c50">https://archive.softwareheritage.org/swh:1:dir:439009609bd1ec2052fb1f2cbceab60dc48f5622;origin=https://github.com/CameronBishop/k-mer_mining_SRA;visit=swh:1:snp:0cb753db1380263f4ef875b7e076de0778a176d5;anchor=swh:1:rev:372d29b02972d96e8eff7b6c431883ea8dfb5c50</ext-link></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boding</surname><given-names>L</given-names></name><name><surname>Hansen</surname><given-names>AK</given-names></name><name><surname>Meroni</surname><given-names>G</given-names></name><name><surname>Johansen</surname><given-names>BB</given-names></name><name><surname>Braunstein</surname><given-names>TH</given-names></name><name><surname>Bonefeld</surname><given-names>CM</given-names></name><name><surname>Kongsbak</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>BAH</given-names></name><name><surname>Woetmann</surname><given-names>A</given-names></name><name><surname>Thomsen</surname><given-names>AR</given-names></name><name><surname>Odum</surname><given-names>N</given-names></name><name><surname>von Essen</surname><given-names>MR</given-names></name><name><surname>Geisler</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Midline 1 directs lytic granule exocytosis and cytotoxicity of mouse killer T cells</article-title><source>European Journal of Immunology</source><volume>44</volume><fpage>3109</fpage><lpage>3118</lpage><pub-id pub-id-type="doi">10.1002/eji.201344388</pub-id><pub-id pub-id-type="pmid">25043946</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boding</surname><given-names>L</given-names></name><name><surname>Hansen</surname><given-names>AK</given-names></name><name><surname>Meroni</surname><given-names>G</given-names></name><name><surname>Levring</surname><given-names>TB</given-names></name><name><surname>Woetmann</surname><given-names>A</given-names></name><name><surname>Ødum</surname><given-names>N</given-names></name><name><surname>Bonefeld</surname><given-names>CM</given-names></name><name><surname>Geisler</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MID2 can substitute for MID1 and control exocytosis of lytic granules in cytotoxic T cells</article-title><source>APMIS</source><volume>123</volume><fpage>682</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1111/apm.12402</pub-id><pub-id pub-id-type="pmid">25924778</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourdi</surname><given-names>M</given-names></name><name><surname>Davies</surname><given-names>JS</given-names></name><name><surname>Pohl</surname><given-names>LR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mispairing C57BL/6 substrains of genetically engineered mice and wild-type controls can lead to confounding results as it did in studies of JNK2 in acetaminophen and concanavalin A liver injury</article-title><source>Chemical Research in Toxicology</source><volume>24</volume><fpage>794</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1021/tx200143x</pub-id><pub-id pub-id-type="pmid">21557537</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Bushnell</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>BBMap</data-title><source>Sourceforge</source><ext-link ext-link-type="uri" xlink:href="https://jgi.doe.gov">https://jgi.doe.gov</ext-link></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calhan</surname><given-names>OY</given-names></name><name><surname>Seyrantepe</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mice with Catalytically Inactive Cathepsin A Display Neurobehavioral Alterations</article-title><source>Behavioural Neurology</source><volume>2017</volume><elocation-id>4261873</elocation-id><pub-id pub-id-type="doi">10.1155/2017/4261873</pub-id><pub-id pub-id-type="pmid">28133419</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casas</surname><given-names>AI</given-names></name><name><surname>Nogales</surname><given-names>C</given-names></name><name><surname>Mucke</surname><given-names>HAM</given-names></name><name><surname>Petraina</surname><given-names>A</given-names></name><name><surname>Cuadrado</surname><given-names>A</given-names></name><name><surname>Rojo</surname><given-names>AI</given-names></name><name><surname>Ghezzi</surname><given-names>P</given-names></name><name><surname>Jaquet</surname><given-names>V</given-names></name><name><surname>Augsburger</surname><given-names>F</given-names></name><name><surname>Dufrasne</surname><given-names>F</given-names></name><name><surname>Soubhye</surname><given-names>J</given-names></name><name><surname>Deshwal</surname><given-names>S</given-names></name><name><surname>Di Sante</surname><given-names>M</given-names></name><name><surname>Kaludercic</surname><given-names>N</given-names></name><name><surname>Di Lisa</surname><given-names>F</given-names></name><name><surname>Schmidt</surname><given-names>HHHW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>On the Clinical Pharmacology of Reactive Oxygen Species</article-title><source>Pharmacological Reviews</source><volume>72</volume><fpage>801</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1124/pr.120.019422</pub-id><pub-id pub-id-type="pmid">32859763</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dempoya</surname><given-names>J</given-names></name><name><surname>Matsumiya</surname><given-names>T</given-names></name><name><surname>Imaizumi</surname><given-names>T</given-names></name><name><surname>Hayakari</surname><given-names>R</given-names></name><name><surname>Xing</surname><given-names>F</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Okumura</surname><given-names>K</given-names></name><name><surname>Satoh</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Double-stranded RNA induces biphasic STAT1 phosphorylation by both type I interferon (IFN)-dependent and type I IFN-independent pathways</article-title><source>Journal of Virology</source><volume>86</volume><fpage>12760</fpage><lpage>12769</lpage><pub-id pub-id-type="doi">10.1128/JVI.01881-12</pub-id><pub-id pub-id-type="pmid">22973045</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dingjan</surname><given-names>I</given-names></name><name><surname>Verboogen</surname><given-names>DR</given-names></name><name><surname>Paardekooper</surname><given-names>LM</given-names></name><name><surname>Revelo</surname><given-names>NH</given-names></name><name><surname>Sittig</surname><given-names>SP</given-names></name><name><surname>Visser</surname><given-names>LJ</given-names></name><name><surname>Mollard</surname><given-names>GF</given-names></name><name><surname>Henriet</surname><given-names>SS</given-names></name><name><surname>Figdor</surname><given-names>CG</given-names></name><name><surname>Ter Beest</surname><given-names>M</given-names></name><name><surname>van den Bogaart</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lipid peroxidation causes endosomal antigen release for cross-presentation</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>22064</elocation-id><pub-id pub-id-type="doi">10.1038/srep22064</pub-id><pub-id pub-id-type="pmid">26907999</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djeu</surname><given-names>JY</given-names></name><name><surname>Heinbaugh</surname><given-names>JA</given-names></name><name><surname>Holden</surname><given-names>HT</given-names></name><name><surname>Herberman</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Augmentation of mouse natural killer cell activity by interferon and interferon inducers</article-title><source>Journal of Immunology</source><volume>122</volume><fpage>175</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">310826</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebnet</surname><given-names>K</given-names></name><name><surname>Hausmann</surname><given-names>M</given-names></name><name><surname>Lehmann-Grube</surname><given-names>F</given-names></name><name><surname>Müllbacher</surname><given-names>A</given-names></name><name><surname>Kopf</surname><given-names>M</given-names></name><name><surname>Lamers</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Granzyme A-deficient mice retain potent cell-mediated cytotoxicity</article-title><source>The EMBO Journal</source><volume>14</volume><fpage>4230</fpage><lpage>4239</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1995.tb00097.x</pub-id><pub-id pub-id-type="pmid">7556064</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewels</surname><given-names>P</given-names></name><name><surname>Magnusson</surname><given-names>M</given-names></name><name><surname>Lundin</surname><given-names>S</given-names></name><name><surname>Käller</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MultiQC: summarize analysis results for multiple tools and samples in a single report</article-title><source>Bioinformatics</source><volume>32</volume><fpage>3047</fpage><lpage>3048</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw354</pub-id><pub-id pub-id-type="pmid">27312411</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehniger</surname><given-names>TA</given-names></name><name><surname>Cai</surname><given-names>SF</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Bredemeyer</surname><given-names>AJ</given-names></name><name><surname>Presti</surname><given-names>RM</given-names></name><name><surname>French</surname><given-names>AR</given-names></name><name><surname>Ley</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs</article-title><source>Immunity</source><volume>26</volume><fpage>798</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.04.010</pub-id><pub-id pub-id-type="pmid">17540585</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontaine</surname><given-names>DA</given-names></name><name><surname>Davis</surname><given-names>DB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Attention to Background Strain Is Essential for Metabolic Research: C57BL/6 and the International Knockout Mouse Consortium</article-title><source>Diabetes</source><volume>65</volume><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.2337/db15-0982</pub-id><pub-id pub-id-type="pmid">26696638</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>H</given-names></name><name><surname>Shimomura</surname><given-names>K</given-names></name><name><surname>Cox</surname><given-names>RD</given-names></name><name><surname>Ashcroft</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Nicotinamide nucleotide transhydrogenase: a link between insulin secretion, glucose metabolism and oxidative stress</article-title><source>Biochemical Society Transactions</source><volume>34</volume><fpage>806</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1042/BST0340806</pub-id><pub-id pub-id-type="pmid">17052203</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambhir</surname><given-names>L</given-names></name><name><surname>Sharma</surname><given-names>V</given-names></name><name><surname>Kandwal</surname><given-names>P</given-names></name><name><surname>Saxena</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Perturbation in cellular redox homeostasis: Decisive regulator of T cell mediated immune responses</article-title><source>International Immunopharmacology</source><volume>67</volume><fpage>449</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2018.12.049</pub-id><pub-id pub-id-type="pmid">30594775</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Laorden</surname><given-names>MI</given-names></name><name><surname>Stroo</surname><given-names>I</given-names></name><name><surname>Blok</surname><given-names>DC</given-names></name><name><surname>Florquin</surname><given-names>S</given-names></name><name><surname>Medema</surname><given-names>JP</given-names></name><name><surname>de Vos</surname><given-names>AF</given-names></name><name><surname>van der Poll</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Granzymes A and B Regulate the Local Inflammatory Response during Klebsiella pneumoniae Pneumonia</article-title><source>Journal of Innate Immunity</source><volume>8</volume><fpage>258</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1159/000443401</pub-id><pub-id pub-id-type="pmid">26894590</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Laorden</surname><given-names>MI</given-names></name><name><surname>Stroo</surname><given-names>I</given-names></name><name><surname>Terpstra</surname><given-names>S</given-names></name><name><surname>Florquin</surname><given-names>S</given-names></name><name><surname>Medema</surname><given-names>JP</given-names></name><name><surname>van T Veer</surname><given-names>C</given-names></name><name><surname>de Vos</surname><given-names>AF</given-names></name><name><surname>van der Poll</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Expression and Function of Granzymes A and B in <italic>Escherichia coli</italic> Peritonitis and Sepsis</article-title><source>Mediators of Inflammation</source><volume>2017</volume><elocation-id>4137563</elocation-id><pub-id pub-id-type="doi">10.1155/2017/4137563</pub-id><pub-id pub-id-type="pmid">28694562</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Anraku</surname><given-names>I</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Larcher</surname><given-names>T</given-names></name><name><surname>Major</surname><given-names>L</given-names></name><name><surname>Roques</surname><given-names>P</given-names></name><name><surname>Schroder</surname><given-names>WA</given-names></name><name><surname>Higgs</surname><given-names>S</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Chikungunya virus arthritis in adult wild-type mice</article-title><source>Journal of Virology</source><volume>84</volume><fpage>8021</fpage><lpage>8032</lpage><pub-id pub-id-type="doi">10.1128/JVI.02603-09</pub-id><pub-id pub-id-type="pmid">20519386</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garzón-Tituaña</surname><given-names>M</given-names></name><name><surname>Sierra-Monzón</surname><given-names>JL</given-names></name><name><surname>Comas</surname><given-names>L</given-names></name><name><surname>Santiago</surname><given-names>L</given-names></name><name><surname>Khaliulina-Ushakova</surname><given-names>T</given-names></name><name><surname>Uranga-Murillo</surname><given-names>I</given-names></name><name><surname>Ramirez-Labrada</surname><given-names>A</given-names></name><name><surname>Tapia</surname><given-names>E</given-names></name><name><surname>Morte-Romea</surname><given-names>E</given-names></name><name><surname>Algarate</surname><given-names>S</given-names></name><name><surname>Couty</surname><given-names>L</given-names></name><name><surname>Camerer</surname><given-names>E</given-names></name><name><surname>Bird</surname><given-names>PI</given-names></name><name><surname>Seral</surname><given-names>C</given-names></name><name><surname>Luque</surname><given-names>P</given-names></name><name><surname>Paño-Pardo</surname><given-names>JR</given-names></name><name><surname>Galvez</surname><given-names>EM</given-names></name><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Arias</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Granzyme A inhibition reduces inflammation and increases survival during abdominal sepsis</article-title><source>Theranostics</source><volume>11</volume><fpage>3781</fpage><lpage>3795</lpage><pub-id pub-id-type="doi">10.7150/thno.49288</pub-id><pub-id pub-id-type="pmid">33664861</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghezzi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Redox regulation of immunity and the role of small molecular weight thiols</article-title><source>Redox Biology</source><volume>44</volume><elocation-id>102001</elocation-id><pub-id pub-id-type="doi">10.1016/j.redox.2021.102001</pub-id><pub-id pub-id-type="pmid">33994345</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>D</given-names></name><name><surname>Levault</surname><given-names>KR</given-names></name><name><surname>Brewer</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons</article-title><source>Aging Cell</source><volume>13</volume><fpage>631</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1111/acel.12216</pub-id><pub-id pub-id-type="pmid">24655393</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golstein</surname><given-names>P</given-names></name><name><surname>Griffiths</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An early history of T cell-mediated cytotoxicity</article-title><source>Nature Reviews. Immunology</source><volume>18</volume><fpage>527</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1038/s41577-018-0009-3</pub-id><pub-id pub-id-type="pmid">29662120</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordy</surname><given-names>LE</given-names></name><name><surname>Bezbradica</surname><given-names>JS</given-names></name><name><surname>Flyak</surname><given-names>AI</given-names></name><name><surname>Spencer</surname><given-names>CT</given-names></name><name><surname>Dunkle</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Stanic</surname><given-names>AK</given-names></name><name><surname>Boothby</surname><given-names>MR</given-names></name><name><surname>He</surname><given-names>Y-W</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Van Kaer</surname><given-names>L</given-names></name><name><surname>Joyce</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>IL-15 regulates homeostasis and terminal maturation of NKT cells</article-title><source>Journal of Immunology</source><volume>187</volume><fpage>6335</fpage><lpage>6345</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1003965</pub-id><pub-id pub-id-type="pmid">22084435</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>KK</given-names></name><name><surname>Sherman</surname><given-names>PM</given-names></name><name><surname>Cellars</surname><given-names>L</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Baruch</surname><given-names>A</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name><name><surname>Hollenberg</surname><given-names>MD</given-names></name><name><surname>Vergnolle</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis</article-title><source>PNAS</source><volume>102</volume><fpage>8363</fpage><lpage>8368</lpage><pub-id pub-id-type="doi">10.1073/pnas.0409535102</pub-id><pub-id pub-id-type="pmid">15919826</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hazlewood</surname><given-names>JE</given-names></name><name><surname>Dumenil</surname><given-names>T</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Slonchak</surname><given-names>A</given-names></name><name><surname>Kazakoff</surname><given-names>SH</given-names></name><name><surname>Patch</surname><given-names>AM</given-names></name><name><surname>Gray</surname><given-names>LA</given-names></name><name><surname>Howley</surname><given-names>PM</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Hayball</surname><given-names>JD</given-names></name><name><surname>Yan</surname><given-names>K</given-names></name><name><surname>Rawle</surname><given-names>DJ</given-names></name><name><surname>Prow</surname><given-names>NA</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name><name><surname>McFadden</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures</article-title><source>PLOS Pathogens</source><volume>17</volume><elocation-id>e1009215</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009215</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hildebrand</surname><given-names>D</given-names></name><name><surname>Bode</surname><given-names>KA</given-names></name><name><surname>Rieß</surname><given-names>D</given-names></name><name><surname>Cerny</surname><given-names>D</given-names></name><name><surname>Waldhuber</surname><given-names>A</given-names></name><name><surname>Römmler</surname><given-names>F</given-names></name><name><surname>Strack</surname><given-names>J</given-names></name><name><surname>Korten</surname><given-names>S</given-names></name><name><surname>Orth</surname><given-names>JHC</given-names></name><name><surname>Miethke</surname><given-names>T</given-names></name><name><surname>Heeg</surname><given-names>K</given-names></name><name><surname>Kubatzky</surname><given-names>KF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Granzyme A produces bioactive IL-1β through a nonapoptotic inflammasome-independent pathway</article-title><source>Cell Reports</source><volume>9</volume><fpage>910</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.10.003</pub-id><pub-id pub-id-type="pmid">25437548</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoghooghi</surname><given-names>V</given-names></name><name><surname>Palmer</surname><given-names>AL</given-names></name><name><surname>Frederick</surname><given-names>A</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Merkens</surname><given-names>JE</given-names></name><name><surname>Balakrishnan</surname><given-names>A</given-names></name><name><surname>Finlay</surname><given-names>TM</given-names></name><name><surname>Grubb</surname><given-names>A</given-names></name><name><surname>Levy</surname><given-names>E</given-names></name><name><surname>Gordon</surname><given-names>P</given-names></name><name><surname>Jirik</surname><given-names>FR</given-names></name><name><surname>Nguyen</surname><given-names>MD</given-names></name><name><surname>Schuurmans</surname><given-names>C</given-names></name><name><surname>Visser</surname><given-names>F</given-names></name><name><surname>Dunn</surname><given-names>SE</given-names></name><name><surname>Ousman</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cystatin C Plays a Sex-Dependent Detrimental Role in Experimental Autoimmune Encephalomyelitis</article-title><source>Cell Reports</source><volume>33</volume><elocation-id>108236</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108236</pub-id><pub-id pub-id-type="pmid">33027652</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T-T</given-names></name><name><surname>Naeemuddin</surname><given-names>M</given-names></name><name><surname>Elchuri</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Kozy</surname><given-names>HM</given-names></name><name><surname>Carlson</surname><given-names>EJ</given-names></name><name><surname>Epstein</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Genetic modifiers of the phenotype of mice deficient in mitochondrial superoxide dismutase</article-title><source>Human Molecular Genetics</source><volume>15</volume><fpage>1187</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddl034</pub-id><pub-id pub-id-type="pmid">16497723</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>ED</given-names></name><name><surname>Qu</surname><given-names>YY</given-names></name><name><surname>Genik</surname><given-names>SJ</given-names></name><name><surname>Lyons</surname><given-names>RH</given-names></name><name><surname>Pacheco</surname><given-names>CD</given-names></name><name><surname>Lieberman</surname><given-names>AP</given-names></name><name><surname>Samuelson</surname><given-names>LC</given-names></name><name><surname>Nasonkin</surname><given-names>IO</given-names></name><name><surname>Camper</surname><given-names>SA</given-names></name><name><surname>Van Keuren</surname><given-names>ML</given-names></name><name><surname>Saunders</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genetic variation in C57BL/6 ES cell lines and genetic instability in the Bruce4 C57BL/6 ES cell line</article-title><source>Mammalian Genome</source><volume>18</volume><fpage>549</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1007/s00335-007-9054-0</pub-id><pub-id pub-id-type="pmid">17828574</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Q</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Yao</surname><given-names>K</given-names></name><name><surname>Tan</surname><given-names>B</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment</article-title><source>Oxidative Medicine and Cellular Longevity</source><volume>2020</volume><elocation-id>8837893</elocation-id><pub-id pub-id-type="doi">10.1155/2020/8837893</pub-id><pub-id pub-id-type="pmid">33354280</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joeckel</surname><given-names>LT</given-names></name><name><surname>Bird</surname><given-names>PI</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Are all granzymes cytotoxic in vivo?</article-title><source>Biological Chemistry</source><volume>395</volume><fpage>181</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1515/hsz-2013-0238</pub-id><pub-id pub-id-type="pmid">24002663</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>BJ</given-names></name><name><surname>Le</surname><given-names>TTT</given-names></name><name><surname>Dobbin</surname><given-names>CA</given-names></name><name><surname>Banovic</surname><given-names>T</given-names></name><name><surname>Howard</surname><given-names>CB</given-names></name><name><surname>Flores</surname><given-names>F</given-names></name><name><surname>Vanags</surname><given-names>D</given-names></name><name><surname>Naylor</surname><given-names>DJ</given-names></name><name><surname>Hill</surname><given-names>GR</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production</article-title><source>The Journal of Biological Chemistry</source><volume>280</volume><fpage>4037</fpage><lpage>4047</lpage><pub-id pub-id-type="doi">10.1074/jbc.M411569200</pub-id><pub-id pub-id-type="pmid">15546885</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>New insights into IFN-γ in rheumatoid arthritis: role in the era of JAK inhibitors</article-title><source>Immunological Medicine</source><volume>43</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1080/25785826.2020.1751908</pub-id><pub-id pub-id-type="pmid">32338187</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köntgen</surname><given-names>F</given-names></name><name><surname>Süss</surname><given-names>G</given-names></name><name><surname>Stewart</surname><given-names>C</given-names></name><name><surname>Steinmetz</surname><given-names>M</given-names></name><name><surname>Bluethmann</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Targeted disruption of the MHC class II Aa gene in C57BL/6 mice</article-title><source>International Immunology</source><volume>5</volume><fpage>957</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1093/intimm/5.8.957</pub-id><pub-id pub-id-type="pmid">8398989</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korablev</surname><given-names>A</given-names></name><name><surname>Lukyanchikova</surname><given-names>V</given-names></name><name><surname>Serova</surname><given-names>I</given-names></name><name><surname>Battulin</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>On-Target CRISPR/Cas9 Activity Can Cause Undesigned Large Deletion in Mouse Zygotes</article-title><source>International Journal of Molecular Sciences</source><volume>21</volume><elocation-id>3604</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21103604</pub-id><pub-id pub-id-type="pmid">32443745</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovacic</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>2020, A Decisive Decade for NADPH Oxidases Inhibitors</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>33</volume><fpage>329</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1089/ars.2020.8069</pub-id><pub-id pub-id-type="pmid">32122175</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Linn</surname><given-names>M</given-names></name><name><surname>Bellett</surname><given-names>AJ</given-names></name><name><surname>Parsons</surname><given-names>PG</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Complete removal of mycoplasma from viral preparations using solvent extraction</article-title><source>Journal of Virological Methods</source><volume>52</volume><fpage>51</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/0166-0934(94)00136-5</pub-id><pub-id pub-id-type="pmid">7539444</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leskov</surname><given-names>I</given-names></name><name><surname>Neville</surname><given-names>A</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Pardue</surname><given-names>S</given-names></name><name><surname>Kevil</surname><given-names>CG</given-names></name><name><surname>Granger</surname><given-names>DN</given-names></name><name><surname>Krzywanski</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Nicotinamide nucleotide transhydrogenase activity impacts mitochondrial redox balance and the development of hypertension in mice</article-title><source>Journal of the American Society of Hypertension</source><volume>11</volume><fpage>110</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.jash.2016.12.002</pub-id><pub-id pub-id-type="pmid">28087333</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Dewey</surname><given-names>CN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome</article-title><source>BMC Bioinformatics</source><volume>12</volume><elocation-id>323</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-12-323</pub-id><pub-id pub-id-type="pmid">21816040</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Minimap2: pairwise alignment for nucleotide sequences</article-title><source>Bioinformatics</source><volume>34</volume><fpage>3094</fpage><lpage>3100</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty191</pub-id><pub-id pub-id-type="pmid">29750242</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>JJ</given-names></name><name><surname>Adcock</surname><given-names>IM</given-names></name><name><surname>Chung</surname><given-names>KF</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Roles of mitochondrial ROS and NLRP3 inflammasome in multiple ozone-induced lung inflammation and emphysema</article-title><source>Respiratory Research</source><volume>19</volume><elocation-id>230</elocation-id><pub-id pub-id-type="doi">10.1186/s12931-018-0931-8</pub-id><pub-id pub-id-type="pmid">30466433</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liesche</surname><given-names>C</given-names></name><name><surname>Sauer</surname><given-names>P</given-names></name><name><surname>Prager</surname><given-names>I</given-names></name><name><surname>Urlaub</surname><given-names>D</given-names></name><name><surname>Claus</surname><given-names>M</given-names></name><name><surname>Eils</surname><given-names>R</given-names></name><name><surname>Beaudouin</surname><given-names>J</given-names></name><name><surname>Watzl</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-Fluorescent Protein Reporters Allow Parallel Quantification of Natural Killer Cell-Mediated Granzyme and Caspase Activities in Single Target Cells</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>1840</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01840</pub-id><pub-id pub-id-type="pmid">30135688</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lingappan</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>NF-κB in Oxidative Stress</article-title><source>Current Opinion in Toxicology</source><volume>7</volume><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.cotox.2017.11.002</pub-id><pub-id pub-id-type="pmid">29862377</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>DA</given-names></name><name><surname>Revell</surname><given-names>PA</given-names></name><name><surname>Ley</surname><given-names>TJ</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Granzymes and caspase 3 play important roles in control of gammaherpesvirus latency</article-title><source>Journal of Virology</source><volume>78</volume><fpage>12519</fpage><lpage>12528</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.22.12519-12528.2004</pub-id><pub-id pub-id-type="pmid">15507639</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>TNF inhibitor therapy for rheumatoid arthritis</article-title><source>Biomedical Reports</source><volume>1</volume><fpage>177</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.3892/br.2012.42</pub-id><pub-id pub-id-type="pmid">24648915</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madera</surname><given-names>S</given-names></name><name><surname>Rapp</surname><given-names>M</given-names></name><name><surname>Firth</surname><given-names>MA</given-names></name><name><surname>Beilke</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide</article-title><source>The Journal of Experimental Medicine</source><volume>213</volume><fpage>225</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1084/jem.20150712</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandrup-Poulsen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Granzyme A in the Pathogenesis of Type 1 Diabetes: The Yes and the No</article-title><source>Diabetes</source><volume>66</volume><fpage>2937</fpage><lpage>2939</lpage><pub-id pub-id-type="doi">10.2337/dbi17-0037</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title><source>EMBnet.Journal</source><volume>17</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.14806/ej.17.1.200</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinvalet</surname><given-names>D</given-names></name><name><surname>Dykxhoorn</surname><given-names>DM</given-names></name><name><surname>Ferrini</surname><given-names>R</given-names></name><name><surname>Lieberman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death</article-title><source>Cell</source><volume>133</volume><fpage>681</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.03.032</pub-id><pub-id pub-id-type="pmid">18485875</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCambridge</surname><given-names>G</given-names></name><name><surname>Agrawal</surname><given-names>M</given-names></name><name><surname>Keady</surname><given-names>A</given-names></name><name><surname>Kern</surname><given-names>PA</given-names></name><name><surname>Hasturk</surname><given-names>H</given-names></name><name><surname>Nikolajczyk</surname><given-names>BS</given-names></name><name><surname>Bharath</surname><given-names>LP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Saturated Fatty Acid Activates T Cell Inflammation Through a Nicotinamide Nucleotide Transhydrogenase (NNT)-Dependent Mechanism</article-title><source>Biomolecules</source><volume>9</volume><elocation-id>E79</elocation-id><pub-id pub-id-type="doi">10.3390/biom9020079</pub-id><pub-id pub-id-type="pmid">30823587</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNutt</surname><given-names>MC</given-names></name><name><surname>Lagace</surname><given-names>TA</given-names></name><name><surname>Horton</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Catalytic activity is not required for secreted PCSK9 to reduce low density lipoprotein receptors in HepG2 cells</article-title><source>The Journal of Biological Chemistry</source><volume>282</volume><fpage>20799</fpage><lpage>20803</lpage><pub-id pub-id-type="doi">10.1074/jbc.C700095200</pub-id><pub-id pub-id-type="pmid">17537735</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meimaridou</surname><given-names>E</given-names></name><name><surname>Goldsworthy</surname><given-names>M</given-names></name><name><surname>Chortis</surname><given-names>V</given-names></name><name><surname>Fragouli</surname><given-names>E</given-names></name><name><surname>Foster</surname><given-names>PA</given-names></name><name><surname>Arlt</surname><given-names>W</given-names></name><name><surname>Cox</surname><given-names>R</given-names></name><name><surname>Metherell</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice</article-title><source>The Journal of Endocrinology</source><volume>236</volume><fpage>13</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1530/JOE-16-0638</pub-id><pub-id pub-id-type="pmid">29046340</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mekada</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>K</given-names></name><name><surname>Murakami</surname><given-names>A</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Nakata</surname><given-names>H</given-names></name><name><surname>Moriwaki</surname><given-names>K</given-names></name><name><surname>Obata</surname><given-names>Y</given-names></name><name><surname>Yoshiki</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genetic Differences among C57BL/6 Substrains</article-title><source>Experimental Animals</source><volume>58</volume><fpage>141</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1538/expanim.58.141</pub-id><pub-id pub-id-type="pmid">19448337</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mekada</surname><given-names>K</given-names></name><name><surname>Hirose</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>A</given-names></name><name><surname>Yoshiki</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Development of SNP markers for C57BL/6N-derived mouse inbred strains</article-title><source>Experimental Animals</source><volume>64</volume><fpage>91</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1538/expanim.14-0061</pub-id><pub-id pub-id-type="pmid">25341966</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metkar</surname><given-names>SS</given-names></name><name><surname>Menaa</surname><given-names>C</given-names></name><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wallich</surname><given-names>R</given-names></name><name><surname>Freudenberg</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Raja</surname><given-names>SM</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name><name><surname>Froelich</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Human and Mouse Granzyme A Induce a Proinflammatory Cytokine Response</article-title><source>Immunity</source><volume>29</volume><fpage>720</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.08.014</pub-id><pub-id pub-id-type="pmid">18951048</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyake</surname><given-names>T</given-names></name><name><surname>Kumagai</surname><given-names>Y</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Matsushita</surname><given-names>K</given-names></name><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Kawagoe</surname><given-names>T</given-names></name><name><surname>Kumar</surname><given-names>H</given-names></name><name><surname>Jang</surname><given-names>MH</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Tani</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Poly I:C-Induced Activation of NK Cells by CD8α + Dendritic Cells via the IPS-1 and TRIF-Dependent Pathways</article-title><source>The Journal of Immunology</source><volume>183</volume><fpage>2522</fpage><lpage>2528</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0901500</pub-id><pub-id pub-id-type="pmid">19635904</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizutani</surname><given-names>T</given-names></name><name><surname>Neugebauer</surname><given-names>N</given-names></name><name><surname>Putz</surname><given-names>EM</given-names></name><name><surname>Moritz</surname><given-names>N</given-names></name><name><surname>Simma</surname><given-names>O</given-names></name><name><surname>Zebedin-Brandl</surname><given-names>E</given-names></name><name><surname>Gotthardt</surname><given-names>D</given-names></name><name><surname>Warsch</surname><given-names>W</given-names></name><name><surname>Eckelhart</surname><given-names>E</given-names></name><name><surname>Kantner</surname><given-names>HP</given-names></name><name><surname>Kalinke</surname><given-names>U</given-names></name><name><surname>Lienenklaus</surname><given-names>S</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><name><surname>Strobl</surname><given-names>B</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name><name><surname>Sexl</surname><given-names>V</given-names></name><name><surname>Stoiber</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance</article-title><source>Oncoimmunology</source><volume>1</volume><fpage>1027</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.4161/onci.21284</pub-id><pub-id pub-id-type="pmid">23170251</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moffett</surname><given-names>HF</given-names></name><name><surname>Cartwright</surname><given-names>ANR</given-names></name><name><surname>Kim</surname><given-names>H-J</given-names></name><name><surname>Godec</surname><given-names>J</given-names></name><name><surname>Pyrdol</surname><given-names>J</given-names></name><name><surname>Äijö</surname><given-names>T</given-names></name><name><surname>Martinez</surname><given-names>GJ</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Cantor</surname><given-names>H</given-names></name><name><surname>Sharpe</surname><given-names>AH</given-names></name><name><surname>Novina</surname><given-names>CD</given-names></name><name><surname>Wucherpfennig</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection</article-title><source>Nature Immunology</source><volume>18</volume><fpage>791</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1038/ni.3755</pub-id><pub-id pub-id-type="pmid">28530712</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollah</surname><given-names>ZUA</given-names></name><name><surname>Quah</surname><given-names>HS</given-names></name><name><surname>Graham</surname><given-names>KL</given-names></name><name><surname>Jhala</surname><given-names>G</given-names></name><name><surname>Krishnamurthy</surname><given-names>B</given-names></name><name><surname>Dharma</surname><given-names>JFM</given-names></name><name><surname>Chee</surname><given-names>J</given-names></name><name><surname>Trivedi</surname><given-names>PM</given-names></name><name><surname>Pappas</surname><given-names>EG</given-names></name><name><surname>Mackin</surname><given-names>L</given-names></name><name><surname>Chu</surname><given-names>EPF</given-names></name><name><surname>Akazawa</surname><given-names>S</given-names></name><name><surname>Fynch</surname><given-names>S</given-names></name><name><surname>Hodson</surname><given-names>C</given-names></name><name><surname>Deans</surname><given-names>AJ</given-names></name><name><surname>Trapani</surname><given-names>JA</given-names></name><name><surname>Chong</surname><given-names>MMW</given-names></name><name><surname>Bird</surname><given-names>PI</given-names></name><name><surname>Brodnicki</surname><given-names>TC</given-names></name><name><surname>Thomas</surname><given-names>HE</given-names></name><name><surname>Kay</surname><given-names>TWH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Granzyme A Deficiency Breaks Immune Tolerance and Promotes Autoimmune Diabetes Through a Type I Interferon–Dependent Pathway</article-title><source>Diabetes</source><volume>66</volume><fpage>3041</fpage><lpage>3050</lpage><pub-id pub-id-type="doi">10.2337/db17-0517</pub-id><pub-id pub-id-type="pmid">28733313</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales-Hernandez</surname><given-names>A</given-names></name><name><surname>Martinat</surname><given-names>A</given-names></name><name><surname>Chabot</surname><given-names>A</given-names></name><name><surname>McKinney-Freeman</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Elevated Oxidative Stress Impairs Hematopoietic Progenitor Function in C57BL/6 Substrains</article-title><source>Stem Cell Reports</source><volume>11</volume><fpage>334</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2018.06.011</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>TE</given-names></name><name><surname>Fraser</surname><given-names>RJ</given-names></name><name><surname>Smith</surname><given-names>PN</given-names></name><name><surname>Mahalingam</surname><given-names>S</given-names></name><name><surname>Heise</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Complement Contributes to Inflammatory Tissue Destruction in a Mouse Model of Ross River Virus-Induced Disease</article-title><source>Journal of Virology</source><volume>81</volume><fpage>5132</fpage><lpage>5143</lpage><pub-id pub-id-type="doi">10.1128/JVI.02799-06</pub-id><pub-id pub-id-type="pmid">17314163</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mpande</surname><given-names>CAM</given-names></name><name><surname>Dintwe</surname><given-names>OB</given-names></name><name><surname>Musvosvi</surname><given-names>M</given-names></name><name><surname>Mabwe</surname><given-names>S</given-names></name><name><surname>Bilek</surname><given-names>N</given-names></name><name><surname>Hatherill</surname><given-names>M</given-names></name><name><surname>Nemes</surname><given-names>E</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><collab>The SATVI Clinical Immunology Team</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Functional, Antigen-Specific Stem Cell Memory (TSCM) CD4+ T Cells Are Induced by Human Mycobacterium tuberculosis Infection</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>324</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00324</pub-id><pub-id pub-id-type="pmid">29545791</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müllbacher</surname><given-names>A</given-names></name><name><surname>Ebnet</surname><given-names>K</given-names></name><name><surname>Blanden</surname><given-names>RV</given-names></name><name><surname>Hla</surname><given-names>RT</given-names></name><name><surname>Stehle</surname><given-names>T</given-names></name><name><surname>Museteanu</surname><given-names>C</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia</article-title><source>PNAS</source><volume>93</volume><fpage>5783</fpage><lpage>5787</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.12.5783</pub-id><pub-id pub-id-type="pmid">8650169</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müllbacher</surname><given-names>A</given-names></name><name><surname>Waring</surname><given-names>P</given-names></name><name><surname>Tha Hla</surname><given-names>R</given-names></name><name><surname>Tran</surname><given-names>T</given-names></name><name><surname>Chin</surname><given-names>S</given-names></name><name><surname>Stehle</surname><given-names>T</given-names></name><name><surname>Museteanu</surname><given-names>C</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes</article-title><source>PNAS</source><volume>96</volume><fpage>13950</fpage><lpage>13955</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.24.13950</pub-id><pub-id pub-id-type="pmid">10570179</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muraro</surname><given-names>E</given-names></name><name><surname>Merlo</surname><given-names>A</given-names></name><name><surname>Martorelli</surname><given-names>D</given-names></name><name><surname>Cangemi</surname><given-names>M</given-names></name><name><surname>Dalla Santa</surname><given-names>S</given-names></name><name><surname>Dolcetti</surname><given-names>R</given-names></name><name><surname>Rosato</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>197</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.00197</pub-id><pub-id pub-id-type="pmid">28289418</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalle</surname><given-names>SC</given-names></name><name><surname>Barreira da Silva</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Decker</surname><given-names>M</given-names></name><name><surname>Chalouni</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Posthuma</surname><given-names>G</given-names></name><name><surname>de Mazière</surname><given-names>A</given-names></name><name><surname>Klumperman</surname><given-names>J</given-names></name><name><surname>Baz Morelli</surname><given-names>A</given-names></name><name><surname>Fleire</surname><given-names>SJ</given-names></name><name><surname>Verkman</surname><given-names>AS</given-names></name><name><surname>Trombetta</surname><given-names>ES</given-names></name><name><surname>Albert</surname><given-names>ML</given-names></name><name><surname>Mellman</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Aquaporin-3 regulates endosome-to-cytosol transfer via lipid peroxidation for cross presentation</article-title><source>PLOS ONE</source><volume>15</volume><elocation-id>e0238484</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0238484</pub-id><pub-id pub-id-type="pmid">33232321</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngoi</surname><given-names>SM</given-names></name><name><surname>Tovey</surname><given-names>MG</given-names></name><name><surname>Vella</surname><given-names>AT</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta</article-title><source>Journal of Immunology</source><volume>181</volume><fpage>7670</fpage><lpage>7680</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.11.7670</pub-id><pub-id pub-id-type="pmid">19017955</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>W</given-names></name><name><surname>Nakayama</surname><given-names>E</given-names></name><name><surname>Yan</surname><given-names>K</given-names></name><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Cooper</surname><given-names>TH</given-names></name><name><surname>Hayball</surname><given-names>JD</given-names></name><name><surname>Faddy</surname><given-names>HM</given-names></name><name><surname>Warrilow</surname><given-names>D</given-names></name><name><surname>Allcock</surname><given-names>RJN</given-names></name><name><surname>Hobson-Peters</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>RA</given-names></name><name><surname>Rawle</surname><given-names>DJ</given-names></name><name><surname>Lutzky</surname><given-names>VP</given-names></name><name><surname>Young</surname><given-names>P</given-names></name><name><surname>Oliveira</surname><given-names>NM</given-names></name><name><surname>Hartel</surname><given-names>G</given-names></name><name><surname>Howley</surname><given-names>PM</given-names></name><name><surname>Prow</surname><given-names>NA</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse Models</article-title><source>Vaccines</source><volume>8</volume><elocation-id>E209</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines8020209</pub-id><pub-id pub-id-type="pmid">32380760</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberkampf</surname><given-names>M</given-names></name><name><surname>Guillerey</surname><given-names>C</given-names></name><name><surname>Mouriès</surname><given-names>J</given-names></name><name><surname>Rosenbaum</surname><given-names>P</given-names></name><name><surname>Fayolle</surname><given-names>C</given-names></name><name><surname>Bobard</surname><given-names>A</given-names></name><name><surname>Savina</surname><given-names>A</given-names></name><name><surname>Ogier-Denis</surname><given-names>E</given-names></name><name><surname>Enninga</surname><given-names>J</given-names></name><name><surname>Amigorena</surname><given-names>S</given-names></name><name><surname>Leclerc</surname><given-names>C</given-names></name><name><surname>Dadaglio</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitochondrial reactive oxygen species regulate the induction of CD8+ T cells by plasmacytoid dendritic cells</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>2241</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-04686-8</pub-id><pub-id pub-id-type="pmid">29884826</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogata</surname><given-names>A</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Higa</surname><given-names>S</given-names></name><name><surname>Yoshizaki</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review</article-title><source>Modern Rheumatology</source><volume>29</volume><fpage>258</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1080/14397595.2018.1546357</pub-id><pub-id pub-id-type="pmid">30427250</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Balkow</surname><given-names>S</given-names></name><name><surname>Anel</surname><given-names>A</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cells</article-title><source>European Journal of Immunology</source><volume>32</volume><fpage>1980</fpage><lpage>1985</lpage><pub-id pub-id-type="doi">10.1002/1521-4141(200207)32:7&lt;1980::AID-IMMU1980&gt;3.0.CO;2-Z</pub-id><pub-id pub-id-type="pmid">12115618</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Bosque</surname><given-names>A</given-names></name><name><surname>Brehm</surname><given-names>R</given-names></name><name><surname>Wallich</surname><given-names>R</given-names></name><name><surname>Naval</surname><given-names>J</given-names></name><name><surname>Müllbacher</surname><given-names>A</given-names></name><name><surname>Anel</surname><given-names>A</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis</article-title><source>The Journal of Cell Biology</source><volume>167</volume><fpage>457</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1083/jcb.200406115</pub-id><pub-id pub-id-type="pmid">15534000</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Griesenauer</surname><given-names>B</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Adom</surname><given-names>D</given-names></name><name><surname>Mehrpouya-Bahrami</surname><given-names>P</given-names></name><name><surname>Chakravorty</surname><given-names>S</given-names></name><name><surname>Kazemian</surname><given-names>M</given-names></name><name><surname>Imam</surname><given-names>T</given-names></name><name><surname>Srivastava</surname><given-names>R</given-names></name><name><surname>Hayes</surname><given-names>TA</given-names></name><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Janga</surname><given-names>SC</given-names></name><name><surname>Paczesny</surname><given-names>S</given-names></name><name><surname>Kaplan</surname><given-names>MH</given-names></name><name><surname>Olson</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Granzyme A-producing T helper cells are critical for acute graft-versus-host disease</article-title><source>JCI Insight</source><volume>5</volume><elocation-id>124465</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.124465</pub-id><pub-id pub-id-type="pmid">32809971</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>RA</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name><name><surname>Simmons</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Granzyme A, a noncytolytic component of CD8(+) cell granules, restricts the spread of herpes simplex virus in the peripheral nervous systems of experimentally infected mice</article-title><source>Journal of Virology</source><volume>74</volume><fpage>1029</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1128/jvi.74.2.1029-1032.2000</pub-id><pub-id pub-id-type="pmid">10623769</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plasman</surname><given-names>K</given-names></name><name><surname>Demol</surname><given-names>H</given-names></name><name><surname>Bird</surname><given-names>PI</given-names></name><name><surname>Gevaert</surname><given-names>K</given-names></name><name><surname>Van Damme</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Substrate specificities of the granzyme tryptases A and K</article-title><source>Journal of Proteome Research</source><volume>13</volume><fpage>6067</fpage><lpage>6077</lpage><pub-id pub-id-type="doi">10.1021/pr500968d</pub-id><pub-id pub-id-type="pmid">25383893</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poo</surname><given-names>YS</given-names></name><name><surname>Rudd</surname><given-names>PA</given-names></name><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>JAC</given-names></name><name><surname>Larcher</surname><given-names>T</given-names></name><name><surname>Colle</surname><given-names>M-A</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Nakaya</surname><given-names>HI</given-names></name><name><surname>Warrilow</surname><given-names>D</given-names></name><name><surname>Allcock</surname><given-names>R</given-names></name><name><surname>Bielefeldt-Ohmann</surname><given-names>H</given-names></name><name><surname>Schroder</surname><given-names>WA</given-names></name><name><surname>Khromykh</surname><given-names>AA</given-names></name><name><surname>Lopez</surname><given-names>JA</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection</article-title><source>PLOS Neglected Tropical Diseases</source><volume>8</volume><elocation-id>e3354</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0003354</pub-id><pub-id pub-id-type="pmid">25474568</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prow</surname><given-names>NA</given-names></name><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Poo</surname><given-names>YS</given-names></name><name><surname>Nakayama</surname><given-names>E</given-names></name><name><surname>Hirata</surname><given-names>TDC</given-names></name><name><surname>Nakaya</surname><given-names>HI</given-names></name><name><surname>Slonchak</surname><given-names>A</given-names></name><name><surname>Mukhopadhyay</surname><given-names>P</given-names></name><name><surname>Mahalingam</surname><given-names>S</given-names></name><name><surname>Schroder</surname><given-names>WA</given-names></name><name><surname>Klimstra</surname><given-names>W</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Lower temperatures reduce type I interferon activity and promote alphaviral arthritis</article-title><source>PLOS Pathogens</source><volume>13</volume><elocation-id>e1006788</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006788</pub-id><pub-id pub-id-type="pmid">29281739</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prow</surname><given-names>NA</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Nakayama</surname><given-names>E</given-names></name><name><surname>Cooper</surname><given-names>TH</given-names></name><name><surname>Yan</surname><given-names>K</given-names></name><name><surname>Eldi</surname><given-names>P</given-names></name><name><surname>Hazlewood</surname><given-names>JE</given-names></name><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Setoh</surname><given-names>YX</given-names></name><name><surname>Khromykh</surname><given-names>AA</given-names></name><name><surname>Hobson-Peters</surname><given-names>J</given-names></name><name><surname>Diener</surname><given-names>KR</given-names></name><name><surname>Howley</surname><given-names>PM</given-names></name><name><surname>Hayball</surname><given-names>JD</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1230</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03662-6</pub-id><pub-id pub-id-type="pmid">29581442</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prow</surname><given-names>NA</given-names></name><name><surname>Hirata</surname><given-names>TDC</given-names></name><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Larcher</surname><given-names>T</given-names></name><name><surname>Mukhopadhyay</surname><given-names>P</given-names></name><name><surname>Alves</surname><given-names>TL</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Poo</surname><given-names>YS</given-names></name><name><surname>Nakayama</surname><given-names>E</given-names></name><name><surname>Lutzky</surname><given-names>VP</given-names></name><name><surname>Nakaya</surname><given-names>HI</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>2736</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.02736</pub-id><pub-id pub-id-type="pmid">31849947</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pu</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>Q</given-names></name><name><surname>Leak</surname><given-names>RK</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Mu</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>N</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Hitchens</surname><given-names>TK</given-names></name><name><surname>Bennett</surname><given-names>MVL</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Protease-independent action of tissue plasminogen activator in brain plasticity and neurological recovery after ischemic stroke</article-title><source>PNAS</source><volume>116</volume><fpage>9115</fpage><lpage>9124</lpage><pub-id pub-id-type="doi">10.1073/pnas.1821979116</pub-id><pub-id pub-id-type="pmid">30996120</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>KNS</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Pardue</surname><given-names>S</given-names></name><name><surname>Krzywanski</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Nicotinamide nucleotide transhydrogenase (NNT) regulates mitochondrial ROS and endothelial dysfunction in response to angiotensin II</article-title><source>Redox Biology</source><volume>36</volume><elocation-id>101650</elocation-id><pub-id pub-id-type="doi">10.1016/j.redox.2020.101650</pub-id><pub-id pub-id-type="pmid">32763515</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawle</surname><given-names>DJ</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Dumenil</surname><given-names>T</given-names></name><name><surname>Yan</surname><given-names>K</given-names></name><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Nguyen</surname><given-names>W</given-names></name><name><surname>Watterson</surname><given-names>D</given-names></name><name><surname>Modhiran</surname><given-names>N</given-names></name><name><surname>Hobson-Peters</surname><given-names>J</given-names></name><name><surname>Bishop</surname><given-names>C</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions</article-title><source>PLOS Pathogens</source><volume>17</volume><elocation-id>e1009723</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009723</pub-id><pub-id pub-id-type="pmid">34214142</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regner</surname><given-names>M</given-names></name><name><surname>Pavlinovic</surname><given-names>L</given-names></name><name><surname>Koskinen</surname><given-names>A</given-names></name><name><surname>Young</surname><given-names>N</given-names></name><name><surname>Trapani</surname><given-names>JA</given-names></name><name><surname>Müllbacher</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cutting edge: rapid and efficient in vivo cytotoxicity by cytotoxic T cells is independent of granzymes A and B</article-title><source>Journal of Immunology</source><volume>183</volume><fpage>37</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900466</pub-id><pub-id pub-id-type="pmid">19525394</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regner</surname><given-names>M</given-names></name><name><surname>Pavlinovic</surname><given-names>L</given-names></name><name><surname>Young</surname><given-names>N</given-names></name><name><surname>Müllbacher</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>In vivo elimination of MHC-I-deficient lymphocytes by activated natural killer cells is independent of granzymes A and B</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e23252</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0023252</pub-id><pub-id pub-id-type="pmid">21853094</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riera</surname><given-names>L</given-names></name><name><surname>Gariglio</surname><given-names>M</given-names></name><name><surname>Valente</surname><given-names>G</given-names></name><name><surname>Müllbacher</surname><given-names>A</given-names></name><name><surname>Museteanu</surname><given-names>C</given-names></name><name><surname>Landolfo</surname><given-names>S</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection</article-title><source>European Journal of Immunology</source><volume>30</volume><fpage>1350</fpage><lpage>1355</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(200005)30:5&lt;1350::AID-IMMU1350&gt;3.0.CO;2-J</pub-id><pub-id pub-id-type="pmid">10820381</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ripoll</surname><given-names>VM</given-names></name><name><surname>Meadows</surname><given-names>NA</given-names></name><name><surname>Bangert</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>AW</given-names></name><name><surname>Kadioglu</surname><given-names>A</given-names></name><name><surname>Cox</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nicotinamide nucleotide transhydrogenase (NNT) acts as a novel modulator of macrophage inflammatory responses</article-title><source>FASEB Journal</source><volume>26</volume><fpage>3550</fpage><lpage>3562</lpage><pub-id pub-id-type="doi">10.1096/fj.11-199935</pub-id><pub-id pub-id-type="pmid">22593545</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>JT</given-names></name><name><surname>Thorvaldsdóttir</surname><given-names>H</given-names></name><name><surname>Winckler</surname><given-names>W</given-names></name><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrative genomics viewer</article-title><source>Nature Biotechnology</source><volume>29</volume><fpage>24</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1038/nbt.1754</pub-id><pub-id pub-id-type="pmid">21221095</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronchi</surname><given-names>JA</given-names></name><name><surname>Figueira</surname><given-names>TR</given-names></name><name><surname>Ravagnani</surname><given-names>FG</given-names></name><name><surname>Oliveira</surname><given-names>HCF</given-names></name><name><surname>Vercesi</surname><given-names>AE</given-names></name><name><surname>Castilho</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A spontaneous mutation in the nicotinamide nucleotide transhydrogenase gene of C57BL/6J mice results in mitochondrial redox abnormalities</article-title><source>Free Radical Biology and Medicine</source><volume>63</volume><fpage>446</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.05.049</pub-id><pub-id pub-id-type="pmid">23747984</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rydström</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mitochondrial NADPH, transhydrogenase and disease</article-title><source>Biochimica et Biophysica Acta (BBA) - Bioenergetics</source><volume>1757</volume><fpage>721</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1016/j.bbabio.2006.03.010</pub-id><pub-id pub-id-type="pmid">16730324</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>M</given-names></name><name><surname>Troutman</surname><given-names>TD</given-names></name><name><surname>Seidman</surname><given-names>JS</given-names></name><name><surname>Ouyang</surname><given-names>Z</given-names></name><name><surname>Spann</surname><given-names>NJ</given-names></name><name><surname>Abe</surname><given-names>Y</given-names></name><name><surname>Ego</surname><given-names>KM</given-names></name><name><surname>Bruni</surname><given-names>CM</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Schlachetzki</surname><given-names>JCM</given-names></name><name><surname>Nott</surname><given-names>A</given-names></name><name><surname>Bennett</surname><given-names>H</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Vu</surname><given-names>BT</given-names></name><name><surname>Pasillas</surname><given-names>MP</given-names></name><name><surname>Link</surname><given-names>VM</given-names></name><name><surname>Texari</surname><given-names>L</given-names></name><name><surname>Heinz</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>BM</given-names></name><name><surname>McDonald</surname><given-names>JG</given-names></name><name><surname>Geissmann</surname><given-names>F</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Liver-Derived Signals Sequentially Reprogram Myeloid Enhancers to Initiate and Maintain Kupffer Cell Identity</article-title><source>Immunity</source><volume>51</volume><fpage>655</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.09.002</pub-id><pub-id pub-id-type="pmid">31587991</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salerno</surname><given-names>AG</given-names></name><name><surname>Rentz</surname><given-names>T</given-names></name><name><surname>Dorighello</surname><given-names>GG</given-names></name><name><surname>Marques</surname><given-names>AC</given-names></name><name><surname>Lorza-Gil</surname><given-names>E</given-names></name><name><surname>Wanschel</surname><given-names>ACBA</given-names></name><name><surname>de Moraes</surname><given-names>A</given-names></name><name><surname>Vercesi</surname><given-names>AE</given-names></name><name><surname>Oliveira</surname><given-names>HCF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lack of mitochondrial NADP(H)-transhydrogenase expression in macrophages exacerbates atherosclerosis in hypercholesterolemic mice</article-title><source>Biochemical Journal</source><volume>476</volume><fpage>3769</fpage><lpage>3789</lpage><pub-id pub-id-type="doi">10.1042/BCJ20190543</pub-id><pub-id pub-id-type="pmid">31803904</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santiago</surname><given-names>L</given-names></name><name><surname>Menaa</surname><given-names>C</given-names></name><name><surname>Arias</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>P</given-names></name><name><surname>Jaime-Sánchez</surname><given-names>P</given-names></name><name><surname>Metkar</surname><given-names>S</given-names></name><name><surname>Comas</surname><given-names>L</given-names></name><name><surname>Erill</surname><given-names>N</given-names></name><name><surname>Gonzalez-Rumayor</surname><given-names>V</given-names></name><name><surname>Esser</surname><given-names>E</given-names></name><name><surname>Galvez</surname><given-names>EM</given-names></name><name><surname>Raja</surname><given-names>S</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name><name><surname>Sprague</surname><given-names>SM</given-names></name><name><surname>Gabay</surname><given-names>C</given-names></name><name><surname>Martinez-Lostao</surname><given-names>L</given-names></name><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Froelich</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis</article-title><source>Arthritis &amp; Rheumatology</source><volume>69</volume><fpage>320</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1002/art.39857</pub-id><pub-id pub-id-type="pmid">27598995</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santiago</surname><given-names>L</given-names></name><name><surname>Castro</surname><given-names>M</given-names></name><name><surname>Sanz-Pamplona</surname><given-names>R</given-names></name><name><surname>Garzón</surname><given-names>M</given-names></name><name><surname>Ramirez-Labrada</surname><given-names>A</given-names></name><name><surname>Tapia</surname><given-names>E</given-names></name><name><surname>Moreno</surname><given-names>V</given-names></name><name><surname>Layunta</surname><given-names>E</given-names></name><name><surname>Gil-Gómez</surname><given-names>G</given-names></name><name><surname>Garrido</surname><given-names>M</given-names></name><name><surname>Peña</surname><given-names>R</given-names></name><name><surname>Lanuza</surname><given-names>PM</given-names></name><name><surname>Comas</surname><given-names>L</given-names></name><name><surname>Jaime-Sanchez</surname><given-names>P</given-names></name><name><surname>Uranga-Murillo</surname><given-names>I</given-names></name><name><surname>Del Campo</surname><given-names>R</given-names></name><name><surname>Pelegrín</surname><given-names>P</given-names></name><name><surname>Camerer</surname><given-names>E</given-names></name><name><surname>Martínez-Lostao</surname><given-names>L</given-names></name><name><surname>Muñoz</surname><given-names>G</given-names></name><name><surname>Uranga</surname><given-names>JA</given-names></name><name><surname>Alcalde</surname><given-names>A</given-names></name><name><surname>Galvez</surname><given-names>EM</given-names></name><name><surname>Ferrandez</surname><given-names>A</given-names></name><name><surname>Bird</surname><given-names>PI</given-names></name><name><surname>Metkar</surname><given-names>S</given-names></name><name><surname>Arias</surname><given-names>MA</given-names></name><name><surname>Pardo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Extracellular Granzyme A Promotes Colorectal Cancer Development by Enhancing Gut Inflammation</article-title><source>Cell Reports</source><volume>32</volume><elocation-id>107847</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107847</pub-id><pub-id pub-id-type="pmid">32640217</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santiago-Raber</surname><given-names>M-L</given-names></name><name><surname>Baccala</surname><given-names>R</given-names></name><name><surname>Haraldsson</surname><given-names>KM</given-names></name><name><surname>Choubey</surname><given-names>D</given-names></name><name><surname>Stewart</surname><given-names>TA</given-names></name><name><surname>Kono</surname><given-names>DH</given-names></name><name><surname>Theofilopoulos</surname><given-names>AN</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice</article-title><source>Journal of Experimental Medicine</source><volume>197</volume><fpage>777</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1084/jem.20021996</pub-id><pub-id pub-id-type="pmid">12642605</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schanoski</surname><given-names>AS</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Kaiserman</surname><given-names>D</given-names></name><name><surname>Rowe</surname><given-names>C</given-names></name><name><surname>Prow</surname><given-names>NA</given-names></name><name><surname>Barboza</surname><given-names>DD</given-names></name><name><surname>Santos</surname><given-names>CA</given-names></name><name><surname>Zanotto</surname><given-names>PMA</given-names></name><name><surname>Magalhães</surname><given-names>KG</given-names></name><name><surname>Aurelio</surname><given-names>L</given-names></name><name><surname>Muller</surname><given-names>D</given-names></name><name><surname>Young</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Bird</surname><given-names>PI</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Granzyme A in Chikungunya and Other Arboviral Infections</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>3083</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.03083</pub-id><pub-id pub-id-type="pmid">31993061</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schett</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Resolution of inflammation in arthritis</article-title><source>Seminars in Immunopathology</source><volume>41</volume><fpage>675</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1007/s00281-019-00768-x</pub-id><pub-id pub-id-type="pmid">31720751</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scumpia</surname><given-names>PO</given-names></name><name><surname>Botten</surname><given-names>GA</given-names></name><name><surname>Norman</surname><given-names>JS</given-names></name><name><surname>Kelly-Scumpia</surname><given-names>KM</given-names></name><name><surname>Spreafico</surname><given-names>R</given-names></name><name><surname>Ruccia</surname><given-names>AR</given-names></name><name><surname>Purbey</surname><given-names>PK</given-names></name><name><surname>Thomas</surname><given-names>BJ</given-names></name><name><surname>Modlin</surname><given-names>RL</given-names></name><name><surname>Smale</surname><given-names>ST</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Opposing roles of Toll-like receptor and cytosolic DNA-STING signaling pathways for <italic>Staphylococcus aureus</italic> cutaneous host defense</article-title><source>PLOS Pathogens</source><volume>13</volume><elocation-id>e1006496</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006496</pub-id><pub-id pub-id-type="pmid">28704551</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segalés</surname><given-names>J</given-names></name><name><surname>Perdiguero</surname><given-names>E</given-names></name><name><surname>Serrano</surname><given-names>AL</given-names></name><name><surname>Sousa-Victor</surname><given-names>P</given-names></name><name><surname>Ortet</surname><given-names>L</given-names></name><name><surname>Jardí</surname><given-names>M</given-names></name><name><surname>Budanov</surname><given-names>AV</given-names></name><name><surname>Garcia-Prat</surname><given-names>L</given-names></name><name><surname>Sandri</surname><given-names>M</given-names></name><name><surname>Thomson</surname><given-names>DM</given-names></name><name><surname>Karin</surname><given-names>M</given-names></name><name><surname>Hee Lee</surname><given-names>J</given-names></name><name><surname>Muñoz-Cánoves</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Sestrin prevents atrophy of disused and aging muscles by integrating anabolic and catabolic signals</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>189</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-13832-9</pub-id><pub-id pub-id-type="pmid">31929511</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Markiel</surname><given-names>A</given-names></name><name><surname>Ozier</surname><given-names>O</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Ramage</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Schwikowski</surname><given-names>B</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title><source>Genome Research</source><volume>13</volume><fpage>2498</fpage><lpage>2504</lpage><pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><pub-id pub-id-type="pmid">14597658</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name><name><surname>Sakurai</surname><given-names>M</given-names></name><name><surname>Yumoto</surname><given-names>N</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Mishima-Tsumagari</surname><given-names>C</given-names></name><name><surname>Kukimoto-Niino</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Kawamura</surname><given-names>M</given-names></name><name><surname>Shirouzu</surname><given-names>M</given-names></name><name><surname>Fujii</surname><given-names>S-I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>1450</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.01450</pub-id><pub-id pub-id-type="pmid">31293597</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shresta</surname><given-names>S</given-names></name><name><surname>Goda</surname><given-names>P</given-names></name><name><surname>Wesselschmidt</surname><given-names>R</given-names></name><name><surname>Ley</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Residual cytotoxicity and granzyme K expression in granzyme A-deficient cytotoxic lymphocytes</article-title><source>The Journal of Biological Chemistry</source><volume>272</volume><fpage>20236</fpage><lpage>20244</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.32.20236</pub-id><pub-id pub-id-type="pmid">9242702</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shresta</surname><given-names>S</given-names></name><name><surname>Graubert</surname><given-names>TA</given-names></name><name><surname>Thomas</surname><given-names>DA</given-names></name><name><surname>Raptis</surname><given-names>SZ</given-names></name><name><surname>Ley</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Granzyme A initiates an alternative pathway for granule-mediated apoptosis</article-title><source>Immunity</source><volume>10</volume><fpage>595</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(00)80059-x</pub-id><pub-id pub-id-type="pmid">10367905</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Silver</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2008">2008</year><data-title>In Mouse Genetics Concepts and Applications</data-title><source>The Jackson Laboratory</source><ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/silver/index.shtml">http://www.informatics.jax.org/silver/index.shtml</ext-link></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains</article-title><source>Genome Biology</source><volume>14</volume><elocation-id>R82</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2013-14-7-r82</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><data-title>FastQC: A quality control tool for high throughput sequence data</data-title><source>FastQC</source></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>MJ</given-names></name><name><surname>Street</surname><given-names>SEA</given-names></name><name><surname>Trapani</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cutting Edge: Granzymes A and B Are Not Essential for Perforin-Mediated Tumor Rejection</article-title><source>The Journal of Immunology</source><volume>171</volume><fpage>515</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.171.2.515</pub-id><pub-id pub-id-type="pmid">12847210</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza-Fonseca-Guimaraes</surname><given-names>F</given-names></name><name><surname>Young</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>D</given-names></name><name><surname>Martinet</surname><given-names>L</given-names></name><name><surname>Bruedigam</surname><given-names>C</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Andoniou</surname><given-names>CE</given-names></name><name><surname>Degli-Esposti</surname><given-names>MA</given-names></name><name><surname>Hill</surname><given-names>GR</given-names></name><name><surname>Smyth</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>NK cells require IL-28R for optimal in vivo activity</article-title><source>PNAS</source><volume>112</volume><fpage>E2376</fpage><lpage>E2384</lpage><pub-id pub-id-type="doi">10.1073/pnas.1424241112</pub-id><pub-id pub-id-type="pmid">25901316</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sower</surname><given-names>LE</given-names></name><name><surname>Froelich</surname><given-names>CJ</given-names></name><name><surname>Allegretto</surname><given-names>N</given-names></name><name><surname>Rose</surname><given-names>PM</given-names></name><name><surname>Hanna</surname><given-names>WD</given-names></name><name><surname>Klimpel</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin</article-title><source>Journal of Immunology</source><volume>156</volume><fpage>2585</fpage><lpage>2590</lpage><pub-id pub-id-type="pmid">8786323</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaeny-Dekking</surname><given-names>EH</given-names></name><name><surname>Hanna</surname><given-names>WL</given-names></name><name><surname>Wolbink</surname><given-names>AM</given-names></name><name><surname>Wever</surname><given-names>PC</given-names></name><name><surname>Kummer</surname><given-names>JA</given-names></name><name><surname>Kummer</surname><given-names>AJ</given-names></name><name><surname>Swaak</surname><given-names>AJ</given-names></name><name><surname>Middeldorp</surname><given-names>JM</given-names></name><name><surname>Huisman</surname><given-names>HG</given-names></name><name><surname>Froelich</surname><given-names>CJ</given-names></name><name><surname>Hack</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo</article-title><source>Journal of Immunology</source><volume>160</volume><fpage>3610</fpage><lpage>3616</lpage><pub-id pub-id-type="pmid">9531325</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaeny-Dekking</surname><given-names>EH</given-names></name><name><surname>Kamp</surname><given-names>AM</given-names></name><name><surname>Froelich</surname><given-names>CJ</given-names></name><name><surname>Hack</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Extracellular granzyme A, complexed to proteoglycans, is protected against inactivation by protease inhibitors</article-title><source>Blood</source><volume>95</volume><fpage>1465</fpage><lpage>1472</lpage><pub-id pub-id-type="pmid">10666226</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>CT</given-names></name><name><surname>Abate</surname><given-names>G</given-names></name><name><surname>Sakala</surname><given-names>IG</given-names></name><name><surname>Xia</surname><given-names>M</given-names></name><name><surname>Truscott</surname><given-names>SM</given-names></name><name><surname>Eickhoff</surname><given-names>CS</given-names></name><name><surname>Linn</surname><given-names>R</given-names></name><name><surname>Blazevic</surname><given-names>A</given-names></name><name><surname>Metkar</surname><given-names>SS</given-names></name><name><surname>Peng</surname><given-names>G</given-names></name><name><surname>Froelich</surname><given-names>CJ</given-names></name><name><surname>Hoft</surname><given-names>DF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Granzyme A produced by γ(9)δ(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen</article-title><source>PLOS Pathogens</source><volume>9</volume><elocation-id>e1003119</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003119</pub-id><pub-id pub-id-type="pmid">23326234</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinhubl</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Why have antioxidants failed in clinical trials?</article-title><source>The American Journal of Cardiology</source><volume>101</volume><fpage>14D</fpage><lpage>19D</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2008.02.003</pub-id><pub-id pub-id-type="pmid">18474268</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>SE</given-names></name><name><surname>D’Angelo</surname><given-names>ME</given-names></name><name><surname>Bird</surname><given-names>PI</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Intercellular communication via the endo-lysosomal system: translocation of granzymes through membrane barriers</article-title><source>Biochimica et Biophysica Acta</source><volume>1824</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.bbapap.2011.05.020</pub-id><pub-id pub-id-type="pmid">21683168</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strik</surname><given-names>MCM</given-names></name><name><surname>Wolbink</surname><given-names>A</given-names></name><name><surname>Wouters</surname><given-names>D</given-names></name><name><surname>Bladergroen</surname><given-names>BA</given-names></name><name><surname>Verlaan</surname><given-names>AR</given-names></name><name><surname>van Houdt</surname><given-names>IS</given-names></name><name><surname>Hijlkema</surname><given-names>S</given-names></name><name><surname>Hack</surname><given-names>CE</given-names></name><name><surname>Kummer</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with beta-tryptase monomers</article-title><source>Blood</source><volume>103</volume><fpage>2710</fpage><lpage>2717</lpage><pub-id pub-id-type="doi">10.1182/blood-2003-08-2981</pub-id><pub-id pub-id-type="pmid">14670919</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suhrbier</surname><given-names>A</given-names></name><name><surname>Fernan</surname><given-names>A</given-names></name><name><surname>Burrows</surname><given-names>SR</given-names></name><name><surname>Saul</surname><given-names>A</given-names></name><name><surname>Moss</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>BLT esterase activity as an alternative to chromium release in cytotoxic T cell assays</article-title><source>Journal of Immunological Methods</source><volume>145</volume><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(91)90309-4</pub-id><pub-id pub-id-type="pmid">1722495</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suhrbier</surname><given-names>A</given-names></name><name><surname>Jaffar-Bandjee</surname><given-names>M-C</given-names></name><name><surname>Gasque</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Arthritogenic alphaviruses--an overview</article-title><source>Nature Reviews. Rheumatology</source><volume>8</volume><fpage>420</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2012.64</pub-id><pub-id pub-id-type="pmid">22565316</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Rheumatic manifestations of chikungunya: emerging concepts and interventions</article-title><source>Nature Reviews. Rheumatology</source><volume>15</volume><fpage>597</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1038/s41584-019-0276-9</pub-id><pub-id pub-id-type="pmid">31481759</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suidan</surname><given-names>HS</given-names></name><name><surname>Bouvier</surname><given-names>J</given-names></name><name><surname>Schaerer</surname><given-names>E</given-names></name><name><surname>Stone</surname><given-names>SR</given-names></name><name><surname>Monard</surname><given-names>D</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes</article-title><source>PNAS</source><volume>91</volume><fpage>8112</fpage><lpage>8116</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.17.8112</pub-id><pub-id pub-id-type="pmid">8058766</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suidan</surname><given-names>HS</given-names></name><name><surname>Clemetson</surname><given-names>KJ</given-names></name><name><surname>Brown-Luedi</surname><given-names>M</given-names></name><name><surname>Niclou</surname><given-names>SP</given-names></name><name><surname>Clemetson</surname><given-names>JM</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name><name><surname>Monard</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin</article-title><source>The Biochemical Journal</source><volume>315 (Pt 3)</volume><fpage>939</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1042/bj3150939</pub-id><pub-id pub-id-type="pmid">8645180</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Saredy</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Innate-adaptive immunity interplay and redox regulation in immune response</article-title><source>Redox Biology</source><volume>37</volume><elocation-id>101759</elocation-id><pub-id pub-id-type="doi">10.1016/j.redox.2020.101759</pub-id><pub-id pub-id-type="pmid">33086106</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Susanto</surname><given-names>O</given-names></name><name><surname>Stewart</surname><given-names>SE</given-names></name><name><surname>Voskoboinik</surname><given-names>I</given-names></name><name><surname>Brasacchio</surname><given-names>D</given-names></name><name><surname>Hagn</surname><given-names>M</given-names></name><name><surname>Ellis</surname><given-names>S</given-names></name><name><surname>Asquith</surname><given-names>S</given-names></name><name><surname>Sedelies</surname><given-names>KA</given-names></name><name><surname>Bird</surname><given-names>PI</given-names></name><name><surname>Waterhouse</surname><given-names>NJ</given-names></name><name><surname>Trapani</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mouse granzyme A induces a novel death with writhing morphology that is mechanistically distinct from granzyme B-induced apoptosis</article-title><source>Cell Death and Differentiation</source><volume>20</volume><fpage>1183</fpage><lpage>1193</lpage><pub-id pub-id-type="doi">10.1038/cdd.2013.59</pub-id><pub-id pub-id-type="pmid">23744295</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swann</surname><given-names>JB</given-names></name><name><surname>Hayakawa</surname><given-names>Y</given-names></name><name><surname>Zerafa</surname><given-names>N</given-names></name><name><surname>Sheehan</surname><given-names>KCF</given-names></name><name><surname>Scott</surname><given-names>B</given-names></name><name><surname>Schreiber</surname><given-names>RD</given-names></name><name><surname>Hertzog</surname><given-names>P</given-names></name><name><surname>Smyth</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Type I IFN contributes to NK cell homeostasis, activation, and antitumor function</article-title><source>Journal of Immunology</source><volume>178</volume><fpage>7540</fpage><lpage>7549</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.12.7540</pub-id><pub-id pub-id-type="pmid">17548588</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname><given-names>R</given-names></name><name><surname>Lantsman</surname><given-names>T</given-names></name><name><surname>Peters</surname><given-names>DE</given-names></name><name><surname>Bugge</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin</article-title><source>Development</source><volume>143</volume><fpage>2818</fpage><lpage>2828</lpage><pub-id pub-id-type="doi">10.1242/dev.137968</pub-id><pub-id pub-id-type="pmid">27385010</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Gable</surname><given-names>AL</given-names></name><name><surname>Lyon</surname><given-names>D</given-names></name><name><surname>Junge</surname><given-names>A</given-names></name><name><surname>Wyder</surname><given-names>S</given-names></name><name><surname>Huerta-Cepas</surname><given-names>J</given-names></name><name><surname>Simonovic</surname><given-names>M</given-names></name><name><surname>Doncheva</surname><given-names>NT</given-names></name><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>LJ</given-names></name><name><surname>Mering</surname><given-names>C von</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D607</fpage><lpage>D613</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id><pub-id pub-id-type="pmid">30476243</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teoh</surname><given-names>SSY</given-names></name><name><surname>Vieusseux</surname><given-names>J</given-names></name><name><surname>Prakash</surname><given-names>M</given-names></name><name><surname>Berkowicz</surname><given-names>S</given-names></name><name><surname>Luu</surname><given-names>J</given-names></name><name><surname>Bird</surname><given-names>CH</given-names></name><name><surname>Law</surname><given-names>RHP</given-names></name><name><surname>Rosado</surname><given-names>C</given-names></name><name><surname>Price</surname><given-names>JT</given-names></name><name><surname>Whisstock</surname><given-names>JC</given-names></name><name><surname>Bird</surname><given-names>PI</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Maspin is not required for embryonic development or tumour suppression</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3164</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4164</pub-id><pub-id pub-id-type="pmid">24445777</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To</surname><given-names>EE</given-names></name><name><surname>Erlich</surname><given-names>JR</given-names></name><name><surname>Liong</surname><given-names>F</given-names></name><name><surname>Luong</surname><given-names>R</given-names></name><name><surname>Liong</surname><given-names>S</given-names></name><name><surname>Esaq</surname><given-names>F</given-names></name><name><surname>Oseghale</surname><given-names>O</given-names></name><name><surname>Anthony</surname><given-names>D</given-names></name><name><surname>McQualter</surname><given-names>J</given-names></name><name><surname>Bozinovski</surname><given-names>S</given-names></name><name><surname>Vlahos</surname><given-names>R</given-names></name><name><surname>O’Leary</surname><given-names>JJ</given-names></name><name><surname>Brooks</surname><given-names>DA</given-names></name><name><surname>Selemidis</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mitochondrial Reactive Oxygen Species Contribute to Pathological Inflammation During Influenza A Virus Infection in Mice</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>32</volume><fpage>929</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1089/ars.2019.7727</pub-id><pub-id pub-id-type="pmid">31190565</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toye</surname><given-names>AA</given-names></name><name><surname>Lippiat</surname><given-names>JD</given-names></name><name><surname>Proks</surname><given-names>P</given-names></name><name><surname>Shimomura</surname><given-names>K</given-names></name><name><surname>Bentley</surname><given-names>L</given-names></name><name><surname>Hugill</surname><given-names>A</given-names></name><name><surname>Mijat</surname><given-names>V</given-names></name><name><surname>Goldsworthy</surname><given-names>M</given-names></name><name><surname>Moir</surname><given-names>L</given-names></name><name><surname>Haynes</surname><given-names>A</given-names></name><name><surname>Quarterman</surname><given-names>J</given-names></name><name><surname>Freeman</surname><given-names>HC</given-names></name><name><surname>Ashcroft</surname><given-names>FM</given-names></name><name><surname>Cox</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice</article-title><source>Diabetologia</source><volume>48</volume><fpage>675</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1007/s00125-005-1680-z</pub-id><pub-id pub-id-type="pmid">15729571</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tumiati</surname><given-names>M</given-names></name><name><surname>Hemmes</surname><given-names>A</given-names></name><name><surname>Uusivirta</surname><given-names>S</given-names></name><name><surname>Koopal</surname><given-names>S</given-names></name><name><surname>Kankainen</surname><given-names>M</given-names></name><name><surname>Lehtonen</surname><given-names>E</given-names></name><name><surname>Kuznetsov</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Loss of Rad51c accelerates tumourigenesis in sebaceous glands of Trp53-mutant mice</article-title><source>The Journal of Pathology</source><volume>235</volume><fpage>136</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1002/path.4455</pub-id><pub-id pub-id-type="pmid">25270124</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ubaida-Mohien</surname><given-names>C</given-names></name><name><surname>Lyashkov</surname><given-names>A</given-names></name><name><surname>Gonzalez-Freire</surname><given-names>M</given-names></name><name><surname>Tharakan</surname><given-names>R</given-names></name><name><surname>Shardell</surname><given-names>M</given-names></name><name><surname>Moaddel</surname><given-names>R</given-names></name><name><surname>Semba</surname><given-names>RD</given-names></name><name><surname>Chia</surname><given-names>CW</given-names></name><name><surname>Gorospe</surname><given-names>M</given-names></name><name><surname>Sen</surname><given-names>R</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Discovery proteomics in aging human skeletal muscle finds change in spliceosome, immunity, proteostasis and mitochondria</article-title><source>eLife</source><volume>8</volume><elocation-id>e49874</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.49874</pub-id><pub-id pub-id-type="pmid">31642809</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uranga</surname><given-names>S</given-names></name><name><surname>Marinova</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>C</given-names></name><name><surname>Pardo</surname><given-names>J</given-names></name><name><surname>Aguilo</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In Vivo</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0153028</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0153028</pub-id><pub-id pub-id-type="pmid">27055232</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Daalen</surname><given-names>KR</given-names></name><name><surname>Reijneveld</surname><given-names>JF</given-names></name><name><surname>Bovenschen</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Modulation of Inflammation by Extracellular Granzyme A</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>931</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.00931</pub-id><pub-id pub-id-type="pmid">32508827</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Boogaard</surname><given-names>FE</given-names></name><name><surname>van Gisbergen</surname><given-names>K</given-names></name><name><surname>Vernooy</surname><given-names>JH</given-names></name><name><surname>Medema</surname><given-names>JP</given-names></name><name><surname>Roelofs</surname><given-names>J</given-names></name><name><surname>van Zoelen</surname><given-names>MAD</given-names></name><name><surname>Endeman</surname><given-names>H</given-names></name><name><surname>Biesma</surname><given-names>DH</given-names></name><name><surname>Boon</surname><given-names>L</given-names></name><name><surname>Van’t Veer</surname><given-names>C</given-names></name><name><surname>de Vos</surname><given-names>AF</given-names></name><name><surname>van der Poll</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Granzyme A impairs host defense during Streptococcus pneumoniae pneumonia</article-title><source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source><volume>311</volume><fpage>L507</fpage><lpage>L516</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00116.2016</pub-id><pub-id pub-id-type="pmid">27343190</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Eck</surname><given-names>JA</given-names></name><name><surname>Shan</surname><given-names>L</given-names></name><name><surname>Meeldijk</surname><given-names>J</given-names></name><name><surname>Hack</surname><given-names>CE</given-names></name><name><surname>Bovenschen</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A novel proinflammatory role for granzyme A</article-title><source>Cell Death &amp; Disease</source><volume>8</volume><elocation-id>e2630</elocation-id><pub-id pub-id-type="doi">10.1038/cddis.2017.56</pub-id><pub-id pub-id-type="pmid">28230859</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varet</surname><given-names>H</given-names></name><name><surname>Brillet-Guéguen</surname><given-names>L</given-names></name><name><surname>Coppée</surname><given-names>J-Y</given-names></name><name><surname>Dillies</surname><given-names>M-A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SARTools: A DESeq2- and EdgeR-Based R Pipeline for Comprehensive Differential Analysis of RNA-Seq Data</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0157022</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0157022</pub-id><pub-id pub-id-type="pmid">27280887</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>G</given-names></name><name><surname>Novak</surname><given-names>EA</given-names></name><name><surname>Siow</surname><given-names>VS</given-names></name><name><surname>Cunningham</surname><given-names>KE</given-names></name><name><surname>Griffith</surname><given-names>BD</given-names></name><name><surname>Comerford</surname><given-names>TE</given-names></name><name><surname>Mentrup</surname><given-names>HL</given-names></name><name><surname>Stolz</surname><given-names>DB</given-names></name><name><surname>Loughran</surname><given-names>P</given-names></name><name><surname>Ranganathan</surname><given-names>S</given-names></name><name><surname>Mollen</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Nix-Mediated Mitophagy Modulates Mitochondrial Damage During Intestinal Inflammation</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>33</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1089/ars.2018.7702</pub-id><pub-id pub-id-type="pmid">32103677</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vozenilek</surname><given-names>AE</given-names></name><name><surname>Vetkoetter</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>JM</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Traylor</surname><given-names>JG</given-names></name><name><surname>Klein</surname><given-names>RL</given-names></name><name><surname>Orr</surname><given-names>AW</given-names></name><name><surname>Woolard</surname><given-names>MD</given-names></name><name><surname>Krzywanski</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Absence of Nicotinamide Nucleotide Transhydrogenase in C57BL/6J Mice Exacerbates Experimental Atherosclerosis</article-title><source>Journal of Vascular Research</source><volume>55</volume><fpage>98</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1159/000486337</pub-id><pub-id pub-id-type="pmid">29455203</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>NP</given-names></name><name><surname>Kang</surname><given-names>YP</given-names></name><name><surname>Falzone</surname><given-names>A</given-names></name><name><surname>Boyle</surname><given-names>TA</given-names></name><name><surname>DeNicola</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function</article-title><source>The Journal of Experimental Medicine</source><volume>217</volume><elocation-id>e20191689</elocation-id><pub-id pub-id-type="doi">10.1084/jem.20191689</pub-id><pub-id pub-id-type="pmid">32196080</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>LV</given-names></name><name><surname>Barbarulo</surname><given-names>A</given-names></name><name><surname>Huysentruyt</surname><given-names>J</given-names></name><name><surname>Vanden Berghe</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Ley</surname><given-names>S</given-names></name><name><surname>Vandenabeele</surname><given-names>P</given-names></name><name><surname>Seddon</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-κB</article-title><source>Immunity</source><volume>50</volume><fpage>348</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.01.004</pub-id><pub-id pub-id-type="pmid">30737145</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wensink</surname><given-names>AC</given-names></name><name><surname>Hack</surname><given-names>CE</given-names></name><name><surname>Bovenschen</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Granzymes regulate proinflammatory cytokine responses</article-title><source>Journal of Immunology</source><volume>194</volume><fpage>491</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1401214</pub-id><pub-id pub-id-type="pmid">25556251</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>JL</given-names></name><name><surname>Hall</surname><given-names>CL</given-names></name><name><surname>Meimaridou</surname><given-names>E</given-names></name><name><surname>Metherell</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Loss of Nnt Increases Expression of Oxidative Phosphorylation Complexes in C57BL/6J Hearts</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>6101</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22116101</pub-id><pub-id pub-id-type="pmid">34198873</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>JAC</given-names></name><name><surname>Prow</surname><given-names>NA</given-names></name><name><surname>Schroder</surname><given-names>WA</given-names></name><name><surname>Ellis</surname><given-names>JJ</given-names></name><name><surname>Cumming</surname><given-names>HE</given-names></name><name><surname>Gearing</surname><given-names>LJ</given-names></name><name><surname>Poo</surname><given-names>YS</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Hertzog</surname><given-names>PJ</given-names></name><name><surname>Di Giallonardo</surname><given-names>F</given-names></name><name><surname>Hueston</surname><given-names>L</given-names></name><name><surname>Le Grand</surname><given-names>R</given-names></name><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Mahalingam</surname><given-names>S</given-names></name><name><surname>Roques</surname><given-names>P</given-names></name><name><surname>Bird</surname><given-names>PI</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation</article-title><source>PLOS Pathogens</source><volume>13</volume><elocation-id>e1006155</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006155</pub-id><pub-id pub-id-type="pmid">28207896</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>S</given-names></name><name><surname>Hainz</surname><given-names>N</given-names></name><name><surname>Beckmann</surname><given-names>A</given-names></name><name><surname>Maack</surname><given-names>C</given-names></name><name><surname>Menger</surname><given-names>MD</given-names></name><name><surname>Tschernig</surname><given-names>T</given-names></name><name><surname>Meier</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Brain damage resulting from postnatal hypoxic-ischemic brain injury is reduced in C57BL/6J mice as compared to C57BL/6N mice</article-title><source>Brain Research</source><volume>1650</volume><fpage>224</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2016.09.013</pub-id><pub-id pub-id-type="pmid">27620649</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>CH</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Fabbri</surname><given-names>M</given-names></name><name><surname>Wayne</surname><given-names>AS</given-names></name><name><surname>Seeger</surname><given-names>RC</given-names></name><name><surname>Jong</surname><given-names>AY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells</article-title><source>Journal of Extracellular Vesicles</source><volume>8</volume><elocation-id>1588538</elocation-id><pub-id pub-id-type="doi">10.1080/20013078.2019.1588538</pub-id><pub-id pub-id-type="pmid">30891164</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Mo</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Fan</surname><given-names>C</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Protective Effects of MitoTEMPO on Nonalcoholic Fatty Liver Disease via Regulating Myeloid-Derived Suppressor Cells and Inflammation in Mice</article-title><source>BioMed Research International</source><volume>2020</volume><elocation-id>9329427</elocation-id><pub-id pub-id-type="doi">10.1155/2020/9329427</pub-id><pub-id pub-id-type="pmid">32802885</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>K</given-names></name><name><surname>Vet</surname><given-names>LJ</given-names></name><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Hobson-Peters</surname><given-names>J</given-names></name><name><surname>Rawle</surname><given-names>DJ</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Larcher</surname><given-names>T</given-names></name><name><surname>Hall</surname><given-names>RA</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine</article-title><source>Vaccines</source><volume>8</volume><elocation-id>E368</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines8030368</pub-id><pub-id pub-id-type="pmid">32660106</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yodoi</surname><given-names>J</given-names></name><name><surname>Matsuo</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Masutani</surname><given-names>H</given-names></name><name><surname>Inamoto</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Anti-Inflammatory Thioredoxin Family Proteins for Medicare, Healthcare and Aging Care</article-title><source>Nutrients</source><volume>9</volume><elocation-id>E1081</elocation-id><pub-id pub-id-type="doi">10.3390/nu9101081</pub-id><pub-id pub-id-type="pmid">28961169</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaid</surname><given-names>A</given-names></name><name><surname>Burt</surname><given-names>FJ</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Poo</surname><given-names>YS</given-names></name><name><surname>Zandi</surname><given-names>K</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name><name><surname>Weaver</surname><given-names>SC</given-names></name><name><surname>Texeira</surname><given-names>MM</given-names></name><name><surname>Mahalingam</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses</article-title><source>The Lancet. Infectious Diseases</source><volume>21</volume><fpage>e123</fpage><lpage>e133</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30491-6</pub-id><pub-id pub-id-type="pmid">33160445</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells</article-title><source>Science</source><volume>368</volume><elocation-id>eaaz7548</elocation-id><pub-id pub-id-type="doi">10.1126/science.aaz7548</pub-id><pub-id pub-id-type="pmid">32299851</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70207.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Takayanagi</surname><given-names>Hiroshi</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>The University of Tokyo</institution><country>Japan</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.03.16.435730" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.03.16.435730"/></front-stub><body><p>This paper is of great interest as a serendipitous discovery that, in the course of investigating the physiological role of granzyme A, has revealed the significance of the <italic>Nnt</italic> gene mutation in the inflammatory responses in mouse models. For many researchers in the fields of medicine and biology using C57BL/6 mice, the data obtained in this study will provide a useful opportunity to revisit previous findings and to gain new insights.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70207.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Takayanagi</surname><given-names>Hiroshi</given-names></name><role>Reviewing Editor</role><aff><institution>The University of Tokyo</institution><country>Japan</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.03.16.435730">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.03.16.435730v1.full">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Widespread discrepancy in Nnt genotypes complicate granzyme A and other knockout mouse studies&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Carlos Isales as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Please provide histological data of the feet of B6N, B6N-NntΔexon8-12, and B6J mice administered MitoTEMPO after infection with CHIKV, to demonstrate the difference in leukocyte infiltration. (as suggested by Reviewer #2)</p><p>2) The ROS levels in T cells should be examined. Is there difference between mice with or lacking NNT activity? (as suggested by Reviewer #2)</p><p>3) Please provide some data and/or discussion about the possibility that the truncated Nnt allele in heterozygosis may generate an intermediate phenotype. (as suggested by Reviewer #1)</p><p>4) Please revise and improve the manuscript according to the comments by both reviewers.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>– Although the text is very explanative, the excessive use of abbreviations (together with the absence of an abbreviation list since it is not required by the journal) make it sometimes difficult to read fluently. I suggest reducing the use of abbreviations whenever possible.</p><p>– Nicotinamide nucleotide transhydrogenase is the name of the gene encoding the protein. Indeed, &quot;NNT&quot; has also been extensively used to refer to the protein. However, in enzyme databases the official name of this enzyme is proton-translocating NAD(P)+ transhydrogenase (EC 7.1.1.1). I suggest adding this information to the introduction.</p><p>– The Methods section does not seem logically organized. Please, re-order the topics, for example by the type of procedure (e.g. putting any treatment just after the description of mice, and grouping all procedures involving RNA/rtPCR, and then genome and bioinformatics).</p><p>– The presence of the truncated Nnt allele in heterozygosis may generate an intermediate phenotype (as suggested in PMID 27474736). Did the assessment carried out on SRA-NCBI data or even the GzmA-/- sequencing allow to detect heterozygous carriers? The authors may wish to include some data and/or discussion on this issue.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Even though the conclusions of this paper are well supported by ample data, it would be more convincing if the authors could provide the following data.</p><p>Histological section of the feet of B6N, B6N-NntΔexon8-12, and B6J mice administered MitoTEMPO after infection with CHIKV to demonstrate the difference in leukocyte infiltration.</p><p>The difference in ROS levels in T cells of mouse strains due to presence or absence of NNT activity.</p><p>Validation of RNA-seq data by quantitative RT-PCR.</p><p>The authors should address whether or not is C57BL/6N-GzmaS211A knock-in mice is available to other researchers.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70207.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Please provide histological data of the feet of B6N, B6N-NntΔexon8-12, and B6J mice administered MitoTEMPO after infection with CHIKV, to demonstrate the difference in leukocyte infiltration. (as suggested by Reviewer #2)</p></disp-quote><p>This data has been provided in new Figure 4c,d, 5c,d,e and f, and Supplementary Figures 6 and 7. Actually the results indicated a somewhat more nuanced outcome with 6N<sup>NntΔexon8-12</sup> mice showing increased edema rather than infiltrates, and MitoTEMPO treatment showing reduced edema and infiltrates. To unravel this issue we undertook RNA-Seq analyses for the two comparisons to produce a new Figure 4e. The results highlight that <italic>Nnt</italic> and the 6N background both likely have a role in limiting arthritic inflammation. Adjustments to reflect this new data have been made throughout the manuscript including the title.</p><disp-quote content-type="editor-comment"><p>2) The ROS levels in T cells should be examined. Is there difference between mice with or lacking NNT activity? (as suggested by Reviewer #2)</p></disp-quote><p>Given that 6N<sup>NntΔexon8-12</sup> mice did not show differences in cellular infiltrates, it is clear our speculation on NNT regulating T cell migration in this setting was misplaced. That ROS regulates T cell migration is established, and we show that MitoTEMO also inhibits cellular infiltration; however, in this model at least, NNT emerges only to significantly ameliorate arthritic edema. We have thus removed our speculation on T cell migration and NNT, and have replaced this with new histology and RNA-Seq data, which details the cytokines and chemokines affected by NNT and MitoTEMPO (see Figure 4e). We have also been unable to see differences in ROS levels using a number of florescent dyes in 6N<sup>NntΔexon8-12</sup> vs 6N splenic T cells under a range of in vitro conditions; levels are actually quite low as activation causes a metabolic shift to glycolysis. NNT has been reported independently by two groups to regulate mitochondrial ROS in macrophages, with APC function thus a more likely target for NNT.</p><disp-quote content-type="editor-comment"><p>3) Please provide some data and/or discussion about the possibility that the truncated Nnt allele in heterozygosis may generate an intermediate phenotype. (as suggested by Reviewer #1)</p></disp-quote><p>This is a good point and we have attempted to compare the foot swelling phenotype for 6N<sup>NntΔexon8-12</sup> homozygotes and heterozygotes. However, given the inherent variability in foot swelling, this is not a good model to obtain clear answers on intermediate phenotypes. We are currently exploring this issue in another model, specifically SARS-CoV-2 lethality in K18-hACE2 mice, where the phonotype is considerably less variable.</p><p>The issue is clearly also very pertinent to interpreting the implications of k-mer mining results, where we did not distinguish between homozygotes and heterozygotes. At the end of the k-mer mining section we have thus added:</p><p>“It is worth noting that herein we have only compared phenotypes of homozygotes (Figure 7a), with intermediate phenotypes potentially seen for heterozygotes (Ronchi et al., 2013). Our k-mer mining analysis also did not distinguish between <italic>Nnt<sup>+/+</sup></italic> and <italic>Nnt<sup>+/-</sup></italic>genotypes, doing so would require extraction of <italic>Nnt</italic> reads, alignment to the C3H/HeJ genome, and analysis using Sashimi plots (as in Figure 3d)”.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>– Although the text is very explanative, the excessive use of abbreviations (together with the absence of an abbreviation list since it is not required by the journal) make it sometimes difficult to read fluently.</p></disp-quote><p>We have added an abbreviation list that the journal can hopefully add as a footnote to address this issue. Unfortunately, this is a complex story with many players, with many abbreviations difficult to avoid.</p><disp-quote content-type="editor-comment"><p>– Nicotinamide nucleotide transhydrogenase is the name of the gene encoding the protein. Indeed, &quot;NNT&quot; has also been extensively used to refer to the protein. However, in enzyme databases the official name of this enzyme is proton-translocating NAD(P)+ transhydrogenase (EC 7.1.1.1). I suggest adding this information to the introduction.</p></disp-quote><p>Good point – added as requested.</p><disp-quote content-type="editor-comment"><p>– The Methods section does not seem logically organized.</p></disp-quote><p>We have reordered the Methods in order of the appearance of data in the figures.</p><disp-quote content-type="editor-comment"><p>– The presence of the truncated Nnt allele in heterozygosis may generate an intermediate phenotype (as suggested in PMID 27474736). Did the assessment carried out on SRA-NCBI data or even the GzmA-/- sequencing allow to detect heterozygous carriers?</p></disp-quote><p>We have discussed this issue and explained how heterozygotes might be identified using RNA-Seq data; however, as a screening approach this would require some extraordinarily large amount of computing power given the size of the SRA data base. We have now clarified that our K-mer mining approach does not provide insights into heter/homozygosity. See response to editor’s comments above.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Even though the conclusions of this paper are well supported by ample data, it would be more convincing if the authors could provide the following data.</p><p>Histological section of the feet of B6N, B6N-NntΔexon8-12, and B6J mice administered MitoTEMPO after infection with CHIKV to demonstrate the difference in leukocyte infiltration.</p></disp-quote><p>This data has been provided in new Figure 4c,d, 5c,d and Supplementary Figures 6 and 7. Please see responses to editor’s comments above.</p><disp-quote content-type="editor-comment"><p>The difference in ROS levels in T cells of mouse strains due to presence or absence of NNT activity.</p></disp-quote><p>Please see responses to editor’s comments above.</p><disp-quote content-type="editor-comment"><p>Validation of RNA-seq data by quantitative RT-PCR.</p></disp-quote><p>RNA-Seq is now a well characterized methodology and does not suffer from the limited dynamic range of microarray technology, where RT-PCR validation was frequently required. We should also note that we are not making claims regarding expression of any specific individual genes, but are using pathway analyses where the changes of a large number of mRNAs are combined. The only gene were we do make claims is <italic>Nnt</italic> and for this gene we have provided RT PCR data (Figure 3e). For GzmA we also provide protein expression data (Supplementary Figure 1e).</p><p>To perhaps address concerns to some extent, we have added our quality control approaches for the RNA-Seq in the Methods, which encompasses both RNA quality, as well as bioinformatic approaches including FastQC, RNAseqQC, with per base sequence quality for &gt;90% bases &gt;Q30 for all samples.</p><disp-quote content-type="editor-comment"><p>The authors should address whether or not is C57BL/6N-GzmaS211A knock-in mice is available to other researchers.</p></disp-quote><p>These GMO lines are available on request – we have added this to the Data code and mouse availability section.</p></body></sub-article></article>